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Abstract 
 
 
The present thesis describes the synthetic potential of 1,3-bis-silyl-enol ethers. They undergo 
regioselective cyclocondensation reactions with simple substrates providing various complex 
carba- and heterocycles. The TiCl4-mediated cyclocondensation with functionalized 
butenones afforded a variety of halogen-substituted salicylates, while the Me3SiOTf-mediated 
cyclocondensation afforded halogen-substituted γ-pyrones and cyclohexenones. A new type 
of formal [3+3]-cyclization reaction with 2,4,6-tris(trifluoromethyl)-1,3,5-triazine has been 
discovered. It provided a convenient approach to functionalized 2,6-
bis(trifluoromethyl)pyridones. The mechanism was studied by the isolation of an unusual 
bicyclic intermediate. The reactions with 3-methoxalylchromones and their derivatives afford 
a great variety of functionalised 2,4-dihydroxybenzophenones via isolation of an uncommon 
tricyclic intermediate. The products are promising candidates for novel UV-A/B filters.  
 
 
Kurzbeschreibung 
 
 
Die vorliegende Arbeit beschreibt das synthetische Potential von 1,3-Bis-silyl-enolethern. Sie 
durchlaufen regioselektive Cyclokondensationsreaktionen mit einfachen Substraten, um 
verschiedene komplexere Carbo- und Heterocyclen zu liefern. Die TiCl4-vermittelte 
Cyclokondensation mit funktionalizierten Butenonen lieferte eine Vielzahl von 
halogensubstituierten Salicylaten und Phenolen, während die Me3SiOTf-vermittelte 
Cyclokondensation halogensubstituierte γ-Pyrone und Cyclohexenone lieferte. Ein neuer Typ 
von formalen [3+3]-Cyclisierungen mit 2,4,6-Tris(trifluormethyl)-1,3,5-triazin ist entdeckt 
worden. Die Methode bietet einen bequemen Zugang zu funktionalisierten 2,6-
Bis(trifluormethyl)pyridonen. Der Mechanismus wurde durch die Isolierung eines 
ungewöhnlichen bicyclischen Zwischenprodukts untersucht. Die Reaktionen mit 3-
Methoxalylchromon und dessen Derivaten ergaben eine Vielzahl von funktionalisierten 2,4-
Dihydroxybenzophenonen und verlaufen über die Isolierung einer ungewöhnlichen 
tricyclischen Zwischenstufe. Die Produkte sind vielversprechende Kandidaten für neuartige 
UV-A/B Filter. 
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Chapter 1 
Preface 
1.1 Task and Motivation 
“Organic chemistry” is the science that shapes the life, it is everything we see, feel and 
odour. Initially, it was said that organic compounds exist only in living organism and cannot 
be synthesized. Therefore, scientists at that time named these compounds "organic". 
However, in 1828 the first organic substance, namely urea was synthesized by 
Friedrich Wöhler. This was the revolution of organic chemistry, followed later by the 
breakthrough of the concept of chemical structure. It was then clear that the “organic” 
compounds mainly contain the “inorganic” carbon and hydrogen atoms.  
Since then, millions of organic compounds have been synthesized. Organic chemistry 
is now not only creating the life but also supporting it. It is the chemistry that makes possible 
the manufacture of clothing, perfumes, soaps, creams, plastics, fibers, medications, 
insecticides and other products which make life more convenient.  
The last decade of the 19th century represented the breakthrough of the 
pharmaceutical chemistry with the first synthesis and manufacture of Aspirin® by Bayer. The 
beginning of the 20th century symbolized the progress of organic chemistry on highly 
complex molecules and natural compounds. In 1907 the total synthesis of camphor was 
realized, followed by the synthesis of human hormones. Biochemistry, the chemistry of living 
organisms, revolutionizes the end of the 20th century, beginning of the 21th century and the 
organic chemistry. 
The focus of the pharmaceutical industry is nowadays the construction of novel 
complex molecules with various functional groups and stereogenic centers that must be 
synthesized selectively with asymmetric synthesis. 
Therefore, the concept of building up biomolecules with pharmacological and biological 
activity has become a huge interest for organic chemists. Consequently, the present thesis 
relays on the synthesis, characterisation and optimisation of different heterocyclic 
substances, wich are understood to be pharmaceutical active. 
Biomolecules with fluorine-containing functional groups often show different 
physiologically activity than non-fluorinated analogues. The reason is the high 
electronegativity of the fluorine atom, compared for example to that of a hydrogen atom. This 
results in a noticeable change of the reactivity that can afford new drug-receptor interactions 
or restrict undesirable metabolic transformations. Some of the compounds in this thesis 
contain fluorine, like RF-substituted salicylates, γ-pyrones or benzophenones.  
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1.2 State of the art 
It is well known that simple cyclic and heterocyclic compounds are, for example, 
approachable by several cyclisation, condensation and Diels-Alder reactions. Though, it has 
to be taken into consideration that the synthesis of RF-substituted arenes and hetarenes is 
often a difficult task. Trifluoromethyl-substituted compounds have been prepared, for 
example, by the reaction of aryl halides with in situ generated trifluoromethylcopper [1] or by 
transformation of carboxylic acids [2] and C-halides [3] into CF3-groups. These reactions are 
often applicable only to specific substrates. 
Not more than a handful of organofluorine compounds occur in nature and even those 
occur just in small amounts. Consequently, any fluorine-containing substance selected for 
fundamental studies or promoted as a pharmaceutical, agrochemical or advanced material 
has to be hand-made. [4] Therefore, the development of new strategies for the synthesis of 
functionalized benzenes and heterocycles with polifluoralkyl groups located at specific 
positions is of considerable current interest. The new reported strategies are based on the 
use of RF-containing building blocks. [5]  
The research group of Prof. Langer accounted already new pathways for the synthesis 
of RF-substituted salicylates based on [3+3]-cyclizations of 1,3-bis-silyl enol ethers [6] with RF-
containing building blocks like: 4-ethoxy and 4-silyloxy-1,1,1-trifluoroalk-3-en-2-ones [7] or 
,β-unsaturated trifluoromethyl and perfluoroalkyl ketones [8]. The products were not readily 
available by other methods. Recently new routes have been reported for the synthesis of 
fluorine-containing derivatives of heterocycles like coumarines [9] and pyranones [10]. Though, 
the scope of this method is limited to products containing less or no functional group besides 
the RF-group.  
Electron deficient heterocyclic azadienes have proven to be useful reagents for Inverse 
Electron Demand Diels-Alder (IEDDA) reactions with electron-rich dienophiles, providing a 
rapid access to a wide range of highly substituted heterocyclic systems. [11] The IEDDA 
reaction of 2,4,6-tris(trifluoromethyl)-1,3,5-triazine (a masked azadiene) with electron 
excessive aromatic and heteroaromatic amines and enamines has been reported. [12] 
Therefore, this triazine is an interesting substrate for the chemistry of 1,3-bis-silyl enol 
ethers. [13] 
Therefore, reactions of new functionalized substrates with the 1,3-bis-silyl enol ether 
building blocks have been investigated. Additionally, the present thesis describes for the first 
time the influence of different Lewis acids on the product distribution of [3+3]-reactions 
involving 1,3-bis-silyl enol ethers. 
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Chapter 2 
1,3-Bis-silyl enol ethers as masked dianions for cyclization reactions 
2.1 Introduction 
The formation of carbon-carbon bonds is nowadays an important task for the modern 
organic chemist. Essential chemical reactions are carried up by the formation of carbon-
carbon bonds, producing many fundamental chemicals for industry and medicine, such as 
pharmaceuticals, plastic materials, dyes and cosmetics. 
Various reactions like polymerization, cycloaddition or metathesis use dienes or 
dianions A (Figure 2.1) as precursors for the regioselective formation of the C-C-bond. [14] 
Though, their high reactivity can also lead to undesired side products. To overcome this 
limitation, particular dienes, like the Danishefsky`s diene B (Figure 2.1) were developed. 
They are electron rich dienes, therefore very reactive reagents for the Diels-Alder reaction. A 
variety of aromatics and heterocycles are available by [4+2]-cyclisation of Danishefsky`s 
diene. [15] 
OMe
OSiMe3 OSiMe3
OMe
Me3SiO
A B
O
OMe
O
2Li+
OLi
OMe
OLi
C  
Figure 2.1: Dianions (A), Danishefsky`s diene (B) and Chan’s diene (C) 
The present thesis reveals the 1,3-bis-silyl enol ethers, like Chan’s diene C (Figure 
2.1), as equivalents of 1,3-dicarbonyl dianions (masked dianions) for cyclization reactions. [16] 
They react with electrophiles after a typical mechanistic pathway, beginning with the attack at 
the more nucleophilic carbon atom of the diene (terminal C-4 atom). These reactions are 
mediated by Lewis acids. Depending on the Lewis acid and the substitution pattern, the 
electrophile attacks at the central carbon (C-2) or at the oxygen atom of the diene (Scheme 
2.1).  
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Scheme 2.1: Cyclization reactions of masked dianions with dielectrophiles. E = electrophilic centre. 
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The 1,3-bis-silyl enol ethers 3 can be prepared from the respective 1,3-dicarbonyl 
compounds in one or two steps. Simchen et al. reported the one step synthesis of 3 starting 
from the respective diketone, dissolved in ether and treatment with NEt3 and Me3SiOTf 
(Method A, Scheme 2.2). [17] Following Chan and Molander ester-derived 1,3-bis-silyl enol 
ethers 3 were prepared in two steps over mono-silyl enol ethers 2. The respective β-
ketoester is treated with NEt3 and Me3SiCl to give 2, deprotonation with LDA and subsequent 
addition of Me3SiCl gave 3 (Method B, Scheme 2.2). [18]  
R2 = OAlkyl, OAryl, Alkyl
R2 = Alkyl, Aryl
R2
O O
R1
A
1
OSiMe3
R2
Me3SiO
R1
O
R2
Me3SiO
R1
B
2
3
 
Scheme 2.2: Methods for the synthesis of bis-silyl enol ethers 3: Simchen (A); i) NEt3 (2 equiv.), Me3SiOTf 
(2 equiv.), Et2O, 0 - 20°C and Molander (B); i) 1) NEt3 (1.6 equiv.), C6H6, 20°C, 2 h; 2) Me3SiCl (1.8 equiv.), 20°C, 
3 d; ii) 1) LDA (1.5 equiv.), THF, -78°C, 1 h; 2) Me3SiCl (1.8 equiv.), –78 - 20 °C, 12 h. 
2.2 Results and discussions 
The following chapters describe the reactions of masked dianions 3 with different 
substrates. Each reaction was well tested by control experiments with various R1 and R2. 
Variation of R2 was easier due to the commercial availability of β-ketoesters. Variation of R1 
requires first of all the synthesis of the respective β-ketoesters 1. Therefore, different β-
ketoesters were prepared by alkylation of 1,3-dicarbonyl dianions with alkyl halides after a 
known procedure. [19] The formation of a dianion as intermediate was necessary, due to the 
fact that monoanions are generally alkylated at the central carbon or at the oxygen atom, but 
not at the terminal carbon atom. They can be generated by reaction of the 1,3-dicarbonyl 
compounds in the presence of strong base, such as LDA. [20] 
The synthesized and the commercially available β-ketoesters were transformed, after 
the known procedure of Molander, into the 1,3-bis-silyl enol ethers 3 (Scheme 2.2). 
Reactions occurred with yields according to the literature and all products were already 
reported. 
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The 1,3-bis-silyl enol ethers 3 used for control experiments are listed in the following 
table. 
Table 2.1: 1,3-bis silyl enol ethers 3  
3 R1 R2 3 R1 R2 
a H OMe s nBu OEt 
b H OEt t nPent OMe 
c H OBn u iPent OMe 
d H OiPr v nHex OMe 
e H OnBu w nHept OEt 
f H OiBu x nOct OMe 
g H OiPent y nNon OMe 
h H OnOct z nUndec OMe 
i H O(CH2)2OMe aa nDodec OMe 
j Me OMe ab nTetradec OMe 
k Et OMe ac nHexadec OMe 
l Et OEt ad (CH2)2Ph OMe 
m OMe OMe ae (CH2)3Ph OMe 
n Cl OMe af (CH2)3Ph OEt 
o Allyl OMe ag (CH2)3Cl OMe 
p nPr OMe ah (CH2)4Cl OMe 
q iPr OEt ai (4-FC6H4)CH2 OMe 
r nBu OMe aj H Ph 
 
All prepared β-ketoesters were stable at room temperature. 1,3-Bis-silyl enol ethers 
were stored at -20°C under dry and inert gas atmosphere for several months without 
decomposition. 
2.3 Conclusions 
The described procedure allows the synthesis of 1,3-bis-silyl enol ethers as 
electroneutral 1,3-dicarbonyl dianions equivalents. These masked dianions can be used as 
reagent for cyclization reactions. The option of changing the alkyl rest and their high 
reactivity with many substrates containing key functional groups, gave the possibility to reach 
new heterocycles and aromatic rings for the natural product synthesis. This matter will be 
elaborated in the next chapters.  
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Chapter 3 
Salicylates vs. Pyrones vs. Cyclohexenones 
3.1 Introduction 
Acetylsalicylic acid (Figure 3.1), also known as Aspirin, is the most spread drug of the 
group of salicylates. They and their precursor the salicylic acid (Figure 3.1) possess 
analgesic, antipyretic and anti-inflammatory properties. Aspirin was the first discovered 
member of the class of non-steroidal anti-inflammatory drugs. Other prominent members of 
this group are Ibuprofen and Naproxen. They have the same mechanism of action by 
inhibition of the enzyme cyclooxygenase. The broad therapeutic uses and the minor side 
effects make Aspirin today one of the most used medications in the world. 
OH
OH
O
Salicylic acid
OH
O
Acetylsalicylic acid
O
O
Me
 
Figure 3.1: The most known salicylates. 
 
The γ-pyrone forms the central core of several natural compounds like maltol and kojic 
acid and of complex structures like chromones and flavones (Figure 3.2). Maltol is the 
natural organic compound that gives malt its sweet flavor. It is used as essence for 
fragrances and flavor enhancer for foods (E 636). Kojic acid, produced by some species of 
fungi, is a well-known tyrosinase (monophenol monooxygenase) inhibitor. Though, simple 
Kojic acid has insufficient inhibitory activity and stability and has low cell permeability. To 
enhance this, metal coordination compounds were prepared, since it is known that maltol 
and kojic acid are good chelation agents, binding to metal centers. [21]  
O O
O
OH
O
HO
OH
O
O
O
O
Maltol Kojic acid Chromone scaffold Flavone scaffold
O
O
-Pyrone  
Figure 3.2: Natural compounds with γ-pyrone core. 
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3.2 Results and discussions 
Recently, we have reported the TiCl4-mediated cyclocondensation of 1,3-bis-silyl enol 
ethers  3 with 4,4-dimethoxy-1,1,1-trifluorobut-3-en-2-one. These reactions provide a 
convenient and regioselective approach to 4-methoxy-6-(trifluoromethyl)salicylates. [22] In the 
present thesis, the influence of the Lewis acid on the product distribution of this reaction is 
discussed. To our surprise, the Me3SiOTf-mediated cyclization of 3 resulted in the formation 
of various γ-pyrones or cyclohexenoenes, depending on the substrates involved in the 
reaction. As a result, the reaction afforded the synthesis of different halogen-substituted 
salicylates, pyrones and cyclohexenones starting from same building blocks but using 
different Lewis acids.  
3.2.1 Preparation of the starting materials 
1,3-Bis-silyl enol ethers 3 were prepared in two steps starting from the corresponding 
β-ketoesters, after the description in chapter 2. Changing their substitution pattern and 
bringing them together with different substrates afforded various functionalized salicylates. 
Therefore, different butenones 8a-d (Scheme 3.1, Table 3.1) were synthesized. The 4,4-
dimethoxy-1,1,1-trifluorobut-3-en-2-one (8a), 4,4-dimethoxy-1,1-difluorobut-3-en-2-one (8b) 
and the 4,4-dimethoxy-1,1,1-trichlorobut-3-en-2-one (8c) were prepared by reaction of the 
respective acetic acid anhydride 5a-c with 1,1,1-trimethoxyethane 6 after a known 
procedure. [23] Anhydride 5a and 5b are commercially available. Only anhydride 5c required a 
one-step synthesis, starting from 2,2-difluoroacetic acid 4. [24] The synthesis of 4,4-
dimethylthio-1,1,1-trifluorobut-3-en-2-one 8d followed an alternative procedure starting from 
the commercially available 1,1,1-trifluoroacetone 7. [25] 
R3
O
O
O
R3i
CH3C(OMe)3
R4
R4 O
R3
R3
O
OH ii
4 5a-c
8a-d
O
CF3
7
iii
R4 = OMe
R4 = SMe
R3 = CF2H
2 x
6
 
Scheme 3.1:  Synthesis of 5c: i) P2O5, 140°C, 2 h. Synthesis of 8a-c: ii) pyridine, CH2Cl2, 0 - 20°C, 12 h. 
Synthesis of 8d: iii) 1) NaH, CS2, DMF, 0 - 20°C, 1 h; 2) MeI 0 - 20°C, 18 h. 
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Table 3.1: Synthesis of 8a-d. 
8 R3 R4 Yield a % 
a CF3 OMe 75 
b CF2H OMe 76 
c CCl3 OMe 60 
d CF3 SMe 44 
a Yields of isolated products. 
3.2.2 TiCl4-mediated cyclocondensation 
The TiCl4-mediated reaction of the dielektrophile 8 and the dinucleophile 3 afforded the 
salicylates 9 respectively 10 and the phenol 10ak in moderate yields (Scheme 3.2, Table 
3.2). 
R2
OSiMe3Me3SiO
8
R1
3
O
i
OH
R2
O
R1
9
OH
R2
O
R1
10
and/or
R4
R4
R3 R4 R3 R3 R4
 
Scheme 3.2: Synthesis of 9 and 10: i) TiCl4, CH2Cl2, -78 - 20°C, 12 - 14 h. 
The most reactions proceeded with very good regioselectivities, though, there are 
special cases were the regioselctivity was influenced by the steric effects of the substituents. 
The reaction of dienes 3j,u,ah,ad with enone 8c and the reaction of enone 8d with all 1,3-bis-
silyl enol ethers 3, containing a terminal substituent (R1≠H), afforded mixtures of 
regioisomers. Obviously the larger the terminal substituents R1 and R4 are the less 
regioselectivity is observed, which can be explained by the increased steric effects of bigger 
substituents (Scheme 3.3, Table 3.2).  
OH
R2
O
R3
OH
R2
O
R3R
4
R1
R4
R1
thermodynamically unstable thermodynamically stable  
Scheme 3.3: Regioisomer formation due to steric effects. 
The CF3-group of salicylates 9a-q is located on ortho position to the ester group, while 
for salicylates 10aj-10aq the CF3-group is on para position to the ester group (Scheme 3.4). 
Obviously, the change in the regioselectivity is a result of the replacement of the methoxy 
group by methylthio group in the 1,1,1-trifluorobut-3-en-2-one. This fact proposes different 
 16 
Chapter 3: Salicylates vs. Pyrones vs. Cyclohexenones 
mechanistic pathways. Apparently, the addition of 1,3-bis-silyl enol ethers to keteneacetals 
proceeds by a 1,4-pathway, while the addition to thioketeneacetals occurs by 1,2-addition. [26] 
Another reason might be the fact that the thio group is larger than the methoxy group. 
ortho
9a-q
para
10aj-10aq
OH
R2
O
R1
CF3MeO
OH
R2
O
R1
SMeF3C
 
Scheme 3.4: OMe vs. SMe substitution pattern. 
Table 3.2: Synthesis of 9 and 10. 
3 8 R1 R2 R3 R4 9/10 9:10 Yield a % 
a a H OMe CF3 OMe 9a - 47b 
b a H OEt CF3 OMe 9b - 34b 
c a H OBn CF3 OMe 9c - 32b 
d a H OiPr CF3 OMe 9d - 36b 
i a H O(CH2)2OMe CF3 OMe 9e - 35b 
j a Me OMe CF3 OMe 9f - 34b 
l a Et OEt CF3 OMe 9g - 44b 
o a Allyl OMe CF3 OMe 9h - 42b 
p a nPr OMe CF3 OMe 9i - 41b 
r a nBu OMe CF3 OMe 9j - 40b 
v a nHex OMe CF3 OMe 9k - 30b 
x a nOct OMe CF3 OMe 9l - 30b 
z a nUndec OMe CF3 OMe 9m - 30b 
ad a (CH2)2Ph OMe CF3 OMe 9n - 38b 
ae a (CH2)3Ph OMe CF3 OMe 9o - 43b 
m a OMe OMe CF3 OMe 9p - 50b 
ag a (CH2)3Cl OMe CF3 OMe 9q - 57b 
a b H OMe CF2H OMe 9r - 35 
b b H OEt CF2H OMe 9s - 33 
c b H OBn CF2H OMe 9t - 30 
d b H OiPr CF2H OMe 9u - 58 
e b H OnBu CF2H OMe 9v - 37 
g b H OiPent CF2H OMe 9w  24 
i b H O(CH2)2OMe CF2H OMe 9x - 30 
j b Me OMe CF2H OMe 9y - 10 
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a c H OMe CCl3 OMe 9z - 30 
c c H OBn CCl3 OMe 9aa - 30 
j c Me OMe CCl3 OMe 9ab + 10ab 1:0.1 42 
k c Et OMe CCl3 OMe 9ac - 46 
o c Allyl OMe CCl3 OMe 9ad - 32 
u c iPent OMe CCl3 OMe 9ae + 10ae 1:0.3 41 
ag c (CH2)3Cl OMe CCl3 OMe 9af - 45 
ah c (CH2)4Cl OMe CCl3 OMe 9ag + 10ag 1:0.2 35 
ad c (CH2)2Ph OMe CCl3 OMe 9ah + 10ah 1:0.2 60 
ai c (4-FC6H4)CH2 OMe CCl3 OMe 9ai - 20 
a d H OMe CF3 SMe 10aj - 52c 
b d H OEt CF3 SMe 10ak - 51c 
c d H OBn CF3 SMe 10al - 51c 
d d H OiPr CF3 SMe 10am - 56c 
f d H OiBu CF3 SMe 10an - 49c 
g d H OiPent CF3 SMe 10ao - 56c 
h d H OnOct CF3 SMe 10ap - 55c 
aj d H Ph CF3 SMe 10aq - 39c 
j d Me OMe CF3 SMe 9ar +10ar 0.1:1 69c 
k d Et OMe CF3 SMe 9as +10as 0.1:1 54c 
p d nPr OMe CF3 SMe 9at + 10at 0.1:1 39c 
q d iPr OEt CF3 SMe 9au +10au 0.4:1 50c 
r d nBu OEt CF3 SMe 9av+10av 0.5:1 30c 
t d nPent OEt CF3 SMe 9aw + 10aw 1:1 36c 
w d nHep OEt CF3 SMe 9ax+ 10ax 0.7:1 34c 
x d nOct OMe CF3 SMe 9ay + 10ay 0.7:1 50c 
o d Allyl OMe CF3 SMe 9az + 10az 0.5:1 44c 
ag d (CH2)3Cl OMe CF3 SMe 9ba + 10ba 0.4:1 54c 
ae d (CH2)3Ph OEt CF3 SMe 9bb + 10bb 1:1 23c 
a Yields of isolated products. 
b Yields already reported. [27] 
c Yields obtained during master thesis support. [28] 
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Having established the 1,2-addition as the major mechanistic pathway for the reaction 
of dithioketeneacetal 8d, it was interesting to study the reaction of 8d with 1,3-bis-silyl enol 
ethers 3 containing a terminal substituent. As described, the regioselectivity of the 
nucleophilic attack depends on the steric effects of the substituents. In fact, the 
regioselectivity dropped, allthough the 1,2-attack was still dominant. The reactions afforded a 
mixture of salicylates 9ar-9bb (1,4-addition) and salicylates 10ar–10bb (1,2-addition) in 
variable conversions (23–69%) and proportions (Table 3.2). Additionally, the less reactive 
benzoyl acetone derived diene 3aj gave the benzophenone 10aq with 39% yield.  
The reaction of enone 8b with terminal substituted diene 3 did not take place. 
Therefore the synthesis of C-3 substituted CF2H-salicylates (R1≠H) was not possible 
(Scheme 3.5). The terminal carbon atom C-4 of the 1,3-bis-silyl enol ethers 3 has the highest 
electron density and the C-3 carbon atom of butenones 8 has the lowest electron density. 
The substituents R1-R4 have strong influence on the electronic state of these molecules and 
on the product distribution. For instance, replacing the CF3-group with the CF2H-group leads 
to a weaker electron withdrawing effect and to a higher electron density at the C-3 atom of 
the butenone. This leads to a reduced electropilicity of the butenone. This fact and the steric 
hindrance of R1, could explain why the synthesis C-3 substituted 6-difluoromethyl-4-
methoxysalicylates (R1≠H) failed. 
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Scheme 3.5: CF3 vs. CF2H; inductive effect on the electronic state of the enone 8. 
 
The optimization of the reaction showed that the temperature and the stoichiometry 
play an important role. Best yields were obtained when the reaction took place under cooling 
conditions (-78 - 20°C), with excess of silyl enol ether 3 (2.0 equiv) and high concentrated 
solution (Table 3.3). The optimization of 9a has been already reported. [29] 
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The moderate yields can be explained by a possible hydrolysis or TiCl4-mediated 
oxidative dimerization of diene 3. This type of process has been previously reported. [30] The 
reaction control by TLC-method shows a small amount of β-ketoester formed by hydrolysis of 
the remaining excess of diene 3. Its chromatographic separation from the product was 
difficult in some cases. Therefore, practical problems during the chromatographic purification 
also influenced the yields.  
The products are stable at 20 °C for several months without decomposition. No 
sensitivity against air or water was observed. 
 
Table 3.3: Optimization of the synthesis of 9u, 9z and 10am. 
 Ratio of 8:3 (mmol) CH2Cl2 
(mL) 
Yield a 
(%) 
9u 1:2 2 48 
1:1 5 38 
1:2 5 58 
1:3 5 42 
1:2 10 55 
9z 1:2 1 28 
1:1 2 10 
1:2 2 30 
1:3 2 25 
1:2 5 27 
10am 1:1 0 26 
1:1 1 33 
1:2 1 56 
1:3 1 21 
1:2 2 38 
1:2 5 39 
a Yields of isolated products. 
3.2.2.1 Structure identification 
All structures were confirmed by spectroscopic methods NMR, IR, mass spectrometry 
and elemental analysis. The hydroxyl protons showed low field 1H-NMR shifts (12 ppm), 
indicating that the protons were involved in intramolecular hydrogen bond with the ester 
group (Scheme 3.6). This seemed not to be the case for the benzophenone 10aq. The shift 
to a higher field (8 ppm) indicated the absence or weakness of the hydrogen bond. In 
addition, long-range couplings were observed between protons H-3 and H-5 of C-3-
unsubstituted salicylates (4JH,H ~ 3 Hz). The CF2H-group appeared as a triplet at ca. 7 ppm 
(2JH,F ~ 56 Hz). 
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Scheme 3.6: Observations from 1H-NMR spectra. 
The 13C-NMR Spectroscopy confirmed the structures of RF-substituted salicylates 10 
and 9. Long-run 13C-NMR analysis gave spectra with typical triplets and quartets and 
expected 1JC,F 2JC,F, 3JC,F coupling constants. The CF2H moiety appears as a triplet at ca. 
112 ppm with a coupling constant 1JC,F ~ 238 Hz. A triplet with 3JC,F = 4.0 Hz was observed 
for carbon atom C-1 clearly showing that the CF2H-group is located ortho to the ester group 
(A, Scheme 3.7). There is no proof that the CF2H-group is located at carbon atom C-4, since 
there is no 3JC-F–coupling to C-3. In fact, there exists a 5JC-F-long-range-coupling to C-3 of ca. 
2 Hz.  
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Scheme 3.7: Observations from 13C-NMR spectra. 
Quartets of a quaternary carbon were observed at 123 ppm, with 1JC-F coupling 
constants of approximately 273 Hz, indicating the CF3-group. Long-run 13C-NMR spectra of 
compounds 10aj-bb show no couplings to carbon atom C-1. According to DEPT-experiments 
there are two quartets (3JC-F = 4 Hz) of two tertiary C-atoms that match to C-3 and C-5. 
Conclusively, C-3 unsubstituted thiosalicylates have the CF3-group on para position to the 
ester group (B, Scheme 3.6).  
Furthermore, the structures of 9u and 10am were confirmed by 2D NMR experiments 
(NOESY and HMQC). The correlations are shown in Scheme 3.8. The NOESY-experiment 
shows a weak correlation between the proton of the CF2H-group and the CH-group of the 
ester moiety (9u). NOESY-correlations were also observed between proton H-3 and the 
hydroxyl proton. In the HMQC-experiment, proton H-3 gives cross-peaks with carbon atom 
C-3, which appears as a broad singlet due to the C-F-long-range-coupling (9u) or as a 
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quartet (10am), respectively. Proton H-5 correlates with carbon atom C-5, which appears as 
a triplet resp. quartet. 
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Scheme 3.8: Observations from NOESY and HMQC experiments. 
 
The 19F-NMR spectra show duplets for the CF2H-group that appear at ca. -113 ppm 
(2JF,H ~ 56 Hz). The CF3-group appears as a singlet at ca. -60 ppm. The theoretical shifts for 
CF3 attached to aromatics are at -64 ppm. [31] 
IR spectra confirm the presence of the OH and aromatic CH-groups, showing weak to 
middle intensive bands at ~ 3000 cm-1. Strong C=O stretching bands are observed at 1650 – 
1730 cm-1. 
The structures of 9z, 9ac, 10aj and 10aq were independently confirmed by X-ray 
crystal structure analysis (Table 3.4). [32] The lengths of the aromatic double bonds are as 
expected ca. 1.39 Å and the aromatic angles 118 - 120° reach the theoretical value. 
Interesting are the values of the torsion angle O1-C7-C1-C2 between the oxygen atom of the 
ester group and the aromatic ring. While for compounds 9z, 9ac and 10aj the torsion angle of 
12 - 37° allows the formation of H-bonds O3H3     O1 with lengths from 1.72 - 1.94 (near to 
theoretical length), for 10aq the 81° torsion angle makes the O1-H2 distance too long for a 
H-bond (Table 3.3). This remark matches with the observations from the 1H-NMR 
experiment.  
Table 3.3: Torsion angle and H-bond length.  
 9z 9ac 10aj 10aq 
Torsion angle (°) 34 37 12 81 
H-bond (Å) 1.94 1.88 1.72 3.81 
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Table 3.4: Crystal structures of salicylates 9z, 9ac, 10aj, 10aq.  
Crystal structure Compound Structure 
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3.2.2.2 Mechanistic pathway 
The addition of 1,3-bis-silyl enol ethers to keteneacetals proceeds by a 1,4-pathway, 
while the addition to thioketeneacetals occurs by 1,2-addition. 
The regioselective formation of salicylates 9 can be explained by reaction of 8 with 
TiCl4 as a Lewis acid, to give cation A containing an allylic carbon unit, followed by 1,4-
addition of the terminal carbon atom of 3 onto the β-carbon atom of A (intermediate B) and 
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subsequent cyclization by attack of the central carbon atom of the bis-silyl enol ether onto the 
activated carbonyl group of 8 giving intermediate C. Aromatization follows giving 9 (Scheme 
3.9). 
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Scheme 3.9: Possible mechanism of the formation of 9 and 10. 
 
The formation of the other regioisomer 10, proceeds by 1,2-addition of the terminal 
carbon atom of 3 onto the activated carbonyl group of A (intermediate D), cyclization 
(intermediate E), and subsequent aromatization under mild acidic conditions.  
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3.2.3 Me3SiOTf-mediated cyclocondensation 
The reaction of butenones 8 with 1,3-bis-silyl enol ethers 3, carried out in the presence 
of Me3SiOTf, instead of TiCl4, resulted in the formation of γ-pyrones 11 or cyclohexenones 12 
and 13, depending on the substituents R1, R3 and R4 (Scheme 3.10, Table 3.5). 
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Scheme 3.10: Synthesis of 11, 12 and 13: i) Me3SiOTf, CH2Cl2, -78 - 20°C, 12-14 h. 
 
The Me3SiOTf-mediated reactions of 8a,b with 1,3-bis-silyl enol ethers containing no 
terminal substituent (R1 = H), provided γ-pyrones 11a-g. The reaction conditions were 
optimized for the synthesis of derivatives 11d and 11g (Table 3.6). The yield could be 
significantly improved when the reaction was carried out in a more dilute solution, on the 
contrary to the TiCl4-mediated syntheses of salicylates 3, that was carried out in a highly 
concentrated solution. 
 
Table 3.6: Optimization of the synthesis of 11d,g,i and 12i. 
 Ratio of 8:3 
(mmol) 
CH2Cl2 
(mL) 
Yield a(%) 
11 12 
11d 1:2 1 42 0 
1:2 2 50 0 
1:2 10 64 0 
1:2 15 60 0 
1:1 15 31 0 
11g 1:2 5 34 0 
1:2 10 60 0 
1:2 15 55 0 
11i/12i 1:1 2 10 15 
1:2 5 24 19 
1:1 10 9 20 
1:2 10 12 38 
1:3 10 10 12 
1:2 15 12 26 
a Yields of isolated products 
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On the one hand, the Me3SiOTf-mediated reactions of 8b with 1,3-bis-silyl enol ethers
that contain an alkyl group located at carbon C-4 of the diene moiety (R1≠H), afforded also 
the γ-pyrone 11h. On the other hand, the reaction of 8a under same conditions provided the 
cyclohexenones 12i-q. Alone the cyclization of 8a with diene 3j was of special interest 
because both γ-pyrone 11i (12%) and cyclohexenone 12i (38%) could be isolated. This can 
be explained by the fact that the steric influence of the methyl group (R1 = Me) is relatively 
small. The influence of the reaction conditions on the product distribution was studied also for 
this reaction (Table 3.6). The best yield for 12i was observed when 2.0 equiv of diene 3j was 
used and when the cyclization was carried out in a relatively dilute solution.  
 
Table 3.5: Synthesis of 11, 12 and 13. 
3 8 11/12/13 R1 R2 R3 R4 Yield a % 
11 12 13 
a a a H OMe CF3 OMe 63 0 0 
b a b H OEt CF3 OMe 69 0 0 
c a c H OBn CF3 OMe 32 0 0 
d a d H OiPr CF3 OMe 64 0 0 
f a e H OiBu CF3 OMe 64 0 0 
i a f H O(CH2)2OMe CF3 OMe 40 0 0 
b b g H OEt CF2H OMe 60 0 0 
p b h nPr OMe CF2H OMe 32 0 0 
j a i Me OMe CF3 OMe 12 38 0 
k a j Et OMe CF3 OMe 0 50 0 
t a k nPent OEt CF3 OMe 0 39 0 
u a l iPent OMe CF3 OMe 0 55 0 
w a m nHep OEt CF3 OMe 0 35 0 
x a n nOct OMe CF3 OMe 0 62 0 
y a o nNon OMe CF3 OMe 0 57 0 
aa a p nDodec OMe CF3 OMe 0 58 0 
ab a q nHexdec OMe CF3 OMe 0 54 0 
a d r H OMe CF3 SMe 0 0 39 
e d s H OnBu CF3 SMe 0 0 52 
g d t H OiPent CF3 SMe 0 0 36 
h d u H OnOct CF3 SMe 0 0 34 
a Yields of isolated products 
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Starting with 8d and dienes 3a,e,g,h, which do not contain a terminal substituent (R1 = 
H), the CF3-substituted cyclohexenones 13r-u, which are regioisomeric to 12i-q, were 
obtained. Obviously, the change in the regioselectivity was again a result of the replacement 
of the methoxy group by methylthio group and the 1,4-addition vs. 1,2-addition in the 
mechanistic pathways. In contrast to the formation of products 9 and 10, no elimination of the 
hydroxyl group and aromatization occured when the Me3SiOTf was used (Scheme 3.11). 
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Scheme 3.11: Regioselctivity of 12 vs. 13. 
 
3.2.3.1 Structure identification 
The structures were confirmed by modern analytic methods like NMR, IR, mass 
spectrometry and elemental analysis. Characteristic for γ-pyrones are the 1H-NMR signals of 
H-3 and H-5 protons (Scheme 3.12), which appear as doublets in the range of δ ~ 6 ppm 
with 4JH,H ~ 3 Hz. The CF2H-group appears as a triplet at ca. 6 ppm. 
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Scheme 3.12: Observations from 1H-NMR spectra. 
Long-run 13C-NMR-Spectroscopy showed typical quartets for the CF3–substituent and 
triplets for the CF2H-substituent with expected 1JC,F, 2JC,F, 3JC,F coupling constants. Quartets 
of a quaternary carbon were observed at 118 - 120 ppm, with 1JC,F coupling constants of 
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approximately 272 Hz and triplets of a tertiary carbon at 108 ppm, with 1JC,F coupling 
constants of approximately 241 Hz, indicating the CF3 and CF2H-group, respectivly. The 
presence of the α-CH2-group was clearly confirmed by DEPT experiments.  
While the 19F-NMR signals of salicylates appear at ca. -60 ppm for CF3-substitution and 
at 113 ppm for CF2H-substitution, the signals of γ-pyrones appear at ca. -70 resp. -123 ppm. 
This shift to lower field can be explained by the fact that the CF3 and CF2H-group of the γ-
pyrones are located in the neighbourhood of the ring oxygen atom.  
Cyclohexenones 12i-q showed interesting 1H-NMR spectra with two characteristic 
dublets in the range of δ = 2.80 - 3.10 ppm for protons H-5 (2JH,H ~ 17 Hz) (Scheme 3.13). 
Their regioisomers, the C-3 unsubstituted thiocyclohexenones 13r-u, showed multiples for 
the two protons of H-5 due to the 1H,1H-long-range-couplings to proton H-3. The proton of the 
OH-group appeared as a singlet at δ ~ 5.6 ppm. The chemical shift suggests that there is a 
weaker or no intramolecular hydrogen bond to the keto group.  
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Scheme 3.13: Observations from 1H-NMR spectra. 
The structures of 11a, 12i, and 13r were independently confirmed by X-ray crystal 
structure analysis (Table 3.4). [32] As expected, the cyclohexoneone ring is not planar and the 
double bonds are 1.35 Å long, shorter than the aromatic double bonds. 
The X-ray structure of 12i clearly proved the relative configuration of this molecule. The 
hydroxyl and the ester group are located cis to each other and the distance O5H5     O1 is 2.2 
Å long (Scheme 3.14). The theoretical weak intramolecular hydrogen bond corresponds to 
the NMR observations. 
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Scheme 3.14: Relative configuration of 12i. 
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Table 3.7: Crystal structures of 11a, 12i, 13r. 
Crystal structure Compound Structure 
 
11a 
O
OMe
O
O CF3  
 
12i 
O OMe
O
MeO CF3
O
H
H
 
 
13r 
O O
OMe
F3C SMe
HO
 
 
Under the conditions of GC-MS, elimination of water from cyclohexenones 12 and 13 
was observed and only the molecular ions of the aromatized products could be detected. The 
correct molecular ions were observed when the measurements were carried out using the 
milder EI (electron ionization) or ESI technique (electrospray ionization). 
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3.2.3.2 Mechanistic pathway 
The formation of cyclohexenones 12i-q and 13r-u can be explained by a mechanism 
related to the one suggested for the formation of products 9 and 10 (Scheme 3.9 and 
Scheme 3.15). 
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Scheme 3.15: Possible mechanism for the formation of 12 and 13. 
 
Activated diene 8a (Intermediate A) reacts with 3 by 1,4-addition on the terminal 
carbon atom giving intermediate B. Cyclization follows, by attack of the central carbon atom 
of the 1,3-bis-silyl enol ethers onto the activated carbonyl group of 8a giving intermediate C. 
In contrast to the formation of salicylates 9, no elimination of the hydroxyl group and 
aromatization occurs. This result is surprising since the aromatization should be a facile 
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process. It is assumed that intermediate C (Scheme 3.9), containing a titanium alkoxide 
moiety, readily undergoes an elimination of TiCl3OH and aromatization. On the other side, 
the intermediate C (Scheme 3.15) containins a Me3Si protecting group, which is more stable. 
Accordingly, the addition of hydrochloric acid (10%), during the aqueous work up, resulted in 
the cleavage of Si-O bond giving 12i-q. No cleaveage of C-O bond and no aromatization 
occurred. Salicylates 9 were not observed. 
The formation of the other regioisomer 13r-u, proceeds by 1,2-addition of the terminal 
carbon atom of 3 onto the activated carbonyl group of A (intermediate D), cyclization 
(intermediate E) and once more no elimination to 10.  
Due to the novelty of the described reactions, further investigations are necessary in 
order to establish a mechanistic pathway. For the formation of γ-pyrones there are also two 
assumed mechanisms (Scheme 3.16). 
Pathway A: The reaction follows the mechanistic type of a formal and sequential [4+2] 
cyclization. Accordingly, the regioselective formation of the product can be explained by the 
attack of the terminal carbon atom of 8 onto A (intermediate B), followed by the activation of 
the electrophiliic center of the butenone (intermediate F) and the subsequent attack of the 
oxygen atom of 8. Elimination follows under mild acidic conditions giving 11a-i. 
Pathway B: The reaction follows the mechanistic type of 3+3-cyclization reactions. It 
is assumed that the C3-C4-bond of the diene in intermediate B rotates, making possible the 
cyclization via the oxygen of the 1,3-bis-silyl enol ethers (intermediate H). The elimination of 
silanol results in the formation of γ-pyrone 11a-i.  
The formation of cyclohexenones 12i-q rather than γ-pyrones can be explained by the 
steric influence of the R1 substituent (R1 = Allyl), leading to a change of the conformation of 
the intermediate H with regard to B. As mentioned before, the influence of the methyl group 
(R1 = Me) is relatively small making the isolation of both cyclohexenone and pyrone possible.  
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Scheme 3.16: Possible mechanism of the formation of 11a-i. 
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3.2.4 Other Lewis Acids 
The influence of different Lewis acids on the product distribution and mechanism of the 
1,3-bis-silyl enol ether reactions is now under intensive investigation, including calculations 
an in situ IR-Spectroscopy. The first efforts toward increasing the yields, regisoselectivities 
and chemoselectivities were tried on the substrate 8d. When the reaction of 8d with 3a,b 
was mediated by AlCl3 (1.0 equiv) in CH2Cl2, salicylates 10aj,ak were isolated with higher 
yields (75–80%). Unfortunately the reaction with other 1,3-bis-silyl enol ether gave no results. 
Only the terminal substituted diene 3j (R1 = Me) under AlCl3 conditions provided the stable 
cyclohexenone 12v with 52% yield. The structure was similar to the one observed for the 
other cyclohexenones 12 and so regioselective to 13 (Scheme 3.17). Attempts to synthesize 
other derivatives 12 in the presence of AlCl3/THF as well as salicylates 10 using BF3/DCM or 
ZnCl2/THF failed. 
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Scheme 3.17: AlCl3 vs. Me3SiOTf: i) AlCl3, CH2Cl2, -78 - 20°C, 14 h. ii) Me3SiOTf, CH2Cl2, -78 - 20°C, 12-14 h. 
The X-ray crystal structure analysis of 12v [32] attested the relative configuration of the 
molecule. The hydroxyl and the ester group are located cis to each other and an 
intramolecular hydrogen bond O4H4….O2 (2.1 Å) is present (Table 3.8). The mechanism 
follows the 1,4-addition pathway like 12i-q. The change of the reaction route can be 
explained by the steric influence of the methyl group. 
Table 3.8: Crystal structure of 12v. 
Crystal structure Compound Structure 
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3.3 Applications 
The large diversity of products offers a broad follow up chemistry. For example, the 
methoxy group can be deprotected (BBr3) and subsequently functionalized (via the 
corresponding triflate) by palladium(0)-catalyzed cross-coupling reactions. Alkylation or 
coupling reactions of OH-group could provide interesting building block for the synthesis of 
more complex compounds. Derivates 10aj and 9z were alkylated with 2-
bromoacetophenone, 2-(bromomethyl)oxirane or methyl bromoacetate, after a known 
procedure [33], to give ether derivatives 14–17 with 31–99% yields (Scheme 3.18).  
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Scheme 3.18: Applications of 9z and 10aj: i) K2CO3 , acetone, 55°C, 8 h; ii) MeONa, MeOH / CH2Cl2, 50°C, 6 h. 
Recently, derivatives of ortho-acylated phenols and thiophenols were used for the 
synthesis of benzofurans and benzothiophenes. [34] Therefore derivate 16 represented an 
interesting building block for the formation of a benzofuran. Cyclization took place after 6 h 
heating in methanol in the presence of sodium methoxide giving bezofuran 18 with 31% 
yield.  
  
 34 
Chapter 3: Salicylates vs. Pyrones vs. Cyclohexenones 
3.4 Conclusions 
The influence of different Lewis acids on the formal [3+3]-cyclocondensation of 1,3-bis-
silyl enol ethers with different halogenated butenones was described for the first time. The 
TiCl4-mediated reaction afforded a variety of functionalized salicylates (9 and 10, Scheme 
3.20). Depending on the substituents of the butenone and diene the regioselectivity was 
either very good or droped at all.  
The Me3SiOTf-mediated reaction was also influenced by the steric or the inductive 
effect of the substituents. Cyclization via the oxygen atom of the diene formed γ-pyrones 
(11), while cyclization via carbon atom afforded cyclohexenones (12, 13). Allthough some 
butenones afforded regioisomers, the reactions took place mostly with very good 
regioselectivities. The influence of the AlCl3 on the regioselectivity of the cyclization remains 
unclear. Deeper investigations with these and other lewis acids are in progress. 
The products constitute an important structural subunit of a variety of biologically active 
compounds, which are not readily available by other methods. They could serve as versatile 
and useful building blocks in the construction of functionalized heterocycles bearing a 
trifluoromethyl group. 
R2
OSiMe3Me3SiO
R1
3
Me3SiOTf
TiCl4 AlCl3
OH
R2
O
R1
R3 R4
OH
R2
O
R1
R4 R3
8a,b,c,d
8c,d
9
10
OH O
R2
R1
R4 R3
8d
O
R2
O
R1
R4 R3
8d
R1=H
O
R2
O
R1
O R3
8a, R1=H
8b
O
R2
O
R1
R4 R3
OH
OH
8a
O
R2
O
R1
R3 R4
8d
HO
11 12 13
12
10
 
Scheme 3.20: TiCl3 vs. AlCl3 vs. Me3SiOTf 
 
 
 35 Chapter 4: 1,3-Bis-silyl enol ethers as dienophiles for a novel type of reaction 
Chapter 4 
1,3-Bis-silyl enol ethers as dienophiles for a novel type of reaction 
4.1 Introduction 
By virtue of its excellent chemo-, regio- and diastereoselectivity, the Diels-Alder (DA) 
reaction is one of the most important and elegant methods for the construction of six 
membered ring compounds. Diels-Alder reactions can be classified into three types: (I) 
Normal HOMOdiene-controlled, (II) Neutral and (III) LUMOdiene-controlled or inverse electron 
demand Diels-Alder (IEDDA) reactions. [35] 
Nitrogen containing compounds are one of the most spread in nature, like for example 
the alkaloids. Therefore, they are important building blocks for the synthesis of potential 
medicinally active substances or natural compounds. Electron-deficient azadienes proved to 
be useful reagents for IEDDA reactions with electron-rich dienophiles, giving a rapid access 
to a wide range of highly substituted nitrogen containing heterocyclic systems. [36] Therfore, 
IEDDA reactions gained a wide popularity as synthetic tool for the assembly of complex 
carbocyclic and heterocyclic products [37] as well as natural products [38] and drug-like 
scaffolds [39]  
It is known that the Diels-Alder reaction accelerates when the energy separation 
between HOMO (Highest occupied molecule orbital) and LUMO (Lowes unoccupied 
molecule orbital) decreases. The electronic influence of the substituents of the diene and 
dienophile affects the molecule orbital energy separation. In the normal Diels-Alder reaction 
(type I), electron-donating groups on the diene and electron-withdrawing groups on the 
dienophile increase the reaction rate. In type III, namely the IEDDA reactions, the electronic 
effect of the substituents is the reverse of those of type I. 
Therefore, several strategies were investigated to accelerate the participation of 
electron-deficient heterocyclic azadienes in IEDDA reactions. For example, additional 
substitution of the heterocyclic azadiene system with electron withdrawing groups increase 
the electron-deficient nature of the diene and permits the use of electron-rich, strained, or 
even simple olefins as dienophiles. [40] For example, CF3-containing electron poor 
heterocyclic masked azadienes, such as 3,6-bis(trifluoromethyl)-1,2,4,5-tetrazine and 3,6-
bis(trifluoromethyl)-1,2,4-triazine, were recently explored for the assembly of heterocyclic and 
carbocyclic frameworks. [41] It was also reported that the IEDDA reaction of 2,4,6-
tris(trifluoromethyl)-1,3,5-triazine with electron-excessive heteroaromatic amines, anilines, 
and enamines gave annulated 2,6-bis(trifluoromethyl)pyrimidines including important purine 
scaffolds. [42] Their reactions with dienophiles generally involved the formation of a bridged 
intermediate.  
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Based on these results and on the experience with the chemistry of 1,3-bis-silyl enol 
ethers, it was motivating to study the reaction with 2,4,6-tris(trifluoromethyl)-1,3,5-triazine. 
This reaction can produce a novel synthetic access to 2-(2,6-bis(trifluoromethyl)pyrimidin-4-
yl)acetate derivatives (21, Scheme 4.1), which was not yet reported in the literature. 
4.2 Results and discussions 
Surprisingly, the reaction of 2,4,6-tris(trifluoromethyl)-1,3,5-triazine 19 with 1,3-bis-silyl 
enol ethers 3 followed an unusual pathway and led to the formation of γ-pyridone 20 instead 
of expected pyrimidine 21. Encouraged by this finding, the scope, the limitations and the 
mechanism of the new cyclization reaction were investigated. 
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Scheme 4.1: Synthesis of 20: i) 1) Me3SiOTf, CH2Cl2, -78 - 20°C, 12 h; 2) 10% HCl; 3) EtOH, 50 -60°C, 10-25 h 
The reaction was carried out in three steps to give 2,6-bis(trifluoromethyl)-1,4-dihydro-
4-oxopyridines 20a–j in good yields and with very good chemoselectivity (Table 4.2). The 
yield was significantly improved when in the first step, a CH2Cl2 solution of the reaction 
mixture was stirred in the presence of Me3SiOTf with slow warming from -78 to 20 °C during 
12-14 h. In the third step, an ethanol solution of the crude product was heated at 50-60 °C. 
The reflux at 80°C instead of only heating resulted in a dramatic decrease of the yield and 
the formation of several unidentified products. The use of Me3SiOTf proved to be important; 
the yield decreased to 30% when the reaction was carried out in the absence of Me3SiOTf 
(Table 4.1). 
Table 4.1: Optimization of the synthesis of 20a. 
Ratio 19 : 3 : Me3SiOTf % (20a)a 
1 : 2 : 0 30 
1 : 2 : 1 78 
a Yields of isolated products   
 37 
Chapter 4: 1,3-Bis-silyl enol ethers as dienophiles for a novel type of reaction 
Table 4.2: Yields of 2,6-bis(trifluoromethyl)-1,4-dihydro-4-oxopyridines 20a-n. 
20 3 R1 R2 % (20) a 
a a H OMe 78 
b b H OEt 95 
c c H OBn 57 
d d H OiPr 64 
e f H OiBu 69 
f g H OiPent 40 
g h H OnOct 54 
h i H O(CH2)2OMe 77 
i j Me OMe 35 
j k Et OMe 23 
k n Cl OMe 0 
l ad (CH2)2Ph OMe 0 
m ag (CH2)3Cl OMe 0 
n ah (CH2)4Cl OMe 0 
a Yields of isolated products. 
The reactions of dienes containing no substituent located at carbon C-4 proceeded with 
very good yields (20a-j). The yields decreased for dienes 3j and 3k having a methyl or an 
ethyl group at carbon C-4 of the diene. No product could be isolated when dienes 20k-n or 
C-2 substituted 1,3-bis-silyl enol ethers were employed. The reaction resulted in the 
formation of a complex mixture. This could be explained by the steric influence of the 
substituents that will be described later on. 
4.2.1 Structure identification 
All structures were confirmed by NMR, IR, mass spectrometry and elemental analysis. 
Long-run 13C-NMR-experiments showed typical quartets and expected 1JC-F and 2JC-F 
coupling constants. Two quartets with coupling constants 1JC-F ~ 274 Hz at about 122 ppm 
characterize the two CF3-groups. The 19F-NMR spectra show two singlets at ca. -60 ppm, 
which confirm the aromatic structure of the molecule. 
The structure of product 20b was certified by X-ray crystal structure analysis (Table 
4.3). [43] The compound crystallized as a monohydrate and its structure is as expected planar, 
due to the aromatic ring. The lengths of the aromatic C-C bonds are 1.36-1.42 Å while the C-
N bonds are ca. 1.32 Å long and as expected shorter. A torsion angle O2-C8-C2-C3 of 64° is 
present between the ester-group and the aromatic ring.   
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Table 4.3: Crystal structure of 20b. 
Crystal structure Compound Structure 
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4.2.2. Mechanistic investigations 
Consequently, the mechanism of this new reaction needed to be investigated. It was 
assumed that the first step was mainly responsible for the reaction pathway. Therefore, this 
step was then carried out in the absence of Me3SiOTf and followed by TLC. A weak spot of a 
product that was not identical to 20 was observed at the beginning of the reaction. Once the 
temperature slowly reached 20°C, the intensity of this spot increased and the intensity of the 
starting material 19 decreased until it disappeared. Work-up with 10% HCl was necessary to 
eliminate the Me3Si-groups. The new products were isolated by using flash chromatography 
and their structural elucidation revealed that the bridged heterocycles 22 were formed 
(Scheme 4.2, Table 4.4). The moderate yields can be explained by the fact that the products 
seemed to be unstable on the silica gel and in solution under normal atmosphere.  
The fact that many reactions of masked azadienes involved the formation of a bridge 
intermediate supports these outcomes. As a result, a new type of formal [3+3]-cyclization 
reaction of 1,3-bis-silyl enol ethers was discovered. 
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Scheme 4.2: Reagents and conditions: i) a) CH2Cl2, -78 - 20°C, 12 h; 2) 10% HCl; ii) EtOH, 50-60 °C, 10-25 h. 
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Table 4.4: Yields of compounds 22a-e 
22 3 R1 R2 % (22)a 
a a H OMe 43 
b j Me OMe 54 
c ad (CH2)2Ph OMe 42 
d ag (CH2)3Cl OMe 71 
e ah (CH2)4Cl OMe 48 
a Yields of isolated products 
 
The structures of 22a and 22d were independently confirmed by X-ray crystal structure 
analysis [43]. Both crystalized in a monoclinic system with the space group C2h5 (P 21/n and P 
21/c). The piperidinone ring is in chair conformation and the tetrahydrotriazine ring is in half-
chair conformation and the overall configuration is endo with a C6-C1-N2 angle of 112° resp. 
110° for C4-C3-N3. The C=N bonds are ca. 1.27 Å long while the C-N bonds are 1.36-1.40 Å 
long. The ester-groups are in both cases on the opposite site to the C=N bond, this means 
on the same side with the cyclic NH-group, with a distance C=O    H of 2.50 Å. Therefore no 
hydrogen bond formation was observed. 
Table 4.5: Crystal structures of 22a and 22d. 
Crystal structure Compound Structure 
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1H-NMR spectroscopy confirmed the presence of only two NH-groups with broad 
singlets at ca. 3 ppm resp. 7 ppm. The three singlets of the CF3-groups appeared in 19F-NMR 
spectra at ca. -73, -79 and -83 ppm. The correct molecular ions were observed when the 
measurements were carried out using the milder EI or ESI technique, but not using GC-MS. 
The pure compounds 22a and 22b could be successfully transformed to pyridone 20a 
resp. 20i by simple heating in ethanol at 50–60 °C (see Table 4.6, Scheme 4.2). However, 
the thermal transformation of 22c-e into 20l-n failed. The transformation to 20a occurred with 
62% yield, which is lower than the yield obtained when Me3SiOTf was involved. As described 
before, the use of Me3SiOTf resulted in an increase of the yield (Table 4.1). However, the 
two step transformation, with isolation of the pure intermediate, proceeded with higher yield 
than the direct reaction without Me3SiOTf (62% vs. 30%). This could be a consequence of a 
different method of purification. The intermediate could be isolated by column 
chromatography and then transformed into pyridone with no further need of purification. In 
the direct reaction, pyridone 20 could only be isolated by washing with CH2Cl2, since the 
Rf = 0 made the isolation over column chromatography difficult. Unfortunately this method 
has a higher systematic error since the product can dissolve in CH2Cl2. This can explain also 
the higher yield of 20i (77% vs. 35%) obtained in two steps without Me3SiOTf. 
Table 4.6: Synthesis of 20 starting from 22a-e. 
22 20 R1 R2 % (20)a 
a a H OMe 62 
b i Me OMe 77 
c l (CH2)2Ph OMe 0 
d m (CH2)3Cl OMe 0 
e n (CH2)4Cl OMe 0 
 a Yields of isolated products 
 
However, extending the heating time and increasing the temperature (90°C) of the 
reaction gave a mixture of products and byproducts. The 19F-NMR spectra of the reaction 
mixture showed strong signals in the range of δ =-72, -75, and -80 ppm, with integral ratio of 
1:1:1. These signals do not belong to the pyridone 20. These results suggested that a major 
byproduct was formed. The efforts to isolate this product proved to be successful only in 
case of 22a. The structure of the product, methyl 5,5-bis(2,2,2-trifluoroacetamido)-6,6,6-
trifluoro-3-oxohexanoate 23a, could be identified by X-ray crystal structure analysis [43] (Table 
4.7). 
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Table 4.7: Crystal structure of 23. 
Crystal structure Compound Structure 
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Mechanistically, this transformation can proceed by attack of a water molecule onto 22 
to give intermediate A (Scheme 4.3), followed by C-C bond cleavage of the pyridone ring 
and C-N bond cleavage of the triazine ring. This tandem transformation leads to intermediate 
B, which is transformed by hydrolysis into 23. 
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Scheme 4.3: Possible mechanism for the formation of 23: i) 1) 10% HCl; 2) EtOH, 90°C, >30 h. 
These transformations could explain why compounds 20l-m could not be isolated. It 
seems that the larger the rest R1 is, the more likely the cleavage of the C-C bond takes 
place, making impossible the isolation of the intact pyridone ring. Unfortunately, these 
byproducts could not be isolated. Though, 19F-NMR spectroscopic analysis of the reaction 
mixture revealed that, besides unidentified products, pyridones 20 and compounds 23 were 
present in the ratio given in Table 4.8.  
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Table 4.8: Ratio of 20 to 23 in the reaction mixture (by 19F-NMR). 
22 R1 R2 (20):(23) 
a H Me 4 : 1 
b Me Me 7 : 1 
c (CH2)2Ph Me 1 : 23 
d (CH2)3Cl Me 1 : 21 
e (CH2)4Cl Me 1 : 25 
4.2.3. Mechanistic pathway 
Based on the results discussed above, there are two proposed pathways for the one-
pot synthesis of pyridones 20. Both ways start with the reaction of dienes 3 with triazine 19 to 
give intermediate F, which can be regarded as a silylated analogue of 22 (Scheme 4.4). 
Pathway A follows a sequential process by nucleophilic attack. First the triazine 19 is 
probably activated by interaction with Me3SiOTf to give the highly electrophilic 1,3,5-
triazonium triflate (Intermediate A). This fact can explain the increased yield for the Lewis 
acid mediated reaction. Intermediate B, which can exist in equilibrium with intermediate C, is 
formed by nucleophilic attack of the terminal carbon atom of diene 3 on the C=N bond of A. 
Attack of the central carbon atom of the bis-silyl enol ether follows giving intermediate F. 
The alternative, pathway B, is similar to a pericyclic cycloaddition via transition state D, 
which implies the simultaneous migration of the Me3Si-groups to the nitrogen atoms to give 
intermediate F. Intermediate F undergoes then subsequent desilylation to give 22 and 
extrusion of 2,2,2-trifluoroacetamidine to give 20. 
As mentioned above, products of type 22 were exclusively formed as endo isomers. 
Therefore it can be, that the reaction followed pathway B, a concerted type of reaction like 
the Diels-Alder reaction where the endo rule is dominating. Though, it is worth noting that 
zwitterions 24 and 25 have been previously isolated and characterized [44] (Figure 4.1), fact 
which supports the intermediates B and C and the pathway A. In fact, the sequential 
cyclization is a typical mechanism for the reactions of bis-silyl enol ethers.  
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Figure 4.1: Zwitterions previously isolated and characterized. 
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Scheme 4.4: Possible mechanism of the formation of 20: i) CH2Cl2, -78 - 20°C, 12 h; ii) 10% HCl; iii) EtOH, 50-
60°C, 10-25 h. 
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4.3 Unsuccessful trials 
The conditions described for 20 and 22 have been also tested for the implementation of 
other 1,3,5-triazine derivatives. 
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Unfortunately the test reactions with other derivatives were unsuccessful. The reaction 
of 1,3-bis-silyl enol ether with simple 1,3,5-triazin (A) afforded a product according to TLC, 
but the isolation was not possible since this product was highly volatile. Same difficulties 
occurred when triethyl 1,3,5-triazine-2,4,6-tricarboxylate (C) was involved. The reaction with 
2,4,6-trifluoro-1,3,5-triazine (B) afforded a complex mixture of products which could not be 
separated, but according to TLC small amounts of pyridone were formed. 
4.4 Conclusions 
In conclusion, the [3+3]-reaction reported herein is different to known modes of 
cycloadditions and constitutes a novel type of reaction for the bis-silyl enol ether chemistry. 
The products are not readily available by other methods. The reaction mechanism was 
studied by the isolation of an unusual tricyclic intermediate. 
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Chapter 5 
1,3-Bis-silyl enol ethers as building blocks for potential UV-filters 
5.1 Introduction 
Organisms are using nucleic acids (RNA and DNA) for storage of their genetic 
information encoded in the sequences of the four nucleobases adenine, cytosine, guanine 
and thymine (uracil in RNA). The damage of the DNA and RNA matrix causes mistakes 
during the replication and transcription. In many cases this leads to mutations in the genetic 
material causing cancer. For example, the sunlight ultraviolet radiation (UV) can cause 
damages of nucleic acids, leading to skin cancer. 
The electromagnetic spectrum of the ultraviolet light is divided into UV-A (400-320 nm), 
UV-B (320-280 nm) and UV-C (280−200 nm) bands. The most dangerous radiation of 
sunlight lies in the range of UV-C bands. However this UV light is absorbed by ozone in the 
upper parts of the atmosphere. Only the less energetic UV-B and UV-A radiations reach the 
Earth`s surface and contribute significantly to the negative effects of sun radiation like 
sunburn and cancer. [45] 
Though, there are not only risks but also benefits of sun exposure. For example, UV 
radiation is used as medical treatment for skin disorders such as psoriasis. Although, this 
treatment is less used since it has side effects like skin cancer. UV light with wavelength of 
311 nm proved to be the middle way for an effective treatment. [46] Sunlight is necessary for 
the production of vitamin D in the human body. Too little UV radiation causes a lack of 
vitamin D. Too much UV radiation causes DNA damage, sunburn and skin cancer. An 
appropriate amount of UV light is needed. 
To control the amount of UV radiation and to protect the skin from negative effects, a 
variety of personal care products have been investigated and produced. They contain 
organic substances that can absorb the UV radiation and reduce the negative effects. These 
chemicals are generally called UV filters and they are fundamental for the sunscreen 
industry. Ultraviolet filters can be broadly classified into two types:  
1) UV absorbers, which are mostly organic compounds that absorb the UV light. They 
are classified as either UV-B or UV-A filters or both (UV-A/B filters). 
2) Inorganic particulates that may absorb reflect and scatter the UV light. There are 
only two inorganic particulates approved (zinc oxide and titanium dioxide). Both ingredients 
are considered to have a broad spectrum since they absorb, scatter and reflect UV-B and 
UV-A bands. [47] 
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There are about fifty five ultraviolet filters that are approved for use in sunscreen 
products. [47] These are not sufficient to fully protect us against the sunrays. 
Optimal sun-creams should have a broad and strong absorption of UV-A (400–320 nm) 
and UV-B radiation (320–280 nm), since the UV-C radiation does not reach the skin. They 
should be stable against light, temperature and water and have a moderate lipophilicity. 
Para-amino benzoates (e.g. 4-aminobenzoic acid / PABA) and salicylates (e.g. 2-
ethylhexyl salicylate) were one of the first used UV-B and UV-A filters, respectively. 
Dibenzoyl methanes (so called avobenzone, e.g. butyl methoxydibenzoylmethane), 
cinnamates (e.g 2-ethylhexyl methoxycinnamate) and camphor derivatives (e.g. 4-
methylbenzylidene camphor) are also widely used because of their exceptionally high 
absorption coefficients (Figure 5.1). However, these compounds are still investigated since 
they are thought to be toxic or carcinogenic. Other are not perfect suitable since they are too 
aggressive and discolor the cloths or they are not stable against light and need 
photostabilisers. [47] 
COOH
NH2
PABA
OH
O
O
2-Ethylhexyl salicylate
O O
MeO
Butyl methoxydibenzoylmethane
O
O
MeO
2-Ethylhexyl methoxycinnamate
O
4-Methylbenzylidene camphor  
Figure 5.1: Some approved UV-A or UV-B filters. 
Sun-creams often contain a mixture of UV-A and UV-B filters or they are UV-A/B broad 
spectrum filters, which combine a UV-A and UV-B filter in one molecule. Functionalised 
benzophenones, such as benzophenone-3 (oxybenzone) or benzophenone-8 
(dioxybenzone), are widely used UV-A/B filters in sun-creams [48] (Figure 5.2). 
OH O
MeO
Benzophenone-3
OH O
MeO
OH
Benzophenone-8  
Figure 5.2: Some approved UV-A/B broad spectrum filters.  
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The ability of benzophenones to absorb UV radiation is due to the completely 
conjugated system, consisting of the two phenyl rings which can interact with the π-bond of 
the C=O-group. The π-electron delocalization results in two λmax at 286 nm (UV-B) and at 
324 nm (UV-A). 
Unluckily, benzophenone-3 has been reported to act as photosensitizer, increasing the 
production of free radicals under illumination, fact which possibly makes this UV filter 
photocarcinogenic. [49] Therefore, the EU requires that cosmetic companies label the 
presence of more than 0.5 % of benzophenone-3 on their products with “contains 
oxybenzone”. [50] Consequently, the development of new UV-A/B filters is of considerable 
interest. 
At the same time, functionalized benzophenones have found various medicinal and 
technical applications. They represent important core structures for the development of 
pharmaceuticals. [51] 
The group of Prof. Dr. Peter Langer has previously reported that 3-formylchromones 
react with 1,3-bis-silyl enol ethers to give 2,4-dihydroxybenzophenones. [52] Recently, it has 
been reported the synthesis of 3-methoxalylchromone and its reactions with electron-rich 
nitrogen heterocycles. [53] Hence, the reaction of 3-methoxalylchromone and related 
derivatives with 1,3-bis-silyl enol ethers needed to be investigated. 
5.2 Results and discussions 
The reaction of 1,3-bis-silyl enol ethers with different chromones and thiochromones 
afforded a great variety of functionalized benzophenones and xanthene derivatives. These 
are interesting substrates for the C-C coupling reactions and can be a novel UV-A/B filter. 
5.2.1 Preparation of the starting materials  
The chromones [53] and the thiochromones [54] have been prepared in collaboration with 
group colleagues after already reported literature procedures.  
OH
R4
O
N
Cl R3
O
i
O
O
R3
O
R4
26 a: R4=H
     b: R4=Br
     c: R4=CH3
27 a: R3=CO2CH3
     b: R3=CHCl2
28 a: R3=CO2CH3, R4=H     (82%)
     b: R3=CO2CH3, R4=Br    (80%)
     c: R3=CO2CH3, R4=CH3 (78%)
     d: R3=CHCl2, R4=H        (75%)  
Scheme 5.1: Synthesis of chromones 28: i) pyridine, CH2Cl2, 20°C, 8 h. 
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The 3-methoxalylchromone and derivatives (28a-c) could be prepared in good yields 
by reaction of 26a-c with methyl 2-chloro-2-oxoacetate 27a (Scheme 5.1). The 3-
(dichloromethylcarbonyl)-chromone 28d, containing a CHCl2-group as a masked formyl-
group, has been synthesized after the same procedure starting with 26a and 2,2-
dichlorocetyl chloride 27b. Thiochromones 30a,b could be prepared in three steps, starting 
from commercially available thiochromenone 29 (Scheme 5.2). 
S
O
S
OLi
R3
O
S
OH
R3
O
S
O
R3
O
i ii iii
29 30 a: R3=CF3 (94%)
     b: R3=H     (67%)  
Scheme 5.2:  Synthesis of thiochromones 30: i) LiH, R3CO2Et, benzene, bp, 20 h; ii) 10% H2SO4, CH2Cl2, 20°C, 
16 h; iii) SO2Cl2, CHCl3, 20°C, 20 h. 
5.2.2 Reactions of chromones 
The reactions of 3-methoxalylchromone and derivatives 28a-d with 1,3-bis-silyl enol 
ethers 3 resulted in the formation of highly functionalized xanthene derivatives 31 and 32 
instead of the expected benzophenones. However, only the tetrahydroxanthones 31 could be 
transformed into functionalized benzophenones 33 by treatment with p-toluenesulfonic acid 
(Scheme 5.3). 
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Scheme 5.3:  Synthesis of 33: via isolation of 31 and 32: i)1) Me3SiOTf, 20°C, 1 h; 2) CH2Cl2, 0 - 20°C, 12-14 h; 
3) 10% HCl. ii) p-TsOH (3 mol%), EtOH, reflux, 5-10 h. Two-step one pot: iii) 1) Me3SiOTf, 20°C, 
1 h; 2) CH2Cl2, 0 - 20°C, 12-14 h; 3) 10% HCl; 4) p-TsOH (3 mol%), EtOH, reflux, 5-10 h. 
 49 
Chapter 5: 1,3-Bis-silyl enol ethers as building blocks for potential UV-filters 
Studying the scope and limitation of the reaction, it was obvious that 1,3-bis-silyl enol 
ethers 3 readily reacted with chromones 28 to give the correspondent polycyclic products 31 
and 32 with 41-80% yield and excellent regio and diastereoselectivity (Table 5.1). The 
variation of the substituents had a dramatic influence on the yields. The highest yield was 
obtained for R3 = iBu and R2 = Br. In general, it seemed that the Br-substituted chromone 28b 
attained higher yields in compare to the unsubstituted one (e. g 31d vs. 31h). Large 
substituents at the terminal position of 3 (R1≠H) made the isolation of the pure compounds 31 
difficult.  
The chemical behaviour of chromone 28d seemed not to be similar with that of 
chromones 28a-c. The resulted derivatives 31 exist in enole-form, which can be because of 
the support of an intramolecular hydrogen bond with the R2=CO2CH3. In case of compound 
32, where such bonding is not possible, the keto-form predominates. It should be also 
mentioned that starting with same 1,3-bis-silyl enol ether 3j, the product 32 was formed with 
a higher yield than 31f. However, product 32 was formed as a mixture of diastereomers and 
so the NMR methods were not sufficient to verify the structure obtained. 
Table 5.1: Synthesis of intermediates 31 and 32.  
 28 3 R1 R2 R3 R4 Yield a % 
31a a a H OMe CO2Me H 52 
31b a b H OEt CO2Me H 47 
31c a c H OBn CO2Me H 41 
31d a f H OiBu CO2Me H 43 
31e a g H OiPent CO2Me H 52 
31f a j Me OMe CO2Me H 42 
31g b a H OMe CO2Me Br 51 
31h b f H OiBu CO2Me Br 80 
31i c a H OMe CO2Me Me 71 
31j c d H OiPr CO2Me Me 45 
32 d j Me OMe CCl2H H 54b 
a Yields of isolated products. 
b Mixture of diastereomers 
The optimization of the reaction conditions showed that the use of a Lewis acid for the 
activation of the substrate played an important role. The highest yield was obtained when the 
substrate was mixed with the Me3SiOTf and stirred for at least 1 h, at room temperature, 
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before the solvent and the 1,3-bis-silyl enol ether were added. The reaction temperature and 
the stoichiometry had also significant influence on the conversion. All optimizations were 
carried out only for the reaction to 31f (Table 5.2). 
Table 5.2: Optimization of the synthesis of 31f 
28:3:Me3SiOTf activation time reaction temperature Yield a % 31f 
1 : 2 : 1 1 h 0°C 16 
1 : 2 : 2 1 h 0°C 42 
1 : 2 : 3 1 h 0°C 38 
1 : 4 : 2 1 h 0°C 22 
1 : 2 : 2 15 min 0°C 0b 
1 : 2 : 2 1 h -78°C 0b 
a Yields of isolated products. 
b No conversion (by TLC). 
To perform the ring-open reaction of 31 to give the desired benzophenone 33, acidic 
media was taken into consideration. The substrate 31a was taken as a model for the 
conditions optimization. At first the substrate was refluxed in the presence of TFA or acetic 
acid. Both experiments underwent the desired ring-open reaction but with a disappointing 
yield of ca. 20%. These conditions seemed to be drastic for the substrate. The best yield 
(63%) was obtained when a catalytic amount of para-toluenesulfonic acid (PTSA) in ethanol 
was employed (Scheme 5.3).  
Knowing this, it was now possible to apply a two-step one pot reaction of 1,3-bis-silyl 
enol ether 3 and chromone 28 to directly reach benzophenone 33, without the isolation of the 
polycyclic intermediate 31. The yields in this case were significantly higher (63% vs. 50%, 
Table 5.3). This is expected since there might be loss of intermediate during its purification. 
However, the ring opening reaction, followed by aromatization did not take place for 
intermediate 32. Both acidic media (PTSA/ethanol) and basic media (KOH/methanol) have 
been tried without success.  
The synthesis of 33j took place in only one step, without PTSA/ethanol reflux, after 
which the product precipitated with no need of further purification. This could also be 
observed in case of 33k, unfortunately the aromatization in one step took place with only 
32% yield, so that the second step was needed to get 56% yield. 
The small yield of 33i can be explained by observation and isolation of 33a as 
byproduct with 41% yield. It can be that the reflux with PTSA/ethanol causes the elimination 
of the ethylbenzene-group. 
The formation of benzophenones 33 with very good selectivity confirmed the excellent 
regio and diastereoselectivity of the intermediate 31. The presence of other regiosiomers 
was not observed.   
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Table 5.3: Synthesis of benzophenones 33  
33 28 3 R1 R2 R3 R4 Yield a % 33 
a a a H OMe CO2Me H 63b (50c) 
b a e H OnBu CO2Me H 84b 
c a h H OnOct CO2Me H 80b 
d a j Me OMe CO2Me H 67b (45c) 
e a k Et OMe CO2Me H 66b 
f a y nNon OMe CO2Me H 70b 
g a ab nTetradec OMe CO2Me H 74b 
h a ac nHexadec OMe CO2Me H 72b 
i a ad (CH2)2Ph OMe CO2Me H 37b 
j a ag (CH2)3Cl OMe CO2Me H 53d 
k a ah (CH2)4Cl OMe CO2Me H 56b (32d) 
l b a H OMe CO2Me Br 49b (45c) 
m b f H OiBu CO2Me Br 72b (63c) 
n b j Me OMe CO2Me Br 75b 
o b y nNon OMe CO2Me Br 77b 
p b ac nHexadec OMe CO2Me Br 54b 
q b ah (CH2)4Cl OMe CO2Me Br 82b 
r c a H OMe CO2Me Me 60b (58c) 
s c d H OiPr CO2Me Me 63b 
t c j Me OMe CO2Me Me 74b 
v c y nNon OMe CO2Me Me 63b 
w c ac nHexadec OMe CO2Me Me 72b 
a Yields of isolated products. 
b Two-step one pot path.  
c The yield via the isolation of 31. 
d Product isolated after the first step. 
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5.2.2.1 Structure identification 
The structures were confirmed by spectroscopic methods. The ring CH2-group of the 
polycyclic intermediate was obviously confirmed by NMR spectra. The typical 1H-NMR 
multiplet of this group disappeared after the PTSA/ethanol reflux, which indicateed the 
aromatization. Significant was also the OH-singulet at ca. 4 ppm for the non-aromatic 
intermediate 31. The shift of the second OH-peak at ca. 13 ppm suggested an O-H   H 
hydrogen bond to the ester-group. This was observed also for the OH-groups of the 
benzophenones 33. Both peaks were shifted to 11 ppm due to assumed hydrogen bonds 
formation to the neighboured keto or ester-groups. A coupling constant 3JH,H ~ 13 Hz 
between the bridgehead hydrogen atoms of 31 was observed that indicated a trans 
relationship between these protons (Figure 5.3). 
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Figure 5.3: Observations from NMR experiments. 
The correct molecular ions for polycyclic compounds 31 were only observed with the 
milder EI (electron ionization) or ESI technique (electrospray ionization). Under the 
conditions of GC-MS, elimination took place so that only the molecular ions of the aromatized 
products 33 could be detected. 
Similar to salicylates 9 and 11, the IR spectra confirmed the presence of the OH and 
aromatic CH-groups, showing weak to middle intensive bands at ~ 3000 cm-1. Strong C=O 
stretching bands were observed at 1580-1680 cm-1. 
The structures of intermediates 31b,c, 32 and benzophenones 33i,j,p were 
independently confirmed by X-ray crystal structure analysis. Intermediates 31 crystalized in a 
triclinic system with the space group Ci (P-1). The crystal structure confirmed that these 
compounds exist in enol-form at C-3 (Table 5.4) and a hydrogen bond with the neighbor 
ester-group (O5H5    O2 is ca. 1.6 Å long) maintains its form. For that, the ester-group at C-2 
made a 180° rotation away from the C1-C2-bond. The OH at the asymmetric center C-1 is 
too far-off to be involved in a hydrogen bond. Both non-aromatic rings are in half-chair 
conformation.  
 53 
Chapter 5: 1,3-Bis-silyl enol ethers as building blocks for potential UV-filters 
Table 5.4: Crystal structures. 
Crystal structure Compound Structure 
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Intermediate 32, in comparison, crystalized in a monoclinic system with the space 
group C2h (C 2/c). This compound exists in keto-form at C-3, since there is no possible 
hydrogen bond which can stabilize the enol-form. The ester-group at C-2 rotated with only 
52° away from C1-C2-bond and created a hydrogen bond with the OH-group at C-1 (O2H2     
O3 is 1.9 Å long). The cyclohexane ring is in chair conformation and the pyran ring is in half-
chair conformation. 
All observation agreed with the results of the NMR experiments. The supposed 
hydrogen bonds, the keto/enol-forms and also the trans relationship of the bridge hydrogen 
atoms H-5 and H-6 were confirmed. 
Benzophenones 33i and 33j crystalized in a monoclinic system with the space group 
C2 (P 21) resp. C2h (P 21/n), while benzophenone 33p crystalized in a triclinic system with 
the space group Ci (P-1). All benzophenones showed, as expected, two hydrogen bonds 
(O5H5     O3 and O7H7    O1 ca. 1.8 Å long), one for each OH-group. Therefore, the ester-
group at C-2 rotates with an angle O3-C16-C2-C1 of 160-180° anti-periplanar to C1-C2-bond 
and the unsubstituted phenol ring is in one plane with the linking CO-group. This plane 
makes a torsion angle C8-C7-C6-C5 of 50-60° to the additional ring.  
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Compounds like 33p are of great interest. The long hydrophobic chain and the 
hydrophilic head are good qualities for surfactants. The products are not readily available by 
other methods. 
5.2.2.2 Mechanistic pathway 
The proposed mechanism of this unusual domino reaction is outlined in the following 
scheme and relies on four main steps. 
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Scheme 5.4: Possible mechanism for the formation of 31, 32 and 33: i) Me3SiOTf, 20°C, 1h; ii) CH2Cl2, 0 - 20°C, 
12-14 h; iii) 10% HCl; iv) p-TsOH (3 mol%), EtOH, reflux, 5-10 h.  
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The initial formation of the pyrylium salt A is followed by attack of the carbon atom C-4 
of diene 3 at the activated carbon atom of A to give intermediate B. Subsequent Me3SiOTf-
mediated intramolecular aldol reaction delivers intermediate C.  
The addition of hydrochloric acid (10%) resulted in cleavage of the Me3Si-groups and 
the intermediates 31, which can exist in the keto-form 32, were isolated. The isolation of 
these intermediates is unusual, since up to date, the proposed mechanism for this type of 
reaction should undergo first a retro-Michael reaction [52], followed by intramolecular aldol 
reaction. These kinds of products were not reported before.  
In the fourth step (heating in ethanol with catalytic amount of PTSA) the reaction 
probably proceeds via a ring-open cascade with the formation of intermediate D, followed by 
aromatization. 
5.2.3 Reactions of thiochromones 
While chromones have been broadly investigated, few reports can be found regarding 
the chemical behavior of thiochromones. A reason can be the difficult preparation of these 
compounds. It was reported that 3-trifluoroacylthiochromone 30 (Scheme 5.5) reacted with a 
number of 1,3-NCN-dinucleophiles, such as amidines or guanidines over the thiopyrone ring 
opening cascade, to give tihophenol scaffolds. [55] Also, some reactions of 3-
formylthiochromone with N-nucleophiles, such as hydroxylamine, hydrazine, ethylenediamine 
and primary aromatic amines, have been described. [56] Nevertheless, these reactions mostly 
gave substituted thiochromones where the thiopyrone ring was not opened.  
For that reason and because of the results achieved with the chromones, it was 
interesting to investigate the reaction of 3-trifluoroacylthiochromone with 1,3-bis-silyl enol 
ethers. Note that 3-trifluoroacylthiochromone readily reacts with water to form stable hydrates 
(gem-diols). 
Unfortunately, these substrates were not as active as the chromones. The reaction of 
3-trifluoroacylthiochromone 30 afforded the polycyclic intermediate analogous to intermediate 
32. The optimization tests showed that the reaction works if the activation with Me3SiOTf is 
carried out in the presence of CH2Cl2 (1.5 mL / mmol), unlike the activation of chromones 28. 
The ring opening reaction, followed by aromatization did not take place. Both acidic media 
(PTSA/ethanol) and basic media (KOH/methanol) and different 1,3-bis-silyl enol ethers 3 
have been tried without success. The same behaviour was observed for compound 32. It 
looks like the keto-form of these polycyclic compounds is stable against elimination and 
aromatization. (Scheme 5.5) 
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Scheme 5.5: Synthesis of 34: i)1) Me3SiOTf, CH2Cl2, 20°C, 1 h; 2) CH2Cl2, 0 - 20°C, 12-14 h; 3) 10% HCl.  
 
It was possible to obtain a single crystal for compound 34a. The crystal structure 
showed similar characteristics to 32 (Table 5.5). It crystalized in a monoclinic system with the 
space group C2h (P 2/n). Surprisingly, the OH-group at C-9 was this time involved in a 
hydrogen bond with the keto-group at C-7 instead of the ester-group at C-10 (O2H2B    O1 of 
1.9 Å long). This can be the consequence of the torsion angle O3-C15-C10-C9 of 68° made 
by the ester-group. These parameters should actually support a possible enol-form at C-11, 
but the chair conformation of the cyclohexane ring hindered the formation of a thinkable 
hydrogen bond (distance O3-O5 of ca. 3.8 Å). The bridge hydrogen atoms H-8A and H-13A 
are located trans to each other. 
 
Table 5.5: Crystal structure of 34a. 
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5.3 Applications 
Modification of benzophenones 33 is of great interest, since these scaffolds have high 
potential for a novel UV-filter. A proper UV-filter should absorb as much UV light as possible. 
The insertion of aryl substituents increases the conjugated system of the benzophenone 
which should increas the absorption of UV light. Following this purpose, the Pd-mediated C-
C Suzuki coupling of 33 was investigated.  
Therefore, benzophenone 33a was transformed into the respective bis-triflate 
derivative 35a, which performed as a substrate for the reactions with different arylboronic 
acids. The double Suzuki reaction of 33a with arylboronic acids afforded the novel 
benzophenones derivatives 36a–d in good yields (Scheme 5.6, Table 5.6). 
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Scheme 5.6: Synthesis of 36a-d: i) CH2Cl2, pyridine, -78 - 0 °C, inert atmosphere, 4 h; ii) K3PO4, Pd(PPh3)4, 1,4-
dioxane, 90°C, 4 h. 
The reactions were carried out in 1,4-dioxane using Pd(PPh3)4 (6 mol%) as catalyst 
and potassium phosphate (K3PO4) as base. The employment of CsCO3 as base resulted in a 
decreased overall yield, because its basicity could be to strong for the substrate. All products 
were isolated by chromatographic purification. A small amount of the corresponding 
biphenyls could be detected (by 1H NMR and GC-MS) in the crude product. 
The position of the aryl substituents had a dramatic influence on the yields. The best 
yields were obtained when para-substituted arylboronic acids were used (36a-c). This can 
explain the small yield of 36d, where the metha-trifluoromethylboronic acid was employed. 
The Suzuki reaction with ortho-substituted boronic acids (2,5-substitution) was not 
successful. The reason can be the steric hindrance of the substituents and the electronic 
effects. 
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Table 5.6: Synthesis of benzophenones 36. 
36 R1 Yield a %  
a (4-OCH3)C6H4 60 
b (4-C2H5)C6H4 60 
c (4-Cl)C6H4 70 
d (3-CF3)C6H4 39 
a Yields of isolated products 
Following the same procedure, benzophenone 33l with R2 = Br was successfully 
transformed into the bis-triflate derivative 35b. The subsequent coupling with phenyl boronic 
acid afforded the triple Suzuki reaction. Though, the optimal reaction conditions used for the 
synthesis of 36 failed, providing an inseparable mixture of mono, bi and tri-substituted 
products. Change of the base by using KF instead of K3PO4 afforded the benzophenone 37 
(Scheme 5.7). 
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Scheme 5.7: Synthesis of 37: i) CH2Cl2, pyridine, -78 - 0 °C, inert atmosphere, 4 h; ii) KF, Pd(PPh3)4, 1,4-dioxane, 
90°C, 4 h. 
Of particular interest is also the study of the site-selective (mono) Suzuki reaction of the 
substrates 35. Though, this is a problematic task since the substrates are prepared after a 
multistep method. Besides that, similar selective reactions have been broadly investigated on 
simple benzophenones. [57] 
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5.4 UV measurements 
It is known that highly conjugated systems absorb light in the UV wavelength without 
decomposition. According to the structure of benzophenones, both phenyls can interact with 
the C=O-group through the σ-electrons (inductive effect) and the π-electrons (mesomeric 
effect). The π-electron delocalization stabilizes the system relocating the electronic 
deficiency through the molecule. (Figure 5.4) At the same time one or more internal 
hydrogen bonds of ortho-substituted molecules lower the energy requirements for the ππ* 
resp. nπ* excitations and increase the wavelength of the UV absorbance. This has been 
successfully used in the design of many new UV-filters that have appeared on the market. [47] 
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Figure 5.4: The electron delocalization in the benzophenone molecule. 
To develop a new UV-A/B filter, the UV absorptions of the polycyclic system 31 and of 
the benzophenones 33, 36 and 37 were studied. Electron transfers (ππ* resp. nπ*) in 
the benzophenones 33a-v resulted in tree λmax at ca. 230 nm (UV-C), 240-280 nm (UV-C) 
and 315-380 nm (UV-A/UV-B). (Table 5.7, Figure 5.5)  
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Figure 5.5: UV absorbance spectra of 33 in CH2Cl2.  
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Table 5.7: The UV properties of 33. 
33a λmax (nm) E
b ε
c 
(cm-1mol-1l) logε 33
a λmax 
(nm) E
b ε
c 
(cm-1mol-1l) logε 
33a 229 1,25 22644 4,35 33l 229 1,34 24364 4,39 
 262 0,99 18013 4,26  288 0,34 6182 3,79 
 321 0,56 10267 4,01  350 0,26 4727 3,67 
33b 232 1,83 18290 4,26 33m 229 1,41 25636 4,41 
 262 1,43 14336 4,16  289 0,37 6727 3,83 
 320 0,85 8470 3,93  350 0,30 5455 3,74 
33c 229 1,18 11821 4,07 33n 229 1,41 25636 4,41 
 321 0,53 5311 3,73  315 0,36 6545 3,82 
33d 227 0,92 16733 4,22 33o 227 1,26 22909 4,36 
 247 0,99 18082 4,26  247 0,92 16727 4,22 
 323 0,45 8125 3,91  315 0,33 6000 3,78 
33e 227 0,97 17658 4,25 33p 228 1,32 24000 4,38 
 248 1,03 18753 4,27  247 0,94 17091 4,23 
 323 0,48 8644 3,94  318 0,34 6182 3,79 
33f 227 0,87 15855 4,20 33q 227 0,65 11818 4,07 
 249 0,95 17240 4,24  246 0,47 8545 3,93 
 324 0,44 7929 3,90  318 0,16 2909 3,46 
33g 228 1,63 16263 4,21 33r 227 0,83 15091 4,18 
 249 1,88 18848 4,28  265 0,53 9636 3,98 
 323 0,87 8653 3,94  318 0,26 4727 3,67 
33h 227 1,10 10955 4,04 33s 227 0,80 14545 4,16 
 249 1,18 11765 4,07  265 0,51 9273 3,97 
 324 0,54 5380 3,73  352 0,23 4182 3,62 
33i 227 1,33 13325 4,12 33t 229 1,70 17000 4,23 
 249 1,43 14280 4,15  246 1,66 16600 4,22 
 324 0,65 6490 3,81  321 0,59 5900 3,77 
33j 227 1,16 21060 4,32 33u 227 0,84 15273 4,18 
 246 1,23 22322 4,35  247 0,79 14364 4,16 
 323 0,57 10340 4,01  323 0,29 5273 3,72 
33k 227 0,88 16042 4,21 33v 227 0,75 13636 4,13 
 247 0,92 16707 4,22  247 0,70 12727 4,10 
 324 0,42 7636 3,88  323 0,26 4727 3,67 
a Dissolved in CH2Cl2. 
b E = Extinction 
c ε = Extinction coefficient 
 
As expected, the best absorptions were observed for high conjugated systems like 
benzophenones 36 and 37 with absorption coefficients ε = 25000-37000 cm-1mol-1l, which 
are very high in contrast to other known UV-A/UV-B filters. [47] Surprisingly, the expected 
bathochromic shift to UV-A area was not witnessed. They showed strong absorptions only in 
the range of λmax = 230 nm (UV-C) and 300 nm (UV-B). This can be explained by the 
absence of hydrogen bonding. (Figure 5.6, Table 5.8)   
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Figure 5.6: UV absorbance spectra of 36 and 37 in CH2Cl2. 
 
Table 5.8: The UV properties of 36 and 37. 
Compounda 
λmax,1  
(nm) 
E1b 
ε1
c 
(cm-1mol-1l) 
logε1 
λmax,2  
(nm) 
E2b 
ε2
c 
(cm-1mol-1l) 
logε2 
36a 229 1,52 27636 4,44 304 0,70 12727 4,10 
36b 229 1,44 26182 4,42 291 0,72 13091 4,12 
36c 230 2,03 36909 4,57 - - - - 
36d 230 1,38 25091 4,40 - - - - 
37 228 1,26 28000 4,45 259 1,54 34222 4,53 
a Dissolved in CH2Cl2. 
b E = Extinction 
c ε = Extinction coefficient 
 
Weaker absorption coefficients were observed for the polycyclic system 31 at 
wavelengths similar to the ones of benzophenones 33, making them to a less promising UV-
A/UV-B filter. (Table 5.9, Figure 5.7) 
In general, electron-donor groups led to a slight blue shift, while electron-acceptor 
groups (Br, Cl, CF3) led to a slight red shift. This result is not in agreement with the theory, 
because the energy of the HOMO decreases with electron-acceptor substituents and the 
energy required to afford the ππ* electron excitation is therefore higher, and the 
wavelength that provides this energy is decreased correspondingly. This can only be 
explained by the presence of the nπ* absorption of the C-X-group.  
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Table 5.9: The UV properties of 31. 
31a 
λmax 
(nm) 
Eb 
ε
c 
(cm-1mol-1l) 
logε 32 
λmax 
(nm) 
Eb 
ε
c 
(cm-1mol-1l) 
logε 
31a 229 1,10 10976 4,04 31f 227 0,66 6553 3,82 
 252 2,10 21016 4,32  252 1,14 11428 4,06 
 321 0,59 5862 3,77  323 0,34 3388 3,53 
31b 228 0,70 6994 3,84 31g 232 1,87 18671 4,27 
 251 1,19 11862 4,07  334 0,35 3491 3,54 
 321 0,35 3513 3,55      
31c 228 0,85 8476 3,93 31h 232 2,00 19982 4,30 
 252 1,56 15608 4,19  334 0,39 3879 3,59 
 321 0,39 3929 3,59      
31d 228 0,87 8673 3,94 31i 229 1,00 9993 4,00 
 251 1,66 16576 4,22  255 0,82 8151 3,91 
 321 0,44 4351 3,64  331 0,38 3821 3,58 
31e 228 0,74 7428 3,87 31j 230 1,45 14496 4,16 
 251 1,39 13890 4,14  254 1,86 18614 4,27 
 321 0,38 3822 3,58  331 0,53 5311 3,73 
a Dissolved in CH2Cl2. 
b E = Extinction 
c ε = Extinction coefficient 
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Figure 5.7: UV absorbance spectra of 31 in CH2Cl2  
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5.5 Unsuccessful trials 
The described method is convenient for the synthesis of different benzophenones 
which are potential UV filters. Consequently, other chromones derivatives have been tested 
for this domino-cascade reaction with 1,3-bis-silyl enol ethers under the same conditions. 
O
O
O
O
NO2
S
O
NO2
S
O
H
O
A B C D  
Unfortunately not all chromones led to the desired benzophenones. In fact, the reaction 
of 3-nitrochromone (B) and 3-nitrothiochromone (C) did not work at all. Only starting 
materials were obtained after the known procedure. Different 1,3-bis-silyl enol ethers and 
reaction conditions have been tried without succes. The 3-formylthiochromone (D) and the 
3-(2-phenylethynyl)chromone (A) afforded a mixture of inseparable products and no 
formation of benzophenone was observed. 
5.5 Conclusions 
In summary, the domino-cascade reaction of high functionalized chromones with 1,3-
bis-silyl enol ethers is a novel two-step synthetic strategy for the assembling of new 
benzophenones derivatives. The isolation of the polycyclic intermediate changed the 
theoretical mechanism reported before, which assumed a domino Michael/retro-
Michael/Mukaiyama-aldol reaction pathway. Unfortunately, this new method is limited to 3-
methoxalylchromone and derivatives only.  
Functionalization of the benzophenones was explored by Suzuki C-C-coupling 
reaction. The triple cross-coupling reaction on benzophenones has not been reported before. 
These methods afforded a wide range of novel UV absorbers with good UV absorbing 
properties.  
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Chapter 6 
Summary 
 
 
The scope of this thesis was to show the chemical potential of 1,3-bis-silyl-enol ethers 
3 as building blocks for the synthesis of new interesting ring systems. 
 
As described in Chapter 3, the TiCl4-mediated cyclocondensation with 4,4-dimethoxy-
butenones and 4,4-dimethylthio-butenones afforded a variety of functionalized halogen-
substituted salicylates 9 and 10, while the Me3SiOTf-mediated cyclocondensation afforded 
halogen-substituted γ-pyrones 11 and cyclohexenones 12 and 13. The influence of the Lewis 
acids on the formal [3+3]-cyclization of 1,3-bis-silyl-enol ethers 3 was studied. 
 
According to Chapter 4, a new type of formal [3+3]-cyclization reaction with 2,4,6-
tris(trifluoromethyl)-1,3,5-triazine has been discovered. The reaction provided a convenient 
approach to functionalized 2,6-bis(trifluoromethyl)pyridones 20 starting from the same 1,3-
bis-silyl-enol ethers 3. An unusual bicyclic intermediate 22 was isolated. 
 
Another objective of this work was the synthesis of functionalized benzophenones 
starting from 1,3-bis-silyl-enol ethers 3. Chapter 5 describeed a novel two-step reaction with 
3-methoxalylchromones and their derivatives to give a great variety of functionalized 2,4-
dihydroxybenzophenones. The isolation of a uncommon tricyclic intermediate unlocked new 
concepts over the mechanistic progress of this type of reactions. The benzophenones were 
successfully functionalized by Suzuki C-C-coupling reaction. These methods afforded a wide 
range of novel UV absorbers with good UV absorbing properties. 
 
Scheme 6.1 gives once more an overview of the [3+3]-reactions of 1,3-bis-silyl-enol 
ethers 3 and the obtained products. 
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Scheme 6.1: The chemical potential of 1,3-bis-silyl-enol ethers 3. 
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Experimental part 
1.1. Analytics 
1H-NMR-Spectroscopy: Bruker AV 300 (300 MHz) and Bruker AV 400 (400 MHz). 
References: 0.00 for TMS, 7.26 for CDCl3. Peak characterization: s = singlet, d = doublet, 
t = triplet, dd =double dublet, dt = double triplet, q = quartet, m = multiplet. The spectra were 
measured with standard number of scans. In case of unclear assignment all possible 
hydrogen atoms were stated. 
 
13C-NMR-Spectroscopy: Bruker AV 300 (75 MHz) and Bruker AV 400 (100 MHz). 
References: 0.00 for TMS, 77.00 for CDCl3. Peak characterization: t = triplet, q = quartet. 
DEPT method was used for determining the presence of primary, secondary, tertiary and 
quaternary carbon atoms. All spectra were measured with standard number of scans and 
when necessary with 4000 scans. In case of unclear assignment all possible carbon atoms 
were stated. 
 
19F-NMR-Spectroscopy: Bruker AV 300 (282 MHz). The spectra were measured with 
standard number of scans. 
 
Mass spectrometry (MS): Finnigan MAT 95 XP (electron ionisation EI, 70 eV). 
 
High resolution MS (HRMS): Finnigan MAT 95 XP. Only the measurements with an 
average deviation from the theoretical mass of ± 2 mDa were accounted as correct. 
 
Infrared spectroscopy (IR): Nicolet 550 FT-IR spectrometer with ATR sampling technique 
for solids as well as liquids. Signal characterization: w = weak, m = medium, s = strong. 
 
X-ray crystallography: STOE imaging plate diffraction systems with monochromatic Mo-K 
radiation.  
 
Elemental analysis (EA): Leco 932 C, H, N, S. 
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UV/Vis spectroscopy: Lambda 2 (Perkin Elmer)
 
Melting point determination (mp): Micro-Hot-Stage GalenTM III Cambridge Instruments. 
The melting points are not corrected. 
 
Thin layer chromatography (TLC): Merck Silica 60 F254 on aluminium tin foil from 
Macherey-Nagel. Detection with UV light at 254 nm and afterwards development with 
vanillin-sulfuric acid solution (6 g vanillin, 2.5 mL conc. sulfuric acid, 250 mL ethanol). 
 
Column chromatography: Separation on Fluka silica gel 60 (0.063-0.200 mm, 70-320 
mesh). Eluents were distilled before use. 
 
1.2 Chemicals and techniques 
The 1,3-bis-silyl-enol ethers were obtained according to the literature method [17], [18] and used 
without further purification. Commercially available chemicals were used without further 
purification. All reactions took place in dry Schlenk flasks and inert gas atmosphere. Dry 
THF, CH2Cl2, pyridine and benzene were acquired from Acros. 
 
1.3 General procedures and product characterisations 
 
GP 1: General procedure for the synthesis of 4-methoxy-6-(diifluoromethyl)salicylates and 
the 4-methoxy-6-(trichloromethyl)salicylates 9r-ai: 
 
To a CH2Cl2 solution (2 mL/1.0 mmol of 8) of 8 (1.0 mmol) was added 3 (2.0 mmol) and, 
subsequently, TiCl4 (0.1 mL, 1.0 mmol) at −78 °C. The temperature of the solution was 
allowed to warm to 20 °C during 12−14 h with stirring. To the solution was added 
hydrochloric acid (10%, 10 mL) and the organic and the aqueous layer were separated. The 
latter was extracted with CH2Cl2 (2 × 10 mL). The combined organic layers were dried 
(Na2SO4), filtered and the filtrate was concentrated in vacuo. The residue was purified by 
chromatography to obtain 9r-ai. The purification of 9ab,ae,ag,ah afforded a regioisomer 
mixture with 10ab,ae,ag,ah. 
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Methyl 2-(difluoromethyl)-6-hydroxy-4-methoxybenzoate (9r).  
Starting with 4,4-dimethoxy-1,1-difluorobut-3-en-2-one (8b) (0.166 g, 
1.0 mmol), 1-methoxy-1,3-bis(trimethylsilyloxy)-1,3-butadiene (3a) 
(0.521 g, 2.0 mmol) and TiCl4 (0.1 mL, 1 mmol) in CH2Cl2 (5 mL), the 
product 9r was isolated as a white solid (0.081 g, 35%); mp = 72-
73°C. 1H NMR (250 MHz, CDCl3):  = 3.85 (s, 3H, OCH3), 3.97 (s, 3H, OCH3), 6.55 (d, 
4J = 2.4 Hz, 1H, CH), 6.88 (d, 4J = 2.4 Hz, 1H, CH), 7.24 (t, 2J = 55.6 Hz, 1H, CF2H), 11.60 
(s, 1H, OH). 13C NMR (63 MHz, CDCl3):  = 52.5, 55.7 (OCH3), 102.7 (t, JC-F = 1.6 Hz, C-3), 
102.8 (bs, C-1), 106.7 (t, JC-F = 10.5 Hz, C-5), 111.9 (t, JC-F = 237.7 Hz, CF2H), 136.9 (t, JC-
F = 21.4 Hz, C-6), 164.5, 165.4, 170.2 (C). 19F NMR (282 MHz, CDCl3):  = -113.3 (d, 
2J = 56.4 Hz, CF2H). IR (ATR, cm-1): ~  = 3097 (w), 2950 (w), 2923 (w), 2848 (w), 1652 (s), 
1620 (s), 1583 (s), 1519 (w), 1436 (s) 1259 (s), 999,6 (s), 752 (s). MS (EI, 70 eV): m/Z (%): 
232 (M+, 41), 201 (21), 200 (100), 172 (34), 157 (21). HRMS (EI, 70 eV): calcd. for 
C10H10F2O4 (M+) 232.05417, found 232.05483. 
 
 
Ethyl 2-(difluoromethyl)-6-hydroxy-4-methoxybenzoate (9s).  
Starting with 4,4-dimethoxy-1,1-difluorobut-3-en-2-one (8b) (0.166 g, 
1.0 mmol), 1-ethoxy-1,3-bis(trimethylsilyloxy)- 1,3-butadiene (3b) 
(0.549 g, 2.0 mmol) and TiCl4 (0.1 mL, 1.0 mmol) in CH2Cl2 (5 mL), the 
product 9s was isolated as a white solid (0.082 g, 33%); 
mp = 71−72 °C. 1H NMR (300 MHz, CDCl3):  = 1.43 (t, 3J = 7.0 Hz, 3H, CH3), 3.85 (s, 3H, 
OCH3), 4.44 (q, 3J = 7.2 Hz, 2H, CH2), 6.55 (d, 4J = 2.7 Hz, 1H, CH), 6.88 (d, 4J = 2.7 Hz, 1H, 
CH), 7.28 (t, 2J = 55.5 Hz, 1H, CF2H), 11.71 (s, 1H, OH). 13C NMR (75 MHz, CDCl3):  = 13.9 
(CH3), 55.6 (OCH3), 62.0 (CH2), 102.7 (t, JC-F = 1.5 Hz, C-3), 103.1 (t, JC-F = 4.4 Hz, C-1), 
106.6 (t, JC-F = 10.5 Hz, C-5), 111.9 (t, JC-F = 237.7 Hz, CF2H), 136.9 (t, JC-F = 21.3 Hz, C-6), 
164.4, 165.5, 169.7 (C). 19F NMR (282 MHz, CDCl3):  = -113.2 (d, 2J = 56.4 Hz, CF2H). IR 
(ATR, cm−1): ν̃ = 3094 (w), 2983 (w), 2925 (w), 2854 (w), 1649 (m), 1617 (m), 1589 (m), 1527 
(w), 1445 (m), 1370 (s), 1255 (s), 996 (s), 862 (s), 624 (s), 411 (s). GC-MS (EI, 70 eV): m/z 
(%): 246 (M+, 31), 201 (22), 200 (100), 172 (31), 157 (15). HRMS (EI, 70 eV): calcd. for 
C11H12F2O4 (M+) 246.06982, found 246.07028.  
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Benzyl 2-(difluoromethyl)-6-hydroxy-4-methoxybenzoate (9t).  
Starting with 4,4-dimethoxy-1,1-difluorobut-3-en-2-one (8b) (0.166 g, 
1.0 mmol), 1-benzyloxy-1,3-bis(trimethylsilyloxy)-1,3-butadiene (3c) 
(0.673 g, 2.0 mmol) and TiCl4 (0.1 mL, 1.0 mmol) in CH2Cl2 (5 mL), 
the product 9t was isolated as a yellow oil (0.091 g, 30%). 1H NMR 
(300 MHz, CDCl3):  = 3.84 (s, 3H, OCH3), 5.40 (s, 2H, CH2), 6.55 (d, 4J = 2.7 Hz, 1H, CH), 
6.84 (d, 4J = 2.7 Hz, 1H, CH), 7.20 (t, 2J = 57.0 Hz, 1H, CF2H), 7.377.47 (m, 5H, Ph), 11.65 
(s, 1H, OH). 13C NMR (100 MHz, CDCl3):  = 55.6 (OCH3), 67.9 (CH2), 102.7 (bs, C-3), 102.8 
(t, JC-F = 4.0 Hz, C-1), 106.8 (t, JC-F = 11.0 Hz, C-5), 111.7 (t, JC-F = 237.5 Hz, CF2H), 128.6, 
128.8, 134.5 (Ph), 137.0 (t, JC-F = 21.5 Hz, C-6), 164.5, 165.6, 169.5 (C). 19F NMR (282 MHz, 
CDCl3):  = -113.0 (d, 2J = 56.4 Hz, CF2H). IR (ATR, cm−1): ν̃ = 3066 (w), 3033 (w), 2959 (w), 
2852 (w), 1655 (s), 1618 (s), 1581 (m), 1498 (w), 1441 (w), 1373 (s), 1248 (s), 1161 (s), 
1030 (s), 951 (s), 749 (s), 695 (s). GC-MS (EI, 70 eV): m/z (%): 308 (M+, 18), 91 (100). 
HRMS (EI, 70 eV): calcd. for C16H14F2O4 (M+) 308.08547, found 308.08601.  
 
 
Isopropyl 2-(difluoromethyl)-6-hydroxy-4-methoxybenzoate (9u).  
Starting with 4,4-dimethoxy-1,1-difluorobut-3-en-2-one (8b) (0.166 g, 
1.0 mmol), 1-isopropyloxy-1,3-bis(trimethylsilyloxy)-1,3-butadiene (3d) 
(0.577 g, 2.0 mmol) and TiCl4 (0.1 mL, 1.0 mmol) in CH2Cl2 (5 mL), the 
product 9u was isolated as a yellow oil (0.151 g, 58%). 1H NMR 
(300 MHz, CDCl3):  = 1.41 (d, 3J = 6.0 Hz, 6H, (CH3)2), 3.84 (s, 3H, OCH3), 5.26−5.38 (m, 
1H, CH), 6.54 (d, 4J = 2.7 Hz, 1H, CH), 6.84 (d, 4J = 2.7 Hz, 1H, CH), 7.28 (t, 2J = 55.5 Hz, 
1H, CF2H), 11.79 (s, 1H, OH). 13C NMR (75 MHz, CDCl3):  = 21.7 (CH3), 55.6 (OCH3), 70.4 
(CH), 102.7 (bs, C-3), 103.5 (t, JC-F = 4.1 Hz, C-1), 106.5 (t, JC-F = 10.5 Hz, C-5), 111.8 (t, JC-
F = 237.7 Hz, CF2H), 137.0 (t, JC-F = 21.3 Hz, C-6), 164.3, 165.5, 169.3 (C). 19F NMR 
(282 MHz, CDCl3):  = -113.1 (d, 2J = 56.4 Hz, CF2H). IR (ATR, cm−1): ν̃ = 3062 (w), 2983 
(w), 2935 (w), 2853 (w), 1654 (s), 1617 (s), 1583 (m), 1444 (w), 1360 (s), 1254 (s), 1098 (s), 
1032 (s), 954 (s), 757 (s). GC-MS (EI, 70 eV): m/z (%): 260 (M+, 17), 218 (17), 201 (20), 200 
(100), 172 (22). Anal. calcd. for C12H14F2O4 (260.23): C, 55.38; H, 5.42. Found: C, 55.77; H, 
5.74. 
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Butyl 2-(difluoromethyl)-6-hydroxy-4-methoxybenzoate (9v).  
Starting with ,4-dimethoxy-1,1-difluorobut-3-en-2-one (8b) (0.166 g, 
1.0 mmol), 1-butoxy-1,3-bis(trimethylsilyloxy)-1,3-butadiene (3e) 
(0.605 g, 2.0 mmol) and TiCl4 (0.1 mL, 1.0 mmol) in CH2Cl2 (5 mL), 
the product 9w was isolated as a white solid (0.101 g, 37%); 
mp = 43 °C. 1H NMR (250 MHz, CDCl3): δ = 0.99 (t, 3J = 7.3 Hz, 3H, CH3), 1.40-1.54 (m, 2H, 
CH2), 1.73-1.84 (m, 2H, CH2), 3.85 (s, 3H, OCH3), 4.39 (t, 3J = 6.7 Hz, 2H, OCH2), 6.55 (d, 
4J = 2.7 Hz, 1H, CH), 6.88 (d, 4J = 2.7 Hz, 1H, CH), 7.26 (t, 2J = 55.6 Hz, 1H, CF2H) 11.74 (s, 
1H, OH). 13C NMR (63 MHz, CDCl3): δ = 13.6 (CH3), 19.2, 30.4 (CH2), 55.6 (OCH3), 66.0 
(OCH2), 102.8 (C-3), 103.1 (t, JC-F = 4.3 Hz, C-1), 106.6 (t, JC-F = 10.8 Hz, C-5), 111.9 (t, JC-
F = 239.2 Hz, CF2H), 136.9 (t, JC-F = 21.5 Hz, C-6), 164.4, 165.5, 169.9 (C). 19F NMR (282 
MHz, CDCl3): δ = -113.4 (d, 2J = 56.4 Hz, CF2H). IR (ATR, cm-1): ν̃ = 2962 (w), 2937 (w), 
2875 (w), 1724 (w), 1658 (s), 1618 (s), 1582 (m), 1504 (w), 1463 (m), 1444 (m), 1433 (m), 
1396 (m), 1372 (s), 1330 (s), 1249 (s), 1205 (s), 1162 (s), 1108 (s), 1051 (m), 1032 (s), 1002 
(s), 954 (s), 843 (m), 757 (s). GC-MS (EI, 70 eV): m/z (%): 274 (M+, 21), 201 (20), 200 (100), 
172 (18), 157 (8), 153 (8). Anal. calcd. for C13H16F2O4 (274.26): C, 56.93; H, 5.88. Found: C, 
57.19; H, 5.95. 
 
2-Methoxyethyl 2-(difluoromethyl)-6-hydroxy-4-methoxybenzoate (9x).  
Starting with 4,4-dimethoxy-1,1-difluorobut-3-en-2-one (8b) 
(0.166 g, 1.0 mmol), 1-(2-methoxyethoxy)-1,3-
bis(trimethylsilyloxy)-1,3-butadiene (3i) (0.609 g, 2.0 mmol) 
and TiCl4 (0.1 mL, 1.0 mmol) in CH2Cl2 (5 mL), the product 
9v was isolated as a white solid (0.082 g, 30%); mp = 63−64 °C. 1H NMR (300 MHz, CDCl3): 
 = 3.43 (s, 3H, OCH3), 3.72 (t, 3J = 4.8 Hz, 2H, CH2), 3.85 (s, 3H, OCH3), 4.50 (t, 
3J = 4.8 Hz, 2H, CH2), 6.54 (d, 4J = 2.7 Hz, 1H, CH), 6.89 (d, 4J = 2.7 Hz, 1H, CH), 7.31 (t, 
2J = 55.3 Hz, 1H, CF2H), 11.47 (s, 1H, OH). 13C NMR (75 MHz, CDCl3):  = 55.6, 58.9 
(OCH3), 64.5, 69.8 (CH2), 102.6 (bs, C-3), 103.0 (t, JC-F = 4.5 Hz, C-1), 106.7 (t, JC-
F = 10.5 Hz, C-5), 112.0 (t, JC-F = 237.5 Hz, CF2H), 137.3 (t, JC-F = 21.5 Hz, C-6), 164.5, 
165.3, 169.4 (C). 19F NMR (282 MHz, CDCl3):  = -113.1 (d, 2J = 56.4 Hz, CF2H). IR (ATR, 
cm−1): ν̃ = 3339 (w), 3095 (w), 2995 (w), 2922 (w), 2852 (w), 2820 (w), 1649 (s), 1613 (s), 
1590 (s), 1488 (w), 1436 (s), 1372 (s), 1258 (s), 1205 (s), 1107 (s), 1024 (s), 995 (s), 755 (s), 
543 (s). GC-MS (EI, 70 eV): m/z (%): 276 (M+, 27), 218 (12), 201 (41), 200 (100), 172 (18). 
HRMS (EI, 70 eV): calcd. for C12H14F2O5 (M+) 276.08038, found 276.08054.  
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Methyl 2-(trichloromethyl)-6-hydroxy-4-methoxybenzoate (9z).  
Starting with 4,4-dimethoxy-1,1,1-trichlorobut-3-en-2-one (8c) 
(0.233 g, 1.0 mmol), 1-methoxy-1,3-bis(trimethylsilyloxy)-1,3-
butadiene (3a) (0.520 g, 2.0 mmol) and TiCl4 (0.1 mL, 1 mmol) in 
CH2Cl2 (2 mL), the product 9z was isolated as a slight yellow solid 
(0.086 g, 30%); mp = 93-95°C. 1H NMR (300 MHz, CDCl3):  = 3.85 (s, 3H, OCH3), 3.92 (s, 
3H, OCH3), 6.54 (d, 4J = 3 Hz, 1H, CH), 7.34 (d, 4J = 2.4 Hz, 1H, CH), 9.61 (s, 1H, OH). 13C 
NMR (75 MHz, CDCl3):  = 52.2, 55.8 (OCH3), 96.4 (CCl3), 102.3 (Ar), 105.9 (C), 110.0 (CH), 
144.3, 161.5, 162.1, 170.0 (C). IR (ATR, cm-1): ν̃ = 3214 (w), 3120 (w), 3025 (w), 3011 (w), 
2973 (w), 2954 (w), 2844 (w), 2616 (w), 1737 (w), 1672 (s), 1612 (s), 1570 (m), 1481 (w), 
1442 (m), 1425 (s), 1326 (s), 1250 (s), 1193 (s), 1152 (s), 956 (s), 766 (s). GC-MS (EI, 70 
eV): m/Z (%): 300 (M+, 31), 299 (M+, 3), 298 (M+, 34), 270 (34), 268 (100), 267 (31), 266 (97), 
233 (30), 231 (38), 227 (41), 212 (58), 210 (27), 205 (29), 203 (40), 149 (33). HRMS (EI, 
70 eV): calcd. for C10H9Cl237ClO4 (M+) 299.95314, found 299.95339. Anal. calcd for 
C10H9Cl3O4 (299.54): C, 40.10; H, 3.03. Found: C, 40.27; H, 3.49.  
 
 
Benzyl 2-(trichloromethyl)-6-hydroxy-4-methoxybenzoate (9aa). 
Starting with 4,4-dimethoxy-1,1,1-trichlorobut-3-en-2-one (8c) 
(0.233 g, 1.0 mmol), 1-benzyloxy-1,3-bis(trimethylsilyloxy)-1,3-
butadiene (3c) (0.673 g, 2.0 mmol) and TiCl4 (0.1 mL, 1 mmol) in 
CH2Cl2 (2 mL), the product 9aa was isolated as a dark yellow solid 
(0.110 g, 30%); mp = 88-89°C. 1H NMR (300 MHz, CDCl3):  = 3.83 (s, 3H, OCH3), 6.37 (s, 
2H, CH2), 6.53 (d, 4J = 2.4 Hz, 1H, CH), 7.30-7.46 (m, 6H, CH+Ph), 9.49 (s, 1H, OH). 13C 
NMR (75 MHz, CDCl3):  = 55.7 (OCH3), 68.2 (CH2), 96.3 (CCl3), 102.3 (Ar), 105.2 (C), 
109.9, 128.5, 128.7, 129.4 (CH), 134.1, 144.2, 161.2, 162.0, 169.4 (C). IR (ATR, cm-1): 
ν̃ = 3235 (w), 3087 (w), 3063 (w), 3027 (w), 2961 (w), 2936 (w), 2685 (w), 1703 (s), 1606 (s), 
1589 (m), 1497 (m), 1452 (m), 1257 (s), 1158 (s), 957 (s), 768 (s), 708 (s), 579 (s). HRMS 
(ESI): calcd. for C16H13Cl3NaO4 (M+Na+) 396.9771, found 396.9764.  
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Methyl 6-(trichloromethyl)-2-hydroxy-4-methoxy-3-methylbenzoate (9ab) and methyl 4-
(trichloromethyl)-2-hydroxy-6-methoxy-3-methylbenzoate (10ab). 
OH
OMe
O
CCl3MeO
Me
OH
OMe
O
OMeCl3C
Me
 
Starting with 4,4-dimethoxy-1,1,1-trichlorobut-3-en-2-one (8c) (0.233 g, 1.0 mmol), 1-
methoxy-1,3-bis(trimethylsilyloxy)-1,3-pentadiene (3j) (0.549 g, 2.0 mmol) and TiCl4 (0.1 mL, 
1 mmol) in CH2Cl2 (2 mL), a mixture of regioisomers 9ab and 10ab (1 : 0.1) was isolated as a 
white solid (0.130 g, 42%). 1H NMR (300 MHz, CDCl3): for 9ab  = 2.13 (s, 3H, CH3), 3.92 
(bs, 6H, (OCH3)2), 7.31 (s, 1H, CH), 9.28 (s, 1H, OH); for 10ab  = 2.12 (s, 0.3H, CH3), 3.96 
(s, 0.3H, OCH3), 4.02 (s, 0.3H, OCH3), 7.22 (s, 0.1H, CH), 11.54 (s, 0.08H, OH). 13C NMR 
(75 MHz, CDCl3): for 9ab  = 8.42 (CH3), 52.3, 55.7 (OCH3), 97.0 (CCl3), 103.6 (Ar), 106.9, 
116.4, 141.2, 157.4, 159.3, 170.5 (C). 
 
 
Methyl 6-(trichloromethyl)-3-ethyl-2-hydroxy-4-methoxybenzoate (9ac). 
Starting with 4,4-dimethoxy-1,1,1-trichlorobut-3-en-2-one (8c) 
(0.233 g, 1.0 mmol), 1-benzyloxy-1,3-bis(trimethylsilyloxy)-1,3-
hexadiene (3k) (0.576 g, 2.0 mmol) and TiCl4 (0.1 mL, 1 mmol) in 
CH2Cl2 (2 mL), the product 9ac was isolated as a white crystalline 
solid (0.152 g, 46%); mp = 120-122°C. 1H NMR (300 MHz, CDCl3):  = 1.10 (t, 3J = 7.5 Hz, 
3H, CH3), 2.68 (q, 3J = 7.5 Hz, 2H, CH2), 3.91 (s, 3H, OCH3), 3.92 (s, 3H, OCH3), 7.31 (s, 1H, 
CH), 9.23 (s, 1H, OH). 13C NMR (75 MHz, CDCl3):  = 12.8 (CH3), 16.5 (CH2), 52.3, 55.7 
(OCH3), 97.0 (CCl3), 103.9 (Ar), 107.1, 122.3, 141.3, 157.2, 159.0, 170.5 (C). IR (ATR, cm-1): 
ν̃ = 3254 (w), 3130 (w), 3007 (w), 2968 (w), 2953 (w), 2923 (w), 2874 (w), 2851 (w), 1664 (s), 
1602 (m), 1569 (m), 1496 (m), 1435 (m), 1285 (s), 1127 (s), 822 (s), 761 (s), 693 (s), 613 (s). 
GC-MS (EI, 70 eV): m/Z (%): 328 (M+, 16), 327 (M+, 2), 326 (M+, 17), 260 (68), 258 (100). 
HRMS (EI, 70 eV): calcd. for C12H13Cl3O4 (M+) 325.9873, found 325.9867; calcd. for 
C12H13Cl237ClO4 (M+) 327.9844, found 327.9839; calcd. for C12H13Cl37Cl2O4 (M+) 329.9814, 
found 329.9811. Anal. calcd for C12H13Cl3O4 (327.59): C, 44.00; H, 4.00. Found: C, 44.04; H, 
4.34. 
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Methyl 3-allyl-6-(trichloromethyl)-2-hydroxy-4-methoxybenzoate (9ad). 
Starting with 4,4-dimethoxy-1,1,1-trichlorobut-3-en-2-one (8c) 
(0.233 g, 1.0 mmol), 1-benzyloxy-1,3-bis(trimethylsilyloxy)-1,3,6-
heptatriene (3o) (0.601 g, 2.0 mmol) and TiCl4 (0.1 mL, 1 mmol) in 
CH2Cl2 (2 mL), the product 9ad was isolated as a colourless oil 
(0.109 g, 32%). 1H NMR (300 MHz, CDCl3):  = 3.42-3.45 (m, 2H, CH2), 4.97 (s, 3H, OCH3), 
4.97-5.09 (m, 2H, CH2), 5.83-5.89 (m, 2H, CH), 7.33 (s, 1H, CH), 9.22 (s, 1H, OH). 13C NMR 
(75 MHz, CDCl3):  = 27.3 (CH2), 52.3, 55.8 (OCH3), 96.9 (CCl3), 103.9 (Ar), 107.3 (C), 115.3 
(CH2), 118.0 (C), 134.9, 141.9, 157.3, 159.1, 170.3 (C). IR (ATR, cm-1): ν̃ = 3409 (w), 3079 
(w), 3005 (w), 2950 (w), 2847 (w), 1673 (m), 1638 (w), 1600 (m), 1573 (w), 1497 (w), 1276 
(s), 1186 (s), 1155 (s), 1113 (s), 1034 (s), 758 (s), 603 (s), 370 (s). GC-MS (EI, 70 eV): m/Z 
(%): 340 (M+, 26), 339 (M+, 4), 338 (M+, 28), 303 (30), 273 (50), 272 (76), 271 (78), 270 
(100), 237 (26), 207 (49). HRMS (EI, 70 eV): calcd. for C13H13Cl3O4 (M+) 337.9873, found 
337.9871. Anal. calcd for C13H13Cl3O4 (339.60): C, 45.98; H, 3.86. Found: C, 48.22; H, 4.34. 
 
 
Methyl 6-(trichloromethyl)-2-hydroxy-3-isopentyl-4-methoxybenzoate (9ae) and methyl 
4-(trichloromethyl)-2-hydroxy-3-isopentyl-6-methoxybenzoate (10ae). 
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Starting with 4,4-dimethoxy-1,1,1-trichlorobut-3-en-2-one (8c) (0.233 g, 1.0 mmol), 1-
methoxy-7-methyl-1,3-bis(trimethylsilyloxy)-1,3-octadiene (3u) (0.689 g, 2.0 mmol) and TiCl4 
(0.1 mL, 1 mmol) in CH2Cl2 (2 mL), a mixture of regioisomers 9ae and 10ae (1 : 0.3) was 
isolated as a colourless oil (0.153 g, 41%). 1H NMR (300 MHz, CDCl3): for 9ae  = 0.94 (d, 
3J = 6.0 Hz, 6H, (CH3)2), 1.32-1.43 (m, 2H, CH2), 1.52-1.63 (m, 2H, CH2), 2.62-2.68 (m, 2H, 
CH2), 3.91 (s, 3H, OCH3), 3.92 (s, 3H, OCH3), 7.30 (s, 1H, CH), 9.21 (s, 1H, OH); for 10ae 
 = 0.87 (s, 3J = 9.0 Hz, 6H, CH3) 1.32-1.43 (m, 0.6H, CH2), 1.52-1.63 (m, 0.6H, CH2), 2.62-
2.68 (m, 0.6H, CH2), 3.94 (s, 1H, OCH3), 4.01 (s, 1H, OCH3), 7.20 (s, 1H, CH), 11.48 (s, 1H, 
OH). 13C NMR (75 MHz, CDCl3): for 9ae  = 21.2 (CH2), 22.5 (CH3), 28.3 (CH), 37.5 (CH2), 
52.3, 55.7 (OCH3), 97.1 (CCl3), 103.9 (Ar), 107.0, 121.4, 141.2, 157.3, 159.2, 170.5 (C). 
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Methyl 6-(trichloromethyl)-3-(3-chloropropyl)-2-hydroxy-4-methoxybenzoate (9af). 
Starting with 4,4-dimethoxy-1,1,1-trichlorobut-3-en-2-one (9c) 
(0.233 g, 1.0 mmol), 1-methoxy-7-cloro-1,3-
bis(trimethylsilyloxy)-1,3-heptadiene (3ag) (0.674 g, 2.0 mmol) 
and TiCl4 (0.1 mL, 1 mmol) in CH2Cl2 (2 mL), the product 9af 
was isolated as a slight yellow solid (0.171 g, 45%); mp = 69-70°C. 1H NMR (300 MHz, 
CDCl3):  = 1.95-2.05 (m, 2H, CH2), 2.80 (t, 3J = 7.3 Hz, 2H, CH2), 3.54 (t, 3J = 7.4 Hz, 2H, 
CH2), 3.92 (s, 3H, OCH3), 3.93 (s, 3H, OCH3), 7.32 (s, 1H, CH), 9.32 (s, 1H, OH). 13C NMR 
(75 MHz, CDCl3):  = 20.7, 31.4, 44.9 (CH2), 52.4, 55.8 (OCH3), 96.9 (CCl3), 103.8 (Ar), 
107.1 (C), 119.0, 141.9, 157.5, 159.3, 170.4 (C). IR (ATR, cm-1): ν̃ = 3307 (w), 3002 (w), 
2950 (w), 2848 (w), 1674 (m), 1600 (m), 1573 (w), 1497 (w), 1435 (m), 1280 (s), 1153 (s), 
1109 (s), 761 (s), 697 (s). MS (EI, 70 eV): m/Z (%): 376 (M+, 10), 309 (93), 307 (100), 246 
(34), 244 (53). HRMS (EI, 70 eV): calcd. for C13H14Cl4O4 (M+) 373.9640, found 373.9646; 
calcd. for C13H14Cl337ClO4 (M+) 375.9611, found 375.9615; calcd. for C13H14Cl237Cl2O4 (M+) 
377.9581, found 377.9588. Anal. calcd for C13H14Cl4O4 (376.06): C, 41.52; H, 3.75. Found: C, 
42.32; H, 4.14. 
 
 
 
GP 2: General procedure for the synthesis of 6-methylthio-4-(trifluoromethyl)salicylates 10 
and 4-methylthio-6-(trifluoromethyl)salicylates 9. 
 
To a CH2Cl2 solution (1 mL/1.0 mmol of 8d) of 8d (1.0 mmol) was added 3 (2.0 mmol) and, 
subsequently, TiCl4 (0.1 mL, 1.0 mmol) at −78 °C. The temperature of the solution was 
allowed to warm to 20 °C during 12−14 h with stirring. To the solution was added 
hydrochloric acid (10%, 10 mL) and the organic and the aqueous layer were separated. The 
latter was extracted with CH2Cl2 (2 × 10 mL). The combined organic layers were dried 
(Na2SO4), filtered and the filtrate was concentrated in vacuo. The residue was purified by 
chromatography to obtain 10ai-aq. The purification of 10ar-bb afforded a regioisomer 
mixture with 9ar-bb. 
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Methyl 2-hydroxy-6-(methylthio)-4-(trifluoromethyl)benzoate (10aj). 
Starting with 4,4-dimethylthio-1,1,1-trifluorobut-3-en-2-one (8d) 
(0.216 g, 1.0 mmol), 1-methoxy-1,3-bis(trimethylsilyloxy)-1,3-butadiene 
(3a) (0.521 g, 2.0 mmol) and TiCl4 (0.11 mL, 1.0 mmol) in CH2Cl2 
(1.0 mL), the product 10aj was isolated as a colourless solid (0.138 g, 
52%); mp = 91 °C. 1H NMR (300 MHz, CDCl3): δ = 2.47 (s, 3H, SCH3), 4.04 (s, 3H, OCH3), 
6.86 (brs, 1H, CH), 6.99 (d, 4J = 1.1 Hz, 1H, CH), 11.46 (s, 1H, OH). 13C NMR (63 MHz, 
CDCl3): δ = 16.4 (SCH3), 52.4 (OCH3), 110.7 (q, JC-F = 3.8 Hz, C-3), 111.3 (q, JC-F = 3.8 Hz, 
C-5), 112.5 (C-1), 123.1 (q, JC-F = 273.4 Hz, CF3), 135.4 (q, JC-F = 32.8 Hz, C-4), 146.0, 
163.4, 170.2 (C). 19F NMR (282 MHz, CDCl3): δ = -64.2 (CF3). IR (ATR, cm-1): ν̃ = 3041 (w), 
2960 (w), 2922 (w), 1667 (w), 1610 (w), 1575 (w), 1557 (w), 1441 (w), 1416 (w), 1351 (w), 
1338 (w), 1292 (w), 1107 (m), 929 (m), 799 (m), 744 (m), 699 (m). GC-MS (EI, 70 eV): m/z 
(%): 266 (M+, 52), 236 (11), 235 (18), 234 (100), 206 (47), 191 (39), 163 (7). HRMS (EI, 70 
eV): calcd. for C10H9F3O3S (M+) 266.02190, found 266.021597. Anal. calcd. for C10H9F3O3S 
(266.24): C, 45.11; H, 3.41. Found: C, 45.30; H, 3.09. 
 
 
Ethyl 2-hydroxy-6-(methylthio)-4-(trifluoromethyl)benzoate (10ak).  
Starting with 4,4-dimethylthio-1,1,1-trifluorobut-3-en-2-one (8d) 
(0.216 g, 1.0 mmol), 1-ethoxy-1,3-bis(trimethylsilyloxy)-1,3-butadiene 
(3b) (0.549 g, 2.0 mmol) and TiCl4 (0.11 mL, 1.0 mmol) in CH2Cl2 
(1.0 mL), the product 10ak was isolated as a colourless solid (0.143 g, 
51%); mp = 65-66 °C. 1H NMR (300 MHz, CDCl3): δ = 1.49 (t, 3J = 7.1 Hz, 3H, CH3), 2.46 (s, 
3H, SCH3), 4.52 (q, 3J = 7.2 Hz, 2H, CH2), 6.85 (brs, 1H, CH), 6.98 (d, 4J = 1.1 Hz, 1H, CH), 
11.57 (s, 1H, OH). 13C NMR (63 MHz, CDCl3): δ = 14.1 (CH3), 16.4 (SCH3), 62.8 (CH2), 
110.7 (q, JC-F = 3.8 Hz, C-3), 111.2 (q, JC-F = 3.8 Hz, C-5), 112.7 (C-1), 123.2 (q, JC-F = 273.3 
Hz, CF3), 135.3 (q, JC-F = 32.7 Hz, C-4), 146.2, 163.4,  169.8 (C). 19F NMR (282 MHz, CDCl3): 
δ = -64.1 (CF3). IR (ATR, cm-1): ν̃ = 3000 (w), 2925 (w), 1661 (w), 1607 (w), 1576 (w), 1466 
(w), 1450 (w), 1412 (w), 1374 (w), 1349 (m), 1289 (m), 1221 (m), 1014 (w), 956 (m), 801 (m), 
773 (w), 698 (m). GC-MS (EI, 70 eV): m/z (%): 280 (M+, 40), 235 (21), 234 (100), 206 (42), 
191 (29). HRMS (EI, 70 eV): calcd. for C11H11F3O3S (M+) 280.03755, found 280.038326. 
Anal. calcd. for C11H11F3O3S (280.26): C, 47.14; H, 3.96. Found: C, 47.08; H, 3.33. 
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Benzyl 2-hydroxy-6-(methylthio)-4-(trifluoromethyl)benzoate (10al). 
Starting with 4,4-dimethylthio-1,1,1-trifluorobut-3-en-2-one (8d) 
(0.216 g, 1.0 mmol), 1-benzyloxy-1,3-bis(trimethylsilyloxy)-1,3-
butadiene (3c) (0.673 g, 2.0 mmol) and TiCl4 (0.11 mL, 1.0 mmol) in 
CH2Cl2 (1.0 mL), the product 10al was isolated as slight yellow solid 
(0.175 g, 51%); mp = 82-84 °C. 1H NMR (300 MHz, CDCl3): δ = 2.44 (s, 3H, SCH3), 5.50 (s, 
2H, CH2), 6.85 (brs, 1H, CH), 6.98 (d, 4J = 0.9 Hz, 1H, CH), 7.36-7.53 (m, 5H, Ph), 11.48 (s, 
1H, OH). 13C NMR (75 MHz, CDCl3): δ = 16.5 (SCH3), 68.0 (OCH2), 110.7 (q, JC-F = 3.9 Hz, 
C-3), 111.2 (q, JC-F = 3.9 Hz, C-5), 112.5 (C-1), 123.1 (q, JC-F = 273.4 Hz, CF3), 128.5, 128.7, 
128.7 (CH), 134.4 (C), 135.4 (q, JC-F = 32.8 Hz, C-4), 146.3, 163.5, 169.6 (C). 19F NMR (282 
MHz, CDCl3): δ = -64.2 (CF3). IR (ATR, cm-1): ν̃ = 3031 (w), 2988 (w), 2956 (w), 2925 (w), 
1731 (w), 1698 (w), 1663 (m), 1611 (w), 1600 (w), 1577 (m), 1496 (m), 1455 (w), 1428 (m), 
1412 (m), 1387 (m), 1342 (m), 1289 (s), 1218 (s), 1182 (s), 1116 (s), 964 (s), 909 (s), 860 
(s), 846 (s), 799 (s), 762 (m), 746 (s), 695 (s). GC-MS (EI, 70 eV): m/z (%): 342 (M+, 33), 92 
(9), 91 (100). HRMS (EI, 70 eV): calcd. for C16H13F3O3S (M+) 342.05320, found 342.053391. 
 
 
Isopropyl 2-hydroxy-6-(methylthio)-4-(trifluoromethyl)benzoate (10am). 
Starting with 4,4-dimethylthio-1,1,1-trifluorobut-3-en-2-one (8d) 
(0.216 g, 1.0 mmol), 1-isopropyloxy-1,3-bis(trimethylsilyloxy)-1,3-
butadien (3d) (0.577 g, 2.0 mmol) and TiCl4 (0.11 mL, 1.0 mmol) in 
CH2Cl2 (1.0 mL), the product 10am was isolated as a colourless oil 
(0.164 g, 56%). 1H NMR (300 MHz, CDCl3): δ = 1.48 (d, 3J = 6.2 Hz, 6H, (CH3)2), 2.45 (s, 3H, 
SCH3), 5.31-5.44 (m, 1H, OCH), 6.85 (bs, 1H, CH), 6.97 (d, 3J = 1.1 Hz, 1H, CH), 11.65 (s, 
1H, OH). 13C NMR (75 MHz, CDCl3): δ = 16.5 (SCH3), 22.1 (CH3), 71.8 (CH), 110.6 (q, JC-F = 
3.9 Hz, C-3), 111.2 (q, JC-F = 3.9 Hz, C-5), 113.0 (C-1), 123.2 (q, JC-F = 273.4 Hz, CF3), 135.1 
(q, JC-F = 32.6 Hz, C-4), 146.2, 163.4, 169.4 (C). 19F NMR (282 MHz, CDCl3): δ = -64.1 (CF3). 
IR (ATR, cm-1): ν̃ = 2985 (w), 2925 (w), 1724 (w), 1660 (m), 1609 (m), 1575 (m), 1468 (w), 
1455 (w), 1412 (s), 1373 (m), 1342 (s), 1289 (s), 1276 (m), 1221 (s), 1190 (s), 1123 (s), 
1097 (s), 959 (s), 907 (m), 805 (m), 758 (m), 699 (s). GC-MS (EI, 70 eV): m/z (%): 294 (M+, 
24), 252 (17), 235 (22), 234 (100), 206 (27), 191 (16). HRMS (EI, 70 eV): calcd. for 
C12H13F3O3S (M+) 294.05320, found 294.053170. Anal. calcd. for C12H13F3O3S (294.29): C, 
48.97; H, 4.45. Found: C, 48.99; H, 4.32. 
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Isobutyl 2-hydroxy-6-(methylthio)-4-(trifluoromethyl)benzoate (10an).  
Starting with 4,4-dimethylthio-1,1,1-trifluorobut-3-en-2-one (8d) 
(0.216 g, 1.0 mmol), 1-isobutyloxy-1,3-bis(trimethylsilyloxy)-1,3-
butadiene (3f) (0.605 g, 2.0 mmol) and TiCl4 (0.11 mL, 1.0 mmol) in 
CH2Cl2 (1.0 mL), the product 10an was isolated as a colourless solid 
(0.150 g, 49%); mp = 49-50 °C. 1H NMR (300 MHz, CDCl3): δ = 1.08 (d, 3J = 6.8 Hz, 6H, 
(CH3)2), 2.12-2.25 (m, 1H, CH), 2.47 (s, 3H, SCH3), 4.25 (d, 3J = 6.4 Hz, 2H, CH2), 6.86 (brs, 
1H, CH), 6.98 (d, 4J = 1.1 Hz, 1H, CH), 11.69 (s, 1H, OH). 13C NMR (75 MHz, CDCl3): 
δ = 16.5 (SCH3), 19.3 (CH3), 27.6 (CH), 73.1 (CH2), 110.7 (q, JC-F = 3.9 Hz, C-3), 111.1 (q, 
JC-F = 3.9 Hz, C-5), 112.7 (C-1), 123.2 (q, JC-F = 273.4 Hz, CF3), 135.3 (q, JC-F = 32.6 Hz, C-4), 
146.1, 163.3, 170.1 (C). 19F NMR (282 MHz, CDCl3): δ = -64.1 (CF3). IR (ATR, cm-1): 
ν̃ = 3067 (w), 2967 (w), 2924 (w), 2873 (w), 1666 (s), 1610 (w), 1571 (m), 1465 (w), 1414 
(m), 1381 (m), 1369 (m), 1342 (s), 1222 (m), 1184 (s), 1114 (s), 956 (m), 938 (s), 776 (m), 
697 (s). GC-MS (EI, 70 eV): m/z (%): 308 (M+, 27), 252 (11), 235 (25), 234 (100), 206 (20), 
191 (12). HRMS (EI, 70 eV): calcd. for C13H15F3O3S (M+) 308.06885, found 308.068642. 
Anal. calcd. for C13H15F3O3S (308.07): C, 50.64; H, 4.90. Found: C, 49.96; H, 4.77. 
 
 
Isopentyl 2-hydroxy-6-(methylthio)-4-(trifluoromethyl)benzoate (10ao). 
Starting with 4,4-dimethylthio-1,1,1-trifluorobut-3-en-2-one (8d) 
(0.216 g, 1.0 mmol), 1-isopentyloxy-1,3-bis(trimethylsilyloxy)-1,3-
butadiene (3g) (0.633 g, 2.0 mmol) and TiCl4 (0.11 mL, 1.0 mmol) in 
CH2Cl2 (1.0 mL), the product 10ao was isolated as a colourless solid 
(0.180 g, 56%); mp = 32-33 °C. 1H NMR (300 MHz, CDCl3): δ = 0.98 (d, 3J = 6.4 Hz, 6H, 
(CH3)2), 1.71-1.93 (m, 3H, CH2+CH), 2.46 (s, 3H, SCH3), 4.49 (t, 3J = 6.8 Hz, 2H, CH2), 6.85 
(brs, 1H, CH), 6.98 (brs, 1H, CH), 11.63 (s, 1H, OH). 13C NMR (75 MHz, CDCl3): 
δ = 16.5 (SCH3), 22.4 (CH3), 25.0 (CH), 37.1 (CH2), 65.5 (OCH2), 110.7 (q, JC-F = 3.9 Hz, C-
3), 111.2 (q, JC-F = 3.9 Hz, C-5), 112.7 (C-1), 123.2 (q, JC-F = 273.4 Hz, CF3), 135.3 (q, JC-F = 
32.6 Hz, C-4), 146.1, 163.5,  170.0 (C). 19F NMR (282 MHz, CDCl3): δ = -64.1 (CF3). IR 
(ATR, cm-1): ν̃ = 2959 (w), 2929 (w), 2872 (w), 1726 (w), 1665 (m), 1608 (w), 1575 (m), 1464 
(w), 1412 (s), 1349 (s), 1289 (s), 1220 (s), 1189 (s), 1118 (s), 963 (m), 934 (m), 803 (m), 758 
(m), 699 (s). GC-MS (EI, 70 eV): m/z (%): 322 (M+, 28), 252 (11), 235 (32), 234 (100), 206 
(18), 191 (11). HRMS (EI, 70 eV): calcd. for C14H17F3O3S (M+) 322.08450, found 322.084625. 
Anal. calcd. for C14H17F3O3S (323.09): C, 52.16; H, 5.32. Found: C, 52.25; H, 5.30. 
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Octyl 2-hydroxy-6-(methylthio)-4-(trifluoromethyl)benzoate (10ap).
Starting with 4,4-dimethylthio-1,1,1-trifluorobut-3-en-2-one (8d) 
(0.216 g, 1.0 mmol), 1-octyloxy-1,3-bis(trimethylsilyloxy)-1,3-
butadiene (3h) (0.717 g, 2.0 mmol) and TiCl4 (0.11 mL, 1.0 mmol) in 
CH2Cl2 (1.0 mL), the product 10ap was isolated as a colourless solid 
(0.200 g, 55%); mp = 49-50 °C. 1H NMR (300 MHz, CDCl3): δ = 0.89 (t, 3J = 6.7 Hz, 3H, 
CH3), 1.26-1.54 (m, 12H, (CH2)6), 2.46 (s, 3H, SCH3), 4.45 (t, 3J = 6.6 Hz, 2H, OCH2), 6.86 
(brs, 1H, CH), 6.98 (d, 4J = 1.1 Hz, 1H, CH), 11.63 (s, 1H, OH). 13C NMR (63 MHz, CDCl3): 
δ = 14.1 (CH3), 16.5 (SCH3), 22.6, 26.0, 28.4, 29.1, 29.1, 31.7 (CH2), 67.0 (OCH2), 110.7 (q, 
JC-F = 3.8 Hz, C-3), 111.2 (q, JC-F = 3.8 Hz, C-5), 112.7 (C-1), 123.2 (q, JC-F = 273.4 Hz, CF3), 
135.2 (q, JC-F = 32.7 Hz, C-4), 146.1, 163.5, 170.0 (C). 19F NMR (282 MHz, CDCl3): δ = -64.1 
(CF3). IR (ATR, cm-1): ν̃ = 2956 (w), 2924 (m), 2855 (w), 2158 (w), 1976 (w), 1665 (m), 1636 
(w), 1608 (w), 1575 (m), 1457 (w), 1412 (m), 1346 (s), 1289 (s), 1220 (s), 1189 (s), 1118 (s), 
961 (m), 938 (m), 804 (m), 756 (m), 699 (s). GC-MS (EI, 70 eV): m/z (%): 364 (M+, 17), 252 
(11), 235 (28), 234 (100), 206 (11). HRMS (EI, 70 eV): calcd. for C17H23F3O3S (M+) 
364.13145, found 364.130709. Anal. calcd. for C17H23F3O3S (364.42): C, 56.03; H, 6.36. 
Found: C, 56.20; H, 6.39. 
 
4-Trifluoromethyl-2-hydroxy-6-(methylthio)benzophenone (10aq). 
Starting with 4,4-dimethylthio-1,1,1-trifluorobut-3-en-2-one (8d) 
(0.216 g, 1.0 mmol), 1-phenyl-1,3-bis(trimethylsilyloxy)-1,3-butadiene 
(3ak) (0.613 g, 2.0 mmol) and TiCl4 (0.11 mL, 1.0 mmol) in CH2Cl2 
(1.0 mL), the product 10aq was isolated as a brown solid (0.120 g, 
39%); mp = 133 °C. 1H NMR (300 MHz, CDCl3): δ = 2.36 (s, 3H, SCH3), 7.07 (s, 1H, CH), 
7.08 (s, 1H, CH), 7.45-7.50 (m, 2H, Ph), 7.59-7.65 (m, 1H, Ph), 7.75-7.79 (m, 2H, Ph), 8.13 
(brs, 1H, OH). 13C NMR (63 MHz, CDCl3): δ = 17.5 (SCH3), 111.6 (q, JC-F = 3.8 Hz, C-3), 
115.5 (q, JC-F = 4.0 Hz, C-5), 123.2 (q, JC-F = 273.1 Hz, CF3), 126.3 (C-1) 128.8, 129.5, 133.9 
(CH), 134.1 (q, JC-F = 33.0 Hz, C-4), 137.6, 141.5, 157.0, 197.9 (C). 19F NMR (282 MHz, 
CDCl3): δ = -63.5 (CF3). IR (ATR, cm-1): ν̃ = 3331 (w), 3081 (w), 3064 (w), 2928 (w), 1679 
(w), 1653 (m), 1594 (w), 1579 (w), 1484 (m), 1448 (m), 1416 (w), 1345 (w), 1324 (w), 1309 
(w), 1284 (w), 1265 (w), 1244 (w), 1128 (m), 1087 (m), 954 (m), 924 (m), 856 (m), 713 (m), 
683 (m), 626 (w). GC-MS (EI, 70 eV): m/z (%): 312 (M+, 14), 311 (10), 297 (21), 295 (18), 
294 (72), 293 (100), 235 (14), 105 (22), 77 (39), 51 (10), 32 (20), 91 (100). HRMS (EI, 
70 eV): calcd. for C15H11F3O2S (M+) 312.04264, found 312.042315. Anal. calcd. for 
C15H11F3O2S (312.31): C, 57.69; H, 3.55. Found: C, 57.51; H, 3.57. 
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Methyl 4-(trifluoromethyl)-2-hydroxy-6-methoxy-3-propylbenzoate (9at) and methyl 6-
(trifluoromethyl)-2-hydroxy-4-methoxy-3-propylbenzoate (10at). 
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Starting with 4,4-dimethylthio-1,1,1-trifluorobut-3-en-2-one (8d) (0.216 g, 1.0 mmol), 1-
methoxy-1,3-bis(trimethylsilyloxy)-1,3-heptadiene (3p) (0.605 g, 2.0 mmol) and TiCl4 
(0.11 mL, 1.0 mmol) in CH2Cl2 (1.0 mL), the isomer mixture of 9at and 10at was isolated as a 
colourless oil (0.119 g, 39%). 1H NMR (300 MHz, CDCl3): δ = 1.00, 1.01 (t, 3J = 7.4 Hz, 3H, 
CH3), 1.51 – 1.65 (m, 2H, CH2), 2.45, 2.51 (s, 3H, SCH3), 2.70 (t, 3J = 8.0 Hz, 2H, CH2), 2.76 
(t, 3J = 7.9 Hz, 2H, CH2), 3.96, 4.03 (s, 3H, OCH3), 6.90, 7.07 (brs, 1H, Ph), 11.18, 11.78 (s, 
1H, OH). 13C NMR (63 MHz, CDCl3): δ = 14.3 14.5 (CH3), 14.8, 16.2 (SCH3), 20.9, 22.7, 
28.6, 29.1 (CH2), 52.4, 52.7 (OCH3), 106.5, 112.1 (C-3), 111.5 (q, JC-F = 6.4 Hz, C-5), 
113.9 (q, JC-F = 7.2 Hz, C-5), 123.5 (q, JC-F = 273.3 Hz, CF3), 123.8 (q, JC-F = 275.1 Hz, CF3), 
126.3, 131.9 (C-1), 127.8 (q, JC-F = 31.9 Hz, CCF3), 133.1 (q, JC-F = 29.3 Hz, CCF3), 141.4, 
145.6, 159.3, 162.3, 170.2, 170.8 (C). 19F NMR (282 MHz, CDCl3): δ = -60.5, -58.7 (CF3). 
 
Methyl 4-(trifluoromethyl)-2-hydroxy-6-methoxy-3-pentylbenzoate (9aw) and methyl 6-
(trifluoromethyl)-2-hydroxy-4-methoxy-3-pentylbenzoate (10aw). 
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Starting with 4,4-dimethylthio-1,1,1-trifluorobut-3-en-2-one (8d) (0.216 g, 1.0 mmol), 1-
ethoxy-1,3-bis(trimethylsilyloxy)-1,3-nonadiene (3t) (0.689 g, 2.0 mmol) and TiCl4 (0.11 mL, 
1.0 mmol) in CH2Cl2 (1.0 mL), the isomer mixture of 9aw and 10aw was isolated as a 
colourless oil (0.127 g, 36%). 1H NMR (300 MHz, CDCl3): δ = 0.91, 0.91 (t, 3J = 7.1 Hz, 3H, 
CH3), 1.36 – 1.59 (m, 9H, CH3(CH2)3), 2.44, 2.51 (s, 3H, SCH3), 2.71, 2.77 (t, 3J = 7.8 Hz, 2H, 
CH2), 4.42, 4.52 (q, 3J = 7.2 Hz, 2H, OCH2), 6.90, 7.07 (brs, 1H, Ph), 11.31, 11.86 (s, 1H, 
OH). 13C NMR (63 MHz, CDCl3): δ = 13.5, 14.0, 14.0, 14.2 (2CH3) 14.8, 16.3 (SCH3), 22.4, 
22.5, 26.6, 27.1, 27.2, 29.1, 32.0, 32.3 (CH2), 62.3, 62.7 (OCH2), 106.7, 112.3 (C-3), 113.9 
(q, JC-F = 7.3 Hz, C-5), 111.4 (q, JC-F = 6.3 Hz, C-5), 123.5 (q, JC-F = 273.3 Hz, CF3), 
123.9 (q, JC-F = 275.1 Hz, CF3), 126.5, 132.1, (C-1), 127.7 (q, JC-F = 31.6 Hz, CCF3), 132.9 
(q, JC-F = 29.3 Hz, CCF3), 145.2, 141.5, 159.4, 162.3, 169.8, 170.4 (C). 19F NMR (282 MHz, 
CDCl3): δ = -60.4, -57.9 (CF3). 
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Methyl 4-(trifluoromethyl)-2-hydroxy-6-methoxy-3-octylbenzoate (9ay) and methyl 6-
(trifluoromethyl)-2-hydroxy-4-methoxy-3-octylbenzoate (10ay). 
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Starting with 4,4-dimethylthio-1,1,1-trifluorobut-3-en-2-one (8d) (0.216 g, 1.0 mmol), 1-
methoxy-1,3-bis(trimethylsilyloxy)-1,3-dodecadiene (3x) (0.745 g, 2.0 mmol) and TiCl4 
(0.11 mL, 1.0 mmol) in CH2Cl2 (1.0 mL), the isomer mixture of 9ay and 10ay was isolated as 
a coulourless oil (0.190 g, 50%). 1H NMR (300 MHz, CDCl3): δ = 0.88, 0.89 (t, 3J = 6.7 Hz, 
3H, CH3), 1.28 – 1.58 (m, 12H, (CH2)6), 2.44, 2.51 (s, 3H, SCH3), 2.71 (t, 3J = 8.0 Hz, 2H, 
CH2), 2.77 (t, 3J = 7.8 Hz, 2H, CH2), 3.96, 4.03 (s, 3H, OCH3), 6.90, 7.07 (brs, 1H, Ph), 
11.17, 11.77 (s, 1H, OH). 13C NMR (63 MHz, CDCl3): δ = 14.1, 14.1 (CH3), 14.8, 16.2 
(SCH3), 22.7, 22.7, 26.5 27.2, 27.5, 29.2, 29.2, 29.3, 29.4, 29.4, 29.9, 30.1, 31.9, 31.9 (CH2), 
52.4, 52.7 (OCH3), 106.5, 112.1 (C-3) 113.9 (q, JC-F = 7.2 Hz, C-5), 111.5 (q, JC-F = 6.4 Hz, C-
5), 123.5 (q, JC-F = 273.3 Hz, CF3), 123.8 (q, JC-F = 275.1 Hz, CF3), 126.5, 131.9 (C-1), 127.8 
(q, JC-F = 31.7 Hz, (CCF3), 132.0 (q, JC-F = 29.6 Hz, CCF3), 141.3, 145.6, 159.4, 162.3, 170.2, 
170.8 (C). 19F NMR (282 MHz, CDCl3): δ = -60.5, -58.7 (CF3). 
 
 
 
 
GP 3: General procedure for the synthesis of 6-(trifluoromethyl)-4H-pyran-4-ones 11a-f, 6-
(difluoromethyl)-4H-pyran-4-ones 11g,h, 4-methoxy-6-(diifluoromethyl)cyclohexenones 12i-q 
and 6-methylthio-4-(trifluoromethyl)salicylates 13r-u: 
 
To a CH2Cl2 solution (10 mL/1.0 mmol of 8) of 8 (1.0 mmol) was added 3 (2.0 mmol) and, 
subsequently, Me3SiOTf (0.18 mL, 1.0 mmol) at -78 °C. The temperature of the solution was 
allowed to warm to 20 °C during 12-14 h with stirring. To the solution was added hydrochloric 
acid (10%, 10 mL) and the organic and the aqueous layer were separated. The latter was 
extracted with CH2Cl2 (2 × 10 mL). The combined organic layers were dried (Na2SO4), 
filtered and the filtrate was concentrated in vacuo. The residue was purified by 
chromatography. 
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Methyl 2-(6-(trifluoromethyl)-4-oxo-4H-pyran-2-yl)acetate (11a).  
 Starting with 1,1-dimethoxy-4,4,4-trifluorobut-1-en-3-one (8a) (0.184 g, 
1.0 mmol), 1-methoxy-1,3-bis(trimethylsilyloxy)-1,3-butadiene (3a) 
(0.520 g, 2.0 mmol) and Me3SiOTf (0.18 mL, 1.0 mmol) in CH2Cl2 (10 mL), 
the product 11a was isolated as a yellow solid (0.148 g, 63%); 
mp = 83−85 °C. 1H NMR (300 MHz, CDCl3):  = 3.63 (s, 2H, CH2), 3.78 (s, 
3H, OCH3), 6.38 (d, 4J = 2.2 Hz, 1H, CH), 6.69 (d, 4J = 2.2 Hz, 1H, CH). 13C NMR (75 MHz, 
CDCl3):  = 38.8 (CH2), 52.87 (OCH3), 114.6 (q, JC-F = 2.5 Hz, C-5), 117.5 (C-3), 118.2 (q, JC-
F = 271.9 Hz, CF3), 152.8 (q, JC-F = 39.5 Hz, C-6), 161.3, 166.9, 177.3 (C). 19F NMR 
(282 MHz, CDCl3):  = -71.2 (CF3). IR (ATR, cm−1): ν̃ = 3056 (w), 2969 (w), 2940 (w), 1726 
(s), 1672 (s), 1626 (s), 1440 (m), 1415 (m), 1342 (m), 1201 (s), 1139 (s), 1090 (s), 979 (s), 
917 (s), 719 (m). GC-MS (EI, 70 eV): m/z (%): 236 (M+, 100), 205 (10), 192 (65), 189 (13), 
149 (68), 123 (17), 99 (29), 95 (19), 69 (55), 59 (98), 39 (13). Anal. calcd. for C9H7F3O4 
(236.14): C, 45.78; H, 2.9. Found: C, 45.83; H, 3.03.  
 
 
Ethyl 2-(6-(trifluoromethyl)-4-oxo-4H-pyran-2-yl)acetate (11b).  
 Starting with 1,1-dimethoxy-4,4,4-trifluorobut-1-en-3-one (8a) (0.184 g, 
1.0 mmol), 1-ethoxy-1,3-bis(trimethylsilyloxy)-1,3-butadiene (3b) (0.549 g, 
2.0 mmol) and Me3SiOTf (0.18 mL, 1.0 mmol) in CH2Cl2 (10 mL), the 
product (11b) was isolated as a yellow solid (0.172 g, 69%); mp = 73-
75 °C. 1H NMR (300 MHz, CDCl3):  = 1.29 (t, 3J = 7.2 Hz, 3H, CH3), 3.62 
(s, 2H, CH2), 4.24 (q, 3J = 7.3 Hz, 2H, CH2), 6.38 (d, 4J = 2.3 Hz, 1H, CH), 6.69 (d, 
4J = 2.2 Hz, 1H, CH). 13C NMR (75 MHz, CDCl3):  = 14.0 (CH3), 39.2 (CH2), 62.1 (OCH2), 
114.6 (q, JC-F = 2.6 Hz, C-5), 117.5 (C-3), 120.0 (q, JC-F = 272.3 Hz, CF3), 152.6 (q, JC-
F = 39.7 Hz, C-6), 161.6, 166.4, 177.5 (C). 19F NMR (282 MHz, CDCl3):  = -71.2 (CF3). IR 
(ATR, cm-1): ν̃ = 3056 (w), 2990 (w), 2974 (w), 2936 (w), 1722 (s), 1673 (s), 1627 (s), 1414 
(m), 1367 (s), 1334 (s), 1282 (s), 1143 (s), 916 (s), 719 (s). GC-MS (EI, 70 eV): m/Z (%): 250 
(M+, 56), 205 (25), 203 (10), 178 (100), 177 (13), 149 (52), 139 (22), 99 (22), 69 (50), 39 (10). 
Anal. calcd for C10H9F3O4 (250.17): C, 48.01; H, 3.63. Found: C, 48.16; H, 3.79. 
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Benzyl 2-(6-(trifluoromethyl)-4-oxo-4H-pyran-2-yl)acetate (11c).  
 Starting with 1,1-dimethoxy-4,4,4-trifluorobut-1-en-3-one (8a) (0.184 g, 
1.0 mmol), 1-benzyloxy-1,3-bis(trimethylsilyloxy)-1,3-butadiene (3c) 
(0.673 g, 2.0 mmol) and Me3SiOTf (0.18 mL, 1.0 mmol) in CH2Cl2 (10 mL), 
the product 11c was isolated as a yellow oil (0.099 g, 32%). 1H NMR 
(300 MHz, CDCl3):  = 3.65 (s, 2H, CH2), 5.20 (s, 2H, CH2Ph), 6.36, (d, 
4J = 2.2 Hz, 1H, CH), 6.67 (d, 4J = 2.2 Hz, 1H, CH), 7.31−7.40 (m, 5H, Ph). 13C NMR 
(75 MHz, CDCl3):  = 39.0, 67.7 (CH2), 114.6 (q, JC-F = 2.5 Hz, C-5), 117.6 (C-3), 118.1 (q, JC-
F = 272.2 Hz, CF3), 128.3, 128.6, 128.7, 134.6 (Ph), 153.0 (q, JC-F = 39.5 Hz, C-6), 161.2, 
166.2, 177.3 (C). 19F NMR (282 MHz, CDCl3):  = -71.1 (CF3). IR (ATR, cm−1): ν̃ = 3070 (w), 
2938 (w), 1740 (m), 1674 (s), 1641 (m), 1619 (m), 1498 (w), 1362 (w), 1274 (s), 1147 (s), 
1083 (s), 968 (m), 877 (m), 696 (s). GC-MS (EI, 70 eV): m/z (%): 312 (M+, 0.71), 178 (59), 91 
(100), 65 (10). HRMS (EI, 70 eV): calcd. for C15H11F3O4 (M+) 312.06039, found 312.06008.  
 
 
Isopropyl 2-(6-(trifluoromethyl)-4-oxo-4H-pyran-2-yl)acetate (11d).  
 Starting with 1,1-dimethoxy-4,4,4-trifluorobut-1-en-3-one (8a) (0.184 g, 
1.0 mmol), 1-isopropyloxy-1,3-bis(trimethylsilyloxy)-1,3-butadiene (3d) 
(0.577 g, 2.0 mmol) and Me3SiOTf (0.18 mL, 1.0 mmol) in CH2Cl2 (10 mL), 
the product 11d was isolated as a yellow oil (0.170 g, 64%). 1H NMR 
(300 MHz, CDCl3):  = 1.27 (d, 3J = 9.0 Hz, 6H, (CH3)2), 3.60 (s, 2H, CH2), 
5.04−5.13 (m, 1H, CH), 6.37 (d, 4J = 2.1 Hz, 1H, CH), 6.69 (d, 4J = 2.1 Hz, 1H, CH). 13C NMR 
(75 MHz, CDCl3):  = 21.6 (CH3), 39.6 (CH2), 70.0 (CH), 114.7 (q, JC-F = 2.7 Hz, C-5), 117.5 
(C-3), 118.2 (q, JC-F = 272.0 Hz, CF3), 153.1 (q, JC-F = 39.5 Hz, C-6), 161.9, 166.0, 177.5 (C). 
19F NMR (282 MHz, CDCl3):  = -71.3 (CF3). IR (ATR, cm−1): ν̃ = 3076 (w), 2985 (w), 2940 
(w), 1735 (m), 1674 (s), 1643 (m), 1410 (w), 1361 (m), 1274 (s), 1201 (s), 1148 (s), 1083 (s), 
961 (m), 876 (m), 721 (w). GC-MS (EI, 70 eV): m/z (%): 264 (M+, 9), 205 (38), 178 (36), 177 
(11), 149 (38), 99 (11), 69 (19), 43 (100), 41 (19). Anal. calcd. for C11H11F3O4 (264.20): C, 
50.01; H, 4.20. Found: C, 50.16; H, 4.55.  
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Isobutyl 2-(6-(trifluoromethyl)-4-oxo-4H-pyran-2-yl)acetate (11e).  
 Starting with 1,1-dimethoxy-4,4,4-trifluorobut-1-en-3-one (8a) (0.184 g, 
1.0 mmol), 1-isobutyloxy-1,3-bis(trimethylsilyloxy)-1,3-butadiene (3f) 
(0.605 g, 2.0 mmol) and Me3SiOTf (0.18 mL, 1.0 mmol) in CH2Cl2 (10 mL), 
the product 11e was isolated as a brown oil (0.178 g, 64%). 1H NMR 
(300 MHz, CDCl3):  = 0.92 (d, 3J = 6.0 Hz, 6H, (CH3)2), 1.88−2.01 (m, 1H, 
CH), 3.63 (s, 2H, CH2), 3.96 (d, 3J = 6.6 Hz, 2H, CH2), 6.38 (d, 4J = 2.4 Hz, 1H, CH), 6.69 (d, 
4J = 2.1 Hz, 1H, CH). 13C NMR (100 MHz, CDCl3):  = 18.8 (CH3), 27.5 (CH), 39.2, 72.0 
(CH2), 114.6 (q, JC-F = 1.9 Hz, C-5), 117.5 (C-3), 118.2 (q, JC-F = 272.1 Hz, CF3), 152.8 (q, JC-
F = 39.6 Hz, C-6), 161.6, 166.4, 177.4 (C). 19F NMR (282 MHz, CDCl3):  = -71.1 (CF3). IR 
(ATR, cm−1): ν̃ = 3076 (w), 2965 (w), 2878 (w), 1740 (m), 1675 (s), 1644 (m), 1620 (w), 1471 
(w), 1361 (m), 1274 (s), 1201 (s), 1150 (s), 1084 (s), 973 (m), 876 (m), 721 (m). GC-MS (EI, 
70 eV): m/z (%): 278 (M+, 2), 223 (100), 205 (24), 178 (60), 177 (12), 149 (64), 99 (17), 69 
(24), 57 (51), 56 (15), 41 (39), 39 (12), 29 (15). Anal. calcd. for C12H13F3O4 (278.22): C, 
51.80; H, 4.71. Found: C, 51.84; H, 4.82 
 
 
2-Methoxyethyl 2-(6-(trifluoromethyl)-4-oxo-4H-pyran-2-yl)acetate (11f).  
 Starting with 1,1-dimethoxy-4,4,4-trifluorobut-1-en-3-one (8a) 
(0.183 g, 1.0 mmol), 1-(2-methoxyethoxy)-1,3-bis(trimethylsilyloxy)-
1,3-butadiene (3i) (0.549 g, 2.0 mmol) and Me3SiOTf (0.18 mL, 
1.0 mmol) in CH2Cl2 (10 mL), the product 11f was isolated as a 
yellow oil (0.112 g, 40%). 1H NMR (300 MHz, CDCl3):  = 3.84 (s, 
3H, OCH3), 3.61 (t, 3J = 4.5 Hz, 2H, CH2), 3.67 (s, 2H, CH2), 4.34 (t, 3J = 4.5 Hz, 2H, CH2), 
6.39 (d, 4J = 2.1 Hz, 1H, CH), 6.69 (d, 4J = 2.1 Hz, 1H, CH). 13C NMR (75 MHz, CDCl3): 
 = 39.0 (CH2), 59.0 (OCH3), 64.1, 70.2 (CH2), 114.7 (q, JC-F = 2.3 Hz, C-5), 117.7 (C-3), 
118.2 (q, JC-F = 271.5 Hz, CF3), 152.9 (q, JC-F = 39.0  Hz, C-6), 161.4, 166.6, 177.5 (C). 19F 
NMR (282 MHz, CDCl3):  = -71.2 (CF3). IR (ATR, cm-1): ν̃ = 3057 (w), 2928 (w), 2897 (w), 
2849 (w), 2825 (w), 1741 (s), 1675 (s), 1642 (m), 1620 (w), 1362 (m), 1275 (s), 1199 (m), 
1150 (s), 1084 (s), 1032 (m), 974 (m), 877 (s), 722 (s). GC-MS (EI, 70 eV): m/Z (%): 280 (M+, 
2), 250 (15), 222 (20), 178 (87), 161 (11), 149 (56), 99 (19), 69 (29), 58 (33), 45 (100), 43 
(11), 29 (16). Anal. calcd for C11H11F3O5 (280.02): C, 47.15; H, 3.96. Found: C, 47.14; H, 
4.31.  
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Ethyl 2-(6-(difluoromethyl)-4-oxo-4H-pyran-2-yl)acetate (11g).  
 Starting with 4,4-dimethoxy-1,1-difluorobut-3-en-2-one (8b) (0.166 g, 
1.0 mmol), 1-ethoxy-1,3-bis(trimethylsilyloxy)-1,3-butadiene (3b) (0.549 g, 
2.0 mmol) and Me3SiOTf (0.18 mL, 1.0 mmol) in CH2Cl2 (10 mL), the 
product 11g was isolated as an orange solid (0.140 g, 60%); mp = 49-
51 °C. 1H NMR (300 MHz, CDCl3):  = 1.29 (t, 3J = 6.0 Hz, 3H, CH3), 3.59 
(s, 2H, CH2), 4.23 (q, 3J = 7.1 Hz, 2H, CH2), 6.32 (d, 4J = 3.0 Hz, 1H, CH), 6.36 (t, 
2J = 52.5 Hz, 1H, CF2H), 6.56 (d, 4J = 3.0 Hz, 1H, CH). 13C NMR (75 MHz, CDCl3):  = 14.0 
(CH3), 39.3 (CH2), 62.0 (CH2), 108.7 (t, JC-F = 241.1 Hz, CF2H), 114.1 (t, JC-F = 3.7 Hz, C-
5),117.3 (C-3), 157.5 (t, JC-F = 27.3 Hz, C-6), 161.4, 166.7, 178.1 (C). 19F NMR (282 MHz, 
CDCl3):  = -123.4, -123.2 (CF2H). IR (ATR, cm-1): ν̃ = 3233 (w), 3055 (w), 2987 (w), 2973 
(w), 2934 (w), 2855 (w), 1724 (s), 1668 (s), 1622 (s), 1416 (m), 1371 (s), 1337 (s), 1223 (s), 
1114 (s), 1026 (s), 905 (s). GC-MS (EI, 70 eV): m/Z (%): 232 (M+, 63), 187 (24), 160 (100), 
131 (42), 121 (17), 109 (28), 69 (45), 29 (62). Anal. calcd for C10H10F2O4 (232.18): C, 51.73; 
H, 4.34. Found: C, 51.14; H, 4.58. 
 
 
Methyl 2-(6-(difluoromethyl)-4-oxo-3-propyl-4H-pyran-2-yl)acetate (11h).  
Starting with 4,4-dimethoxy-1,1-difluorobut-3-en-2-one (8b) (0.166 g, 
1.0 mmol), 1-methoxy-1,3-bis(trimethylsilyloxy)-1,3-heptadiene (3p) 
(0.605 g, 2.0 mmol) and Me3SiOTf (0.18 mL, 1.0 mmol) in CH2Cl2 (10 mL), 
the product 11h was isolated as an orange oil (0.082 g, 32%). 1H NMR 
(300 MHz, CDCl3): δ = 0.94 (t, 3J = 7.4 Hz, 3H, CH3), 1.41-1.53 (m, 2H, 
CH2), 2.38 (t, 3J = 7.8 Hz, 2H, CH2), 3.67 (s, 2H, CH2), 3.76 (s, 3H, OCH3), 6.31 (t, 
2J = 53.7 Hz, 1H, CF2H), 6.54 (s, 1H, CH). 13C NMR (75 MHz, CDCl3): δ = 14.0 (CH3), 21.5, 
26.5, 37.0 (CH2), 52.7 (OCH3), 108.8 (t, JC-F = 242.4 Hz, CF2H), 112.8 (t, JC-F = 3.9 Hz, C-5), 
129.1 (C-3), 156.6 (t, JC-F = 27.8Hz, C-6), 157.3, 167.8, 178.1 (C). 19F NMR (282 MHz, 
CDCl3): δ = -123.7, -123.5 (CF2H). IR (ATR, cm-1): ν̃ = 3083 (w), 2961 (w), 2936 (w), 
2874 (w), 1741 (s), 1668 (s), 1631 (m), 1609 (s), 1456 (w), 1434 (m), 1420 (m), 1380 (m), 
1338 (m),  1309 (m), 1262 (m), 1195 (m), 1177 (m), 1158 (m), 1136 (s), 1092 (s), 1051 (s), 
1011 (m), 873 (m), 801 (m), 649 (w). GC-MS (EI, 70 eV): m/z (%): 260 (M+, 24), 259 (10), 
246 (11), 245 (100), 232 (50), 229 (17), 228 (24), 213 (14), 201 (41), 200 (12), 199 (25), 187 
(63), 185 (31), 174 (44), 173 (22), 121 (13), 79 (16), 77 (11), 69 (18), 59 (18), 53 (14), 51 
(14). Anal. calcd for C12H14F2O4 (260.23): C, 55.38; H, 5.42. Found: C, 55.16; H, 5.44. 
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Methyl 6-(trifluoromethyl)-6-hydroxy-4-methoxy-3-methyl-2-oxocyclohex-3-
enecarboxylate (12i).  
Starting with 1,1-dimethoxy-4,4,4-trifluorobut-1-en-3-one (8a) 
(0.184 g, 1.0 mmol), 1-methoxy-1,3-bis(trimethylsilyloxy)-1,3-
pentadiene (3j) (0.549 g, 2.0 mmol) and Me3SiOTf (0.18 mL, 
1.0 mmol) in CH2Cl2 (10 mL), the product 12i was isolated as a light 
yellow solid (0.107 g, 38%); mp = 123-126 °C. 1H NMR (300 MHz, CDCl3):  = 1.72-1.74 (m, 
3H, CH3), 2.78 (brd, 2J = 17.6 Hz, 1H, H-5a), 2.95 (d, 2J = 17.5 Hz, 1H, H-5b), 3.69 (s, 0.5H, 
H-1a), 3.70 (s, 0.5H, H-1b), 3.88 (s, 3H, OCH3), 3.89 (s, 3H, OCH3), 5.49 (s, 0.5H, OH-a), 
5.50 (s, 0.5H, OH-b). 13C NMR (100 MHz, CDCl3):  = 7.3 (CH3), 30.4 (C-5), 52.9 (C-1), 53.1, 
55.7 (OCH3), 74.1 (q, JC-F = 29.1 Hz, C-6), 113,4 (C-3), 124.5 (q, JC-F = 286.4 Hz, CF3), 
166.4, 171.3, 188.4 (C). 19F-NMR (282 MHz, CDCl3):  = -81.2 (CF3). IR (ATR, cm−1): 
ν̃ = 3428 (w), 3013 (w), 2965 (w), 2926 (w), 2867 (w), 1739 (s), 1648 (m), 1613 (s), 1461 (w), 
1440 (w), 1164 (s), 1117 (s), 1063 (s), 972 (s), 688 (m). GC-MS (EI, 70 eV): m/z (%): 282 
(M+, 4), 264 (100), 233 (16), 232 (41), 220 (32), 212 (18), 207 (27), 205 (40), 204 (22), 189 
(16), 181 (31), 175 (14), 83 (20), 69 (36) 59 (20), 43 (15). Anal. calcd. for C11H13F3O5 
(282.21): C, 46.81; H, 4.64. Found: C, 46.88; H, 4.63.  
 
Methyl 6-(trifluoromethyl)-3-ethyl-6-hydroxy-4-methoxy-2-oxocyclohex-3-
enecarboxylate (12j).  
Starting with 1,1-dimethoxy-4,4,4-trifluorobut-1-en-3-one (8a) 
(0.184 g, 1.0 mmol), 1-methoxy-1,3-bis(trimethylsilyloxy)-1,3-
hexadiene (3k) (0.577 g, 2.0 mmol) and Me3SiOTf (0.18 mL, 
1.0 mmol) in CH2Cl2 (10 mL), the product 12j was isolated as a white 
solid (0.146 g, 50%); mp = 106-110 °C. 1H NMR (300 MHz, CDCl3):  = 0.93 (t, 3J = 7.4 Hz, 
3H, CH3), 1.21−2.48 (m, 2H, CH2Ar), 2.78 (brd, 2J = 17.7 Hz, 1H, H-5a), 2.94 (d, 
2J = 17.7 Hz, 1H, H-5b), 3.68 (s, 0.5H, H-1a), 3.70 (s, 0.5H, H-1b), 3.89 (s, 3H, OCH3), 5.50 
(s, 0.5H, OH-a), 5.51 (s, 0.5H, OH-b). 13C NMR (75 MHz, CDCl3):  = 12.8 (CH3), 15.6 (CH2), 
30.3 (C-5), 52.9 (C-1), 53.1, 55.7 (OCH3), 74.1 (q, JC-F = 28.7 Hz, C-6), 119,6 (C-3), 124.5 (q, 
JC-F = 279.0 Hz, CF3), 166.3, 171.4, 188.0 (C). 19F-NMR (282 MHz, CDCl3):  = -81.2 (CF3). 
IR (ATR, cm−1): ν̃ = 3437 (w), 3021 (w), 2963 (w), 2942 (w), 2879 (w), 1741 (s), 1649 (m), 
1611 (s), 1441 (w), 1413 (w), 1250 (s), 1165 (s), 1132 (s), 1120 (s), 986 (s), 659 (m). GC-MS 
(EI, 70 eV): m/z (%): 296 (M+, 2), 278 (30), 246 (14), 220 (11), 219 (100), 195 (13), 83 (13), 
69 (19). Anal. calcd. for C12H15F3O5 (296.24): C, 48.65; H, 5.10. Found: C, 48.70; H, 5.12.  
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Ethyl 6-(trifluoromethyl)-6-hydroxy-4-methoxy-2-oxo-3-pentylcyclohex-3-
enecarboxylate (12k).  
Starting with 1,1-dimethoxy-4,4,4-trifluorobut-1-en-3-one (8a) 
(0.184 g, 1.0 mmol), 1-ethoxy-1,3-bis(trimethylsilyloxy)-1,3-nonadiene 
(3t) (0.689 g, 2.0 mmol) and Me3SiOTf (0.18 mL, 1.0 mmol) in CH2Cl2 
(10 mL), the product 12k was isolated as a yellow solid (0.138 g, 
39%); mp = 73-75 °C. 1H NMR (300 MHz, CDCl3):  = 0.86 (t, 3J = 6.9 Hz, 3H, CH3), 
1.25−1.38 (m, 9H, (CH2)3CH3), 2.19-2.34 (m, 2H, CH2Ar), 2.77 (brd, 2J = 17.4 Hz, 1H, H-5a), 
2.94 (d, 2J = 17.4 Hz, 1H, H-5b), 3.64 (s, 1H, H-1), 3.87 (s, 3H, OCH3), 4.35 (q, 3J = 7.2 Hz, 
2H, CH2), 5.59 (s, 0.5H, OH-a), 5.60 (s, 0.5H, OH-b). 13C NMR (75 MHz, CDCl3):  = 13.9, 
14.0 (CH3), 22.1, 22.4, 27.9 (CH2), 30.3 (C-5), 31.7 (CH2), 52.9 (C-1), 55.6 (OCH3), 62.5 
(CH2), 74.1 (q, JC-F = 28.5 Hz, C-6), 118,4 (C-3), 124.6 (q, JC-F = 285.0 Hz, CF3), 166.3, 
171.0, 188.3 (C). 19F-NMR (282 MHz, CDCl3):  = -81.2 (CF3). IR (ATR, cm−1): ν̃ = 3439 (w), 
2959 (w), 2932 (w), 2873 (w), 2849 (w), 1735 (s), 1648 (m), 1612 (s), 1463 (w), 1414 (w), 
1336 (m), 1250 (m), 1171 (s), 1122 (s), 1024 (s), 946 (m), 657 (m). GC-MS (EI, 70 eV): 
m/z (%): 352 (M+, 1), 334 (13), 314 (12), 257 (20), 233 (15), 232 (24), 231 (22), 206 (15), 205 
(100), 69 (11). Anal. calcd. for C16H23F3O5 (352.35): C, 54.54; H, 6.58. Found: C, 54.64; H, 
6.64.  
 
Methyl 6-(trifluoromethyl)-6-hydroxy-3-isopentyl-4-methoxy-2-oxocyclohex-3-
enecarboxylate (12l).  
Starting with 1,1-dimethoxy-4,4,4-trifluorobut-1-en-3-one (8a) 
(0.184 g, 1 mmol), 1-methoxy-7-mthyl-1,3-bis(trimethylsilyloxy)-1,3-
octadiene (3u) (0.661 g, 2 mmol) and Me3SiOTf (0.18 mL, 1.0 mmol) 
in CH2Cl2 (10 mL), the product 12l was isolated as a yellow solid 
(0.193 g, 55%); mp = 90-92 °C. 1H NMR (300 MHz, CDCl3):  = 0.88 (d, 3J = 6.0 Hz 6H, 
(CH3)2), 1.14−1.28 (m, 2H, CH2), 1.45-1.54 (m, 1H, CH), 2.22-2.32 (m, 2H, CH2Ar), 2.77 (brd, 
2J = 17.7 Hz, 1H, H-5a), 2.94 (d, 2J = 17.7 Hz, 1H, H-5b), 3.68 (s, 0.5H, H-1a), 3.70 (s, 0.5H, 
H-1b), 3.87 (s, 3H, OCH3), 3.88 (s, 3H, OCH3), 5.50 (s, 0.5H, OH-a), 5.51 (s, 0.5H, OH-b). 
13C NMR (75 MHz, CDCl3):  = 20.2 (CH2), 22.4, 22.5 (CH3), 28.1 (CH), 30.3 (C-5), 37.3 
(CH2), 53.0 (C-1), 53.1, 55.6 (OCH3), 74.1 (q, JC-F = 28.7 Hz, C-6), 118,6 (C-3), 124.5 (q, JC-
F = 284.7 Hz, CF3), 166.3, 171.4, 188.2 (C). 19F-NMR (282 MHz, CDCl3):  = −81.2 (CF3). IR 
(ATR, cm−1): ν̃ = 3435 (w), 2959 (w), 2933 (w), 2876 (w), 2853 (w), 1740 (s), 1650 (m), 1612 
(s), 1452 (w), 1439 (w), 1342 (m), 1249 (s), 1168 (s), 1140 (s), 1124 (s), 1041 (m), 978 (m), 
658 (m). GC-MS (EI, 70 eV): m/z (%): 338 (M+, 2), 320 (32), 300 (17), 288 (11), 273 (10), 263 
(16), 261 (18), 260 (11), 251 (13), 245 (16), 244 (18), 237 (14), 233 (14), 232 (73), 231 (35), 
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219 (17), 206 (12), 205 (100), 181 (10), 159 (15), 153 (10), 69 (23), 59 (15), 43 (12), 41 (11). 
Anal. calcd. for C15H21F3O5 (338.32): C, 53.25; H, 6.26. Found: C, 54.37; H, 6.61.  
 
 
Ethyl 6-(trifluoromethyl)-3-heptyl-6-hydroxy-4-methoxy-2-oxocyclohex-3-
enecarboxylate (12m).  
 Starting with 1,1-dimethoxy-4,4,4-trifluorobut-1-en-3-one (8a) 
(0.184 g, 1.0 mmol), 1-ethoxy-1,3-bis(trimethylsilyloxy)-1,3-
undecadiene (3w) (0.754 g, 2.0 mmol) and Me3SiOTf (0.18 mL, 
1.0 mmol) in CH2Cl2 (10 mL), the product 12m was isolated as a 
slight yellow solid (0.133 g, 35%); mp = 20-25 °C. 1H NMR (300 MHz, CDCl3):  = 0.86 (t, 
3J = 6.8 Hz, 3H, CH3), 1.25-1.38 (m, 13H, (CH2)5CH3), 2.19-2.31 (m, 2H, CH2Ar), 2.77 (brd, 
2J = 17.7 Hz, 1H, H-5a), 2.94 (d, 2J = 17.4 Hz, 1H, H-5b), 3.64 (s, 1H, H-1), 3.87 (s, 3H, 
OCH3), 4.35 (d, 3J = 7.2 Hz, 2H, CH2), 5.59 (s, 0.5H, OH-a), 5.60 (s, 0.5H, OH-b). 13C NMR 
(75 MHz, CDCl3):  = 13.9, 14.0 (CH3), 22.1, 22.6, 28.3, 29.1, 29.5 (CH2), 30.3 (C-5), 31.8 
(CH2), 52.9 (C-1), 55.6 (OCH3), 62.5 (CH2), 74.1 (q, JC-F = 28.7 Hz, C-6), 118,4 (C-3), 124.6 
(q, JC-F = 285.0 Hz, CF3), 166.3, 171.0, 188.3 (C). 19F-NMR (282 MHz, CDCl3):  = -81.2 
(CF3). IR (ATR, cm−1): ν̃ = 3427 (w), 2960 (w), 2927 (w), 2856 (w), 1722 (m), 1638 (w), 1605 
(s), 1446 (w), 1426 (w), 1375 (m), 1245 (s), 1171 (s), 1122 (s), 1016 (m), 656 (m). GC-MS 
(EI, 70 eV): m/z (%): 380 (M+, 1), 362 (21), 342 (15), 285 (31), 233 (17), 232 (50), 231 (37), 
206 (16), 205 (100), 204 (12), 29 (10). HRMS (ESI): calcd for C18H28F3O5 [(M+H)+] 381.1883, 
found 381.1884; calcd for C18H27F3NaO5 [(M+Na)+] 403.1702, found 403.1705. Anal. calcd. 
for C18H27F3O5 (380.40): C, 56.83; H, 7.15. Found: C, 56.89; H, 7.19.  
 
 
Methyl 6-(trifluoromethyl)-6-hydroxy-4-methoxy-3-octyl-2-oxocyclohex-3-
enecarboxylate (12n).  
Starting with 1,1-dimethoxy-4,4,4-trifluorobut-1-en-3-one (8a) 
(0.184 g, 1.0 mmol), 1-methoxy-1,3-bis(trimethylsilyloxy)-1,3-
dodecadiene (3x) (0.745 g, 2.0 mmol) and Me3SiOTf (0.18 mL, 
1.0 mmol) in CH2Cl2 (10 mL), the product 12n was isolated as a 
yellow solid (0.236 g, 62%); mp = 77-79 °C. 1H NMR (300 MHz, CDCl3):  = 0.87 (t, 
3J = 6.7 Hz, 3H, CH3), 1.24−1.31 (m, 12H, (CH2)6CH3), 2.21-2.31 (m, 2H, CH2Ar), 2.77 (brd, 
2J = 17.6 Hz, 1H, H-5a), 2.94 (d, 2J = 17.6 Hz, 1H, H-5b), 3.68 (s, 0.5H, H-1a), 3.70 (s, 0.5H, 
H-1b), 3.87 (s, 3H, OCH3), 3.88 (s, 3H, OCH3), 5.50 (s, 0.5H, OH-a), 5.51 (s, 0.5H, OH-b). 
13C NMR (100 MHz, CDCl3):  = 14.0 (CH3), 22.2, 22.6, 28.2, 29.2, 29.4, 29.5 (CH2), 30.3 (C-
5), 31.8 (CH2), 53.0 (C-1), 53.1, 55.6 (OCH3), 74.1 (q, JC-F = 29.0 Hz, C-6), 118.4 (C-3), 
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124.5 (q, JC-F = 285.0 Hz, CF3), 166.3, 171.4, 188.2 (C). 19F-NMR (282 MHz, CDCl3):  = -
81.2 (CF3). IR (ATR, cm−1): ν̃ = 3438 (m), 3025 (w), 2958 (w), 2928 (m), 2854 (w), 1739 (s), 
1650 (m), 1612 (s), 1461 (w), 1438 (m), 1341 (m), 1258 (s), 1166 (s), 1123 (s), 1069 (m), 
974 (m), 659 (m). GC-MS (EI, 70 eV): m/z (%): 380 (M+, 1), 362 (28), 342 (17), 232 (27), 219 
(18), 205 (100), 69 (17). HRMS (ESI): calcd for C18H28F3O5 [(M+H)+] 381.1883, found 
381.1880; calcd for C18H27F3NaO5 [(M+Na)+] 403.1702, found 403.1704. Anal. calcd. for 
C18H27F3O5 (380.40): C, 56.83; H, 7.15. Found: C, 56.84; H, 7.12.  
 
 
Methyl 6-(trifluoromethyl)-6-hydroxy-4-methoxy-3-nonyl-2-oxocyclohex-3-
enecarboxylate (12o).  
Starting with 1,1-dimethoxy-4,4,4-trifluorobut-1-en-3-one (8a) 
(0.184 g, 1.0 mmol), 1-methoxy-1,3-bis(trimethylsilyloxy)-1,3-
tridecadiene (3y) (0.745 g, 2.0 mmol) and Me3SiOTf (0.18 mL, 
1.0 mmol) in CH2Cl2 (10 mL), the product 12o was isolated as a 
yellow solid (0.225 g, 57%); mp = 63-64 °C. 1H NMR (300 MHz, CDCl3):  = 0.87 (t, 
3J = 6.7 Hz, 3H, CH3), 1.24−1.31 (m, 14H, (CH2)7CH3), 2.25-2.27 (m, 2H, CH2Ar), 2.77 (brd, 
2J = 17.7 Hz, 1H, H-5a), 2.94 (d, 2J = 17.6 Hz, 1H, H-5b), 3.68 (s, 0.5H, H-1a), 3.70 (s, 0.5H, 
H-1b), 3.87 (s, 3H, OCH3), 3.88 (s, 3H, OCH3), 5.50 (s, 0.5H, OH-a), 5.51 (s, 0.5H, OH-b). 
13C NMR (100 MHz, CDCl3):  = 14.1 (CH3), 22.2, 22.6, 28.2, 29.3, 29.4, 29.5, 29.6 (CH2), 
30.3 (C-5), 31.8 (CH2), 53.0 (C-1), 53.1, 55.6 (OCH3), 74.1 (q, JC-F = 28.9 Hz, C-6), 118.4 (C-
3), 124.5 (q, JC-F = 286.9 Hz, CF3), 166.3, 171.4, 188.2 (C). 19F-NMR (282 MHz, CDCl3):  = -
81.2 (CF3). IR (ATR, cm−1): ν̃ = 3439 (m), 3025 (w), 2958 (w), 2925 (m), 2855 (w), 1739 (s), 
1651 (m), 1613 (s), 1461 (w), 1438 (w), 1248 (s), 1167 (s), 1123 (s), 975 (m), 659 (m). GC-
MS (EI, 70 eV): m/z (%): 394 (M+, 1), 376 (41), 356 (23), 345 (15), 313 (70), 263 (16), 259 
(15), 245 (18), 233 (17), 232 (100), 231 (84), 219 (21), 212 (15), 205 (99), 204 (19), 181 (19), 
69 (16). HRMS (ESI): calcd for C19H30F3O5 [(M+H)+] 395.2039, found 395.2042; calcd for 
C19H29F3NaO5 [(M+Na)+] 417.1859, found 417.1860. Anal. calcd. for C19H29F3O5 (394.20): C, 
57.86; H, 7.41. Found: C, 57.78; H, 7.30.  
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Methyl 6-(trifluoromethyl)-3-dodecyl-6-hydroxy-4-methoxy-2-oxocyclohex-3-
enecarboxylate (12p).  
Starting with 1,1-dimethoxy-4,4,4-trifluorobut-1-en-3-one (8a) 
(0.184 g, 1.0 mmol), 1-methoxy-1,3-bis(trimethylsilyloxy)-1,3-
hexadecadiene (3aa) (0.857 g, 2.0 mmol) and Me3SiOTf (0.18 mL, 
1.0 mmol) in CH2Cl2 (10 mL), the product 12p was isolated as a 
yellow solid (0.252 g, 58%); mp = 74-76 °C. 1H NMR (400 MHz, CDCl3):  = 0.87 (t, 
3J = 6.8 Hz, 3H, CH3), 1.24−1.29 (m, 20H, (CH2)10CH3), 2.20-2.32 (m, 2H, CH2Ar), 2.77 (brd, 
2J = 17.6 Hz, 1H, H-5a), 2.94 (d, 2J = 17.6 Hz, 1H, H-5b), 3.68 (s, 0.5H, H-1a), 3.70 (s, 0.5H, 
H-1b), 3.87 (s, 3H, OCH3), 3.88 (s, 3H, OCH3), 5.49 (s, 0.5H, OH-a), 5.50 (s, 0.5H, OH-b). 
13C NMR (75 MHz, CDCl3):  = 14.1 (CH3), 22.2, 22.6, 28.2, 29.3, 29.4 (CH2), 29.6 (m, 
(CH2)6), 30.3 (C-5), 31.9 (CH2), 52.9 (C-1), 53.1, 55.6 (OCH3), 74.1 (q, JC-F = 28.7 Hz, C-6), 
118,4 (C-3), 124.7 (q, JC-F = 284.9 Hz, CF3), 166.3, 171.4, 188.2 (C). 19F-NMR (282 MHz, 
CDCl3):  = -81.2 (CF3). IR (ATR, cm−1): ν̃ = 3413 (w), 2953 (w), 2916 (m), 2848 (m), 1734 
(m), 1656 (m), 1614 (s), 1463 (w), 1439 (w), 1245 (s), 1160 (s), 1140 (s), 1119 (s), 664 (m). 
HRMS (ESI): calcd for C22H36F3O5 [(M+H)+] 437.2509, found 437.2510; calcd for 
C22H35F3NaO5 [(M+Na)+] 459.2328, found 459.2327. Anal. calcd. for C22H35F3O5 (436.51): C, 
60.53; H, 8.08. Found: C, 60.74; H, 8.08.  
 
 
Methyl 6-(trifluoromethyl)-3-hexadecyl-6-hydroxy-4-methoxy-2-oxocyclohex-3-
enecarboxylate (12q).  
Starting with 1,1-dimethoxy-4,4,4-trifluorobut-1-en-3-one (8a) 
(0.184 g, 1.0 mmol), 1-methoxy-1,3-bis(trimethylsilyloxy)-1,3-
icosadiene (3ab) (0.969 g, 2 mmol) and Me3SiOTf (0.18 mL, 
1.0 mmol) in CH2Cl2 (10 mL), the product 12q was isolated as a 
yellow solid (0.264 g, 54%); mp = 82-84 °C. 1H NMR (400 MHz, CDCl3):  = 0.88 (t, 
3J = 6.8 Hz, 3H, CH3), 1.24−1.31 (m, 28H, (CH2)14CH3), 2.20-2.32 (m, 2H, CH2Ar), 2.77 (brd, 
2J = 18.0 Hz, 1H, H-5a), 2.94 (d, 2J = 17.6 Hz, 1H, H-5b), 3.68 (s, 1H, H-1), 3.86 (s, 3H, 
OCH3), 3.88 (s, 3H, OCH3), 5.49 (s, 0.5H, OH-a), 5.50 (s, 0.5H, OH-b). 13C NMR (75 MHz, 
CDCl3):  = 14.1 (CH3), 22.2, 22.6, 28.2, 29.3, 29.4 (CH2), 29.6 (m, (CH2)10), 30.3 (C-5), 31.9 
(CH2), 52.9 (C-1), 53.1, 55.6 (OCH3), 74.1 (q, JC-F = 28.7 Hz, C-6), 118,4 (C-3), 124.5 (q, JC-
F = 285.0 Hz, CF3), 166.3, 171.4, 188.2 (C). 19F-NMR (282 MHz, CDCl3):  = -81.2 (CF3). IR 
(ATR, cm−1): ν̃ = 3413 (w), 2952 (w), 2916 (s), 2847 (s), 1735 (m), 1655 (m), 1613 (s), 1462 
(m), 1439 (m), 1245 (s), 1161 (s), 1140 (s), 1120 (s), 664 (m). GC-MS (EI, 70 eV): m/z (%): 
492 (M+, 1), 475 (11), 474 (48), 454 (15), 423 (15), 411 (55), 474 (48), 442 (22), 411 (55), 
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263 (16), 233 (25), 232 (100), 231 (83), 205 (83). HRMS (ESI): calcd for C26H44F3O5 [(M+H)+] 
493.3135, found 493.3134; calcd for C26H43F3NaO5 [(M+Na)+] 515.2954, found 515.2955. 
Anal. calcd. for C26H43F3O5 (492.61): C, 63.39; H, 8.80. Found: C, 63.71; H, 8.87.  
 
 
Methyl 4-hydroxy-2-(methylthio)-6-oxo-4-(trifluoromethyl)cyclohex-1-enecarboxylate 
(13r). 
Starting with 4,4-dimethylthio-1,1,1-trifluorobut-3-en-2-one (8d) 
(0.216 g, 1.0 mmol), 1-metoxy-1,3-bis(trimethylsilyloxy)-1,3-butadiene 
3a (0.520 g, 2.0 mmol) and Me3SiOTf (0.18 mL, 1.0 mmol) in CH2Cl2 
(10 mL), the product 13r was isolated as a colourless solid (0.110 g, 
39%); mp = 142-143 °C. 1H NMR (400 MHz, (CD3)2CO):  = 2.53 (s, 3H, SCH3), 2.60-2.88 
(m, 2H, CH2), 3.07-3.23 (m, 2H, CH2), 3.74 (s, 3H, OCH3), 5.69 (s, 1H, OH). 13C NMR 
(100 MHz, (CD3)2CO):  = 14.1 (SCH3), 34.6, 42.0 (CH2), 52.1 (OCH3), 73.7 (q, JC-
F = 29.5 Hz, C-4), 126.2 (q, JC-F = 283.0 Hz, CF3), 129.1 (C-6), 159.7, 166.3, 187.5 (C). 19F-
NMR (282 MHz, (CD3)2CO):  = -83.7 (CF3). IR (ATR, cm−1): ν̃ = 3429 (m), 3252 (w), 3011 
(w), 2957 (w), 2930 (w), 2850 (w), 1721 (s), 1640 (s), 1549 (s), 1431 (m), 1403 (m), 1164 (s), 
1044 (s), 813 (m), 552 (m). HRMS (ESI): calcd for C10H12F3O4S [(M+H)+] 285.0402, found 
285.0400; calcd for C10H11F3NaO4S [(M+Na)+] 307.0222, found 307.0221. Anal. calcd. for 
C10H11F3O4S (284.25): C, 42.25; H, 3.90; S, 11.28. Found: C, 42.45; H, 4.26; S, 11.16.  
 
 
Butyl 4-hydroxy-2-(methylthio)-6-oxo-4-(trifluoromethyl)cyclohex-1-enecarboxylate 
(13b).  
Starting with 4,4-dimethylthio-1,1,1-trifluorobut-3-en-2-one (8d) 
(0.216 g, 1.0 mmol), 1-butoxy-1,3-bis(trimethylsilyloxy)-1,3-butadiene 
3e (0.605 g, 2.0 mmol) and Me3SiOTf (0.18 mL, 1.0 mmol) in CH2Cl2 
(10 mL), the product 13b was isolated as a colourless solid (0.170 g, 
52%); mp = 137-138 °C. 1H NMR (300 MHz, (CD3)2CO):  = 0.93 (t, 3J = 7.5 Hz, 3H, CH3), 
1.36−1.49 (m, 2H, CH2), 1.60-1.70 (m, 2H, CH2), 2.53 (s, 3H, SCH3), 2.59-2.88 (m, 2H, CH2), 
3.05-3.24 (m, 2H, CH2), 4.41 (t, 3J = 6.6 Hz, 2H, CH2), 5.68 (s, 1H, OH). 13C NMR (75 MHz, 
(CD3)2CO):  = 13.9 (CH3), 14.1 (SCH3), 19.7, 31.3, 34.5, 42.0, 65.3 (CH2), 73.7 (q, JC-
F = 29.2 Hz, C-4), 126.2 (q, JC-F = 283.1 Hz, CF3), 129.4 (C-6), 159.1, 165.8, 187.5 (C). 19F-
NMR (282 MHz, (CD3)2CO):  = -83.7 (CF3). IR (ATR, cm−1): ν̃ = 3294 (m), 2963 (w), 2934 
(w), 2874 (w), 1707 (s), 1648 (s), 1558 (m), 1470 (w), 1405 (m), 1180 (s), 1043 (s), 946 (m), 
540 (m). HRMS (ESI): calcd for C13H18F3O4S [(M+H)+] 327.0872, found 327.0869; calcd for 
C13H17F3NaO4S [(M+Na)+] 349.0692, found 325.0694.  
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Isopentyl 4-hydroxy-2-(methylthio)-6-oxo-4-(trifluoromethyl)cyclohex-1-enecarboxylate 
(13t). 
Starting with 4,4-dimethylthio-1,1,1-trifluorobut-3-en-2-one (8d) 
(0.216 g, 1.0 mmol), 1-isopentyloxy-1,3-bis(trimethylsilyloxy)-1,3-
butadiene 3g (0.633 g, 2.0 mmol) and Me3SiOTf (0.18 mL, 
1.0 mmol) in CH2Cl2 (10 mL), the product 13t was isolated as a 
colourless solid (0.110 g, 36%); mp = 130-132 °C. 1H NMR (300 MHz, (CD3)2CO):  = 0.93 
(d, 3J = 9.0 Hz, 6H, (CH3)2), 1.53-1.59 (m, 2H, CH2), 1.72-1.81 (m, 1H, CH), 2.53 (s, 3H, 
SCH3), 2.58-2.88 (m, 2H, CH2), 3.05-3.24 (m, 2H, CH2), 4.21 (t, 3J = 6.7 Hz, 2H, OCH2), 5.69 
(s, 1H, OH). 13C NMR (75 MHz, (CD3)2CO):  = 14.1 (SCH3), 22.6 (CH3), 25.5 (CH), 34.4, 
38.0, 42.0, 64.1 (CH2), 73.7 (q, JC-F = 29.0 Hz, C-4), 126.2 (q, JC-F = 282.9 Hz, CF3), 129.3 
(C-6), 159.3, 165.9, 187.6 (C). 19F-NMR (282 MHz, (CD3)2CO):  = -83.7 (CF3). IR (ATR, 
cm−1): ν̃ = 3312 (m), 2946 (w), 2811 (w), 1720 (s), 1643 (s), 1547 (s), 1430 (m), 1403 (m), 
1267 (s), 1043 (s), 786 (m), 533 (m). HRMS (ESI): calcd for C14H20F3O4S [(M+H)+] 341.1029, 
found 341.1029; calcd for C14H19F3NaO4S [(M+Na)+] 363.0848, found 363.0857. Anal. calcd. 
for C14H19F3O4S (340.36): C, 49.40; H, 5.63; S, 9.42. Found: C, 50.05; H, 5.88; S, 9.45.  
 
Octyl 4-hydroxy-2-(methylthio)-6-oxo-4-(trifluoromethyl)cyclohex-1-enecarboxylate 
(13u).  
Starting with 4,4-dimethylthio-1,1,1-trifluorobut-3-en-2-one (8d) 
(0.216 g, 1.0 mmol), 1-octyloxy-1,3-bis(trimethylsilyloxy)-1,3-
butadiene 3h (0.717 g, 2.0 mmol) and Me3SiOTf (0.18 mL, 
1.0 mmol) in CH2Cl2 (10 mL), the product 13u was isolated as a 
colourless solid (0.130 g, 34%); mp = 98-99 °C. 1H NMR (400 MHz, (CD3)2CO):  = 0.88 (t, 
3J = 6.8 Hz, 3H, CH3), 1.28-1.45 (m, 10H, (CH2)5CH3), 1.64-1.71 (m, 2H, CH2), 2.53 (s, 3H, 
SCH3), 2.60-2.87 (m, 2H, CH2), 3.07-3.23 (m, 2H, CH2), 4.18 (t, 3J = 6.4 Hz, 2H, OCH2), 5.68 
(s, 1H, OH). 13C NMR (75 MHz, (CD3)2CO):  = 14.1 (SCH3), 14.3 (CH3), 23.2, 26.6, 29.8, 
29.9, 32.5, 34.4, 42.0, 65.6 (CH2), 73.7 (q, JC-F = 29.2 Hz, C-4), 126.2 (q, JC-F = 282.9 Hz, 
CF3), 129.3 (C-6), 159.1, 165.8, 187.5 (C). 19F-NMR (282 MHz, (CD3)2CO):  = -83.6 (CF3). 
IR (ATR, cm−1): ν̃ = 3348 (m), 2935 (m), 2855 (w), 1712 (s), 1653 (s), 1564 (s), 1464 (w), 
1437 (w), 1318 (s), 1159 (s), 1045 (s), 938 (m), 544 (m), 488 (m). HRMS (ESI): calcd for 
C17H26F3O4S [(M+H)+] 383.1498, found 383.1503; calcd for C17H25F3NaO4S [(M+Na)+] 
405.1318, found 405.1324. Anal. calcd. for C17H25F3O4S (382.44): C, 53.39; H, 6.59; S, 8.38. 
Found: C, 54.26; H, 6.53; S, 9.20.   
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Methyl 6-hydroxy-3-methyl-4-methylthio-2-oxo-6-(trifluoromethyl)cyclohex-3-
enecarboxylate (12v). 
To a solution of 8d (0.216 g, 1.0 mmol) in CH2Cl2 (10 mL) was added 
1-methoxy-1,3-bis(trimethylsilyloxy)-1,3-pentadiene 3j (0.549 g, 2.0 
mmol) and, subsequently, AlCl3 (0.134 g, 1.0 mmol) at -78°C. The 
temperature of the solution was allowed to warm to 20°C during 12-14 
h with stirring. To the solution was added HCl (10%, 15 mL), and the organic and the 
aqueous layer were separated. The latter was extracted with CH2Cl2 (3 × 15 mL). The 
combined organic layers were dried (Na2SO4), filtered, and the filtrate was concentrated in 
vacuo. The residue was purified by chromatography to give 12v as a colorless solid (0.154 g, 
52%); mp = 93°C. 1H NMR (300 MHz, CDCl3): δ = 1.88 (s, 3 H, CH3), 2.44 (s, 3 H, SCH3), 
2.80 (d, 2J = 17.8 Hz, 4JH,F = 2.1 Hz, 1 H, H-5a), 2.97 (br d, 2J = 17.8 Hz, 1 H, H-5b), 3.72 (s, 
1 H, CH), 3.87 (s, 3 H, OCH3), 5.35 (s, 1 H, OH). 13C NMR (75 MHz, CDCl3): δ = 11.6 (CH3), 
14.0 (SCH3), 33.1 (CH2), 53.1 (CH), 53.3 (OCH3), 74.7 (q, JC,F = 28.8 Hz, C-6), 124.4 (q, JC,F 
= 287.0 Hz, CF3), 127.0, 154.0, 171.0 (C), 184.8 (C=O). 19F NMR (282 MHz, CDCl3): δ = -
81.6 (CF3). IR (ATR, cm–1): ν̃ = 3431 (w), 3285 (w), 3024 (w), 2962 (w), 2935 (w), 2919 (w), 
2858 (w), 2635 (w), 1737 (m), 1651 (m), 1574 (m), 1441 (w), 1414 (w), 1372 (w), 1356 (w), 
1333 (m), 1301 (m), 1267 (m) 1222 (w), 1200 (m), 1162 (m), 1129 (m), 1068 (m), 1003 (m), 
630 (m), 569 (m). GC-MS (EI, 70 eV): m/z (%) = 298 (M+, 13), 281 (13), 280 (100), 265 (30), 
248 (16), 223 (27), 221 (49), 197 (24), 193 (22), 175 (16), 85 (16), 81 (22), 69 (33), 59 (19), 
53 (18). HRMS (EI, 70 eV): calcd for C11H13F3O4S (M+) 298.04812, found 298.048772. Anal. 
Calcd for C11H13F3O4S (298.28): C, 44.29; H, 4.39. Found: C, 44.34; H, 4.67. 
 
 
 
 
GP 4: General Procedure for the Synthesis of Compounds 14, 15, 16 and 17. 
 
To a solution of salicylate 7a in acetone (2.0 mL/1.0 mmol) was added K2CO3 (1.2 mmol) and 
the respective alkyl bromide (1.2 mmol). The mixture was then heated at 55°C for 8 h and 
the resulting suspension was filtered and washed with diethyl ether. The ether solution was 
washed with brine, dried (Na2SO4), filtered, and the filtrate was concentrated in vacuo. The 
residue was purified by chromatography.  
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Methyl 2-methylthio-6-(oxiran-2-ylmethoxy)-4-(trifluoromethyl)benzoate (14). 
Starting with 10aj (0.275 g, 1.1 mmol) and 2-(bromomethyl)oxirane 
(0.170 g, 1.3 mmol) and K2CO3 (0.172 g, 1.3 mmol) in acetone 
(2.1 mL), the product 14 was isolated as a colorless solid (0.330 g, 
99%); mp = 45°C. 1H NMR (300 MHz, CDCl3): δ = 2.49 (s, 3 H, 
SCH3), 2.73 (dd, 2J = 4.9 Hz, 3J = 2.6 Hz, 1 H, OCHH), 2.87 (dd, 2J = 4.9 Hz, 3J = 4.2 Hz, 1 
H, OCHH), 3.28–3.33 (m, 1 H, CH), 3.94 (s, 3 H, OCH3), 4.02 (dd, 2J = 11.1 Hz, 3J = 5.5 Hz, 
OCHH), 4.33 (dd, 2J = 11.3 Hz, 3J = 2.6 Hz, OCHH), 6.99 (br s, 1 H, CH), 7.16 (br s, 1 H, 
CH). 13C NMR (63 MHz, CDCl3): δ = 16.7 (SCH3), 44.2 (OCH2), 49.7 (CH), 52.6 (OCH3), 69.8 
(OCH2), 106.9 (q, JC,F = 3.7 Hz, C-5), 116.6 (q, JC,F = 4.0 Hz, C-3), 123.3 (q, JC,F = 273.0 Hz, 
CF3), 127.1 (C), 132.9 (q, JC,F = 32.7 Hz, C-4), 139.3, 155.7, 166.0 (C). 19F NMR (282 MHz, 
CDCl3): δ = -63.1 (CF3). IR (ATR, cm–1): ν̃ = 3078 (w), 3003 (w), 2960 (w), 2930 (w), 2854 
(w), 1714 (m), 1605 (w), 1573 (w), 1464 (w), 1432 (w), 1425 (w), 1387 (m), 1322 (m), 1283 
(m), 1250 (m), 1201 (m), 1169 (m), 1120 (s), 1086 (m), 1074 (m), 1024 (m), 993 (m), 842 (s), 
704 (m). GC-MS (EI, 70 eV): m/z (%) = 322 (M+, 100), 303 (21), 291 (60), 235 (42), 234 (85), 
206 (38), 191 (44), 163 (12), 57 (49) 45 (54), 31 (23), 29 (45). HRMS (EI, 70 eV): calcd for 
C13H13F3O4S (M+) 322.04812, found 322.048212. Anal. Calcd for C13H13F3O4S (322.05): C, 
48.45; H, 4.07. Found: C, 48.70; H, 4.06. 
 
 
Methyl 2-methylthio-6-phenacyloxy-4-(trifluoromethyl)benzoate (15). 
Starting with 10aj (0.275 g, 1.1 mmol) and 2-bromoacetophenone 
(0.247 g, 1.3 mmol) and K2CO3 (0.172 g, 1.3 mmol) in acetone 
(2.1 mL), the product 11 was isolated as a colorless solid (0.121 g, 
32%); mp = 82°C. 1H NMR (300 MHz, CDCl3): δ = 2.50 (s, 3 H, 
SCH3), 3.89 (s, 3 H, OCH3), 5.31 (s, 2 H, CH2), 6.87 (br s, 1 H, CH), 7.18 (br s, 1 H, CH), 
7.47–7.52 (m, 2 H, Ph), 7.60–7.65 (m, 1 H, Ph), 7.94–7.97 (m, 2 H, Ph). 13C NMR (63 MHz, 
CDCl3): δ = 16.7 (SCH3), 52.6 (OCH3), 71.7 (CH2), 106.6 (q, JC,F = 3.7 Hz, C-5), 117.0 (q, JC,F 
= 3.8 Hz, C-3), 123.2 (q, JC,F = 273.1 Hz, CF3), 128.2, 128.8, 128.9, 132.8 (q, JC,F = 32.8 Hz, 
C-4), 134.1 (CH), 134.1, 139.7, 155.3, 165.9, 192.9 (C). 19F NMR (282 MHz, CDCl3): δ = -
63.0 (CF3). IR (ATR, cm–1): ν̃ = 3084 (w), 3009 (w), 2959 (w), 2925 (w), 2908 (w), 2841 (w), 
1710 (m), 1597 (w), 1579 (w), 1468 (w), 1448 (w), 1421 (m), 1325 (m), 1278 (w), 1255 (m), 
1224 (m), 1180 (w), 1159 (m), 1122 (m), 1093 (m), 1074 (m), 984 (m), 760 (m), 670 (m). GC-
MS (EI, 70 eV): m/z (%) = 384 (M+, 22), 353 (13), 106 (8), 105 (100), 91 (11), 77 (24), 45 (9). 
HRMS (EI, 70 eV): calcd for C18H15F3O4S (M+) 384.06377, found 384.063943. 
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Methyl 2-(2-methoxy-2-oxoethoxy)-6-methylthio-4-(trifluoromethyl)benzoate (16). 
Starting with 10aj (0.400 g, 1.5 mmol), methyl bromoacetate (0.549 
g, 2.0 mmol) and K2CO3 (0.249 g, 1.8 mmol) in acetone (3.0 mL), 
the product 16 was isolated as a yellow solid (0.362 g, 71%); 
mp = 64°C. 1H NMR (300 MHz, CDCl3): δ = 2.50 (s, 3 H, SCH3), 
3.79, 3.96 (s, 3 H, OCH3), 4.68 (s, 2 H, CH2), 6.83 (br s, 1 H, CH), 7.19 (br s, 1 H, CH). 13C 
NMR (75 MHz, CDCl3): δ = 16.7 (SCH3), 52.4, 52.7 (OCH3), 66.2 (OCH2), 106.6 (q, JC,F = 3.7 
Hz, C-3), 117.2 (q, JC,F = 3.9 Hz, C-5), 123.2 (q, JC,F = 273.1 Hz, CF3), 127.3 (C), 135.9 (q, 
JC,F = 32.8 Hz, C-4), 139.8, 155.1, 165.8, 168.0 (C). 19F NMR (282 MHz, CDCl3): δ = -63.1 
(CF3). IR (ATR, cm–1): ν̃ = 3457 (w), 3188 (w), 3098 (w), 3010 (w), 2961 (w), 2915 (w), 2860 
(w), 1733 (m), 1698 (w), 1605 (w), 1580 (w), 1557 (w), 1471 (w), 1449 (w), 1417 (m), 1389 
(w), 1330 (w), 1303 (m), 1249 (m), 1206 (w), 1161 (m), 1120 (m), 1078 (m), 1066 (m), 1018 
(m), 935 (m), 864 (m), 705 (m). GC-MS (EI, 70 eV): m/z (%) = 338 (M+, 47), 319 (17), 307 
(51), 279 (27), 249 (19), 248 (16), 247 (100), 246 (31), 219 (14), 218 (37), 191 (22), 189 (12), 
45 (92). HRMS (ESI): calcd for C13H14F3O5S [(M+H)+] 339.0509, found 339.0508; calcd for 
C13H13F3NaO5S [(M+Na)+] 361.0328, found 361.0329. Anal. Calcd for C13H13F3O5S (338.04): 
C, 46.15; H, 3.87. Found: C, 46.27; H, 3.77.  
 
 
Methyl 2-(2-methoxy-2-oxoethoxy)-4-methoxy-6-(trichloromethyl)benzoate (17). 
 Starting with 9z (0.320 g, 1.1 mmol), methyl bromoacetate (0.196 
g, 1.3 mmol) and K2CO3 (0.177 g, 1.3 mmol) in acetone (2.2 mL), 
the product 17 was isolated as a braun solid (0.390 g, 98%); 
mp = 169°C. 1H NMR (300 MHz, CDCl3): δ = 3.80 (s, 3H, OCH3), 
3.86 (s, 3H, OCH3), 3.91 (s, 3H, OCH3), 4.64 (s, 2H, CH2), 6.48 (d, 4J = 2.3 Hz, 1H, Ar), 
7.29 (d, 4J = 2.3 Hz, 1H, Ar). 13C NMR (75 MHz, CDCl3): δ = 52.4, 52.7, 55.7 (OCH3), 66.7 
(CH2), 95.3 (C), 101.8, 105.6 (CH), 115.5, 142.1, 157.0, 160.3, 166.7, 168.3 (C). IR (ATR, 
cm-1): ν̃ = 3102 (w), 2993 (w), 2953 (w), 2917 (w), 2849 (w), 1763 (m), 1727 (s), 1604 (m), 
1575 (m), 1485 (w), 1461 (w), 1440 (m), 1428 (m), 1399 (w), 1323 (m), 1271 (s), 1232 (m), 
1215 (m), 1201 (s), 1162 (s), 1115 (m), 1102 (m), 1051 (s), 1012 (m), 966 (s), 808 (s), 778 
(s). GC-MS (EI, 70 eV): m/z (%): 372 (M+, 28) 370 (M+, 29), 343 (14), 341 (41), 339 (53), 338 
(15), 337 (65), 336 (16), 335 (100), 306 (13), 305 (20), 304 (20), 303 (26), 285 (17), 227 (15), 
205 (14), 203 (13), 45 (47). HRMS (EI, 70 eV): calcd. for C13H1335Cl3O6 (M+) 369.97722, 
found 369.977530; calcd. for C13H1335Cl237ClO6 (M+) 371.97427, found 371.975175. 
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Methyl 3-hydroxy-4-methylthio-6-(trifluoromethyl)benzofuran-2-carboxylate (18). 
To a solution of 16 (0.160 g, 0.5 mmol) in MeOH/CH2Cl2 (1:1, 
3.0 mL) was added MeONa (0.065 g, 0.6 mmol). The reaction 
mixture was then heated at 50°C for 6 h. To the solution was 
added HCl (10%, 15 mL), and the organic and the aqueous 
layer were separated. The latter was extracted with CH2Cl2 (3 × 15 mL). The combined 
organic layers were dried (Na2SO4), filtered, and the filtrate was concentrated in vacuo. The 
residue was purified by chromatography to give 18 as an yellow solid (0.045 g, 31%); 
mp = 179°C. 1H NMR (300 MHz, CDCl3): δ = 2.61 (s, 3 H, SCH3), 4.02 (s, 3 H, OCH3), 7.16 
(br s, 1 H, CH), 7.44 (s, 1 H, CH), 8.26 (br s, 1 H, OH). 13C NMR (63 MHz, CDCl3): δ = 14.9 
(SCH3), 52.3 (OCH3), 106.4 (q, JC,F = 4.4 Hz, C-7), 114.6 (q, JC,F = 3.7 Hz, C-5), 137.1, 150.9, 
152.5, 162.4 (C). 19F NMR (282 MHz, CDCl3): δ = -62.2 (CF3). IR (ATR, cm–1): ν̃ = 3331 (w), 
3087 (w), 3003 (w), 2959 (w), 2930 (w), 2864 (w), 1688 (w), 1604 (w), 1575 (w), 1499 (w), 
1455 (w), 1377 (w), 1335 (m), 1258 (w), 1216 (m), 1198 (m), 1148 (m), 1115 (m), 1074 (m), 
966 (m), 849 (m), 658 (m). GC-MS (EI, 70 eV): m/z (%) = 306 (M+, 100), 275 (15), 274 (49), 
273 (15), 247 (17), 246 (65), 217 (21), 190 (17), 189 (33), 143 (15), 121 (15). HRMS (EI, 70 
eV): calcd for C12H9F3O4S (M+) 306.01682, found 306.015912.  
 
 
 
 
 
GP 5: General Procedure for the Synthesis of 20. 
 
To a CH2Cl2 solution (2 mL/1 mmol of 19) of 19 (1.0 mmol) was added 3 (2.0 mmol) and, 
subsequently, Me3SiOTf (0.18 mL, 1.0 mmol) at -78 °C. The temperature of the solution was 
allowed to warm to 20 °C during 12-14 h with stirring. To the solution was added HCl (10%, 
10 mL) and the organic and the aqueous layer were separated. The latter was extracted with 
CH2Cl2 (2 × 10 mL). The combined organic layers were dried (Na2SO4), filtered, and the 
filtrate was concentrated in vacuo. The residue was heated at 50-60 °C in EtOH 
(20 mL/1 mmol of 2) during 10-25 h. The solvent was removed in vacuo and the product was 
washed with CH2Cl2. 
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Methyl 4-oxo-2,6-bis(trifluoromethyl)-1,4-dihydropyridine-3-carboxylate (20a).  
Starting with 2,4,6-tris(trifluoromethyl)-1,3,5-triazine (19) (0.18 mL, 
1.0 mmol), 1-methoxy-1,3-bis(trimethylsilyloxy)-1,3-butadiene (3a) 
(0.520 g, 2.0 mmol), Me3SiOTf (0.18 mL, 1.0 mmol) in CH2Cl2 (2 mL) 
and then heating in EtOH (20 mL) for 10 h, the product 20a was 
isolated as a white solid (0.110 g, 78%); mp = 154-156 °C. 1H NMR (300 MHz, DMSO): 
δ = 3.70 (s, 3H, OCH3), 6.58 (s, 1H, CH), 7.22 (bs, 4H, NH+H2O). 13C NMR (75 MHz, 
DMSO): δ = 51.9 (OCH3), 114.5 (CH), 121.7 (q, JC-F = 274.0 Hz, CF3), 121.9 (q, JC-
F = 273.0 Hz, CF3), 122.6 (C), 142.8 (q, JC-F = 32.0 Hz, C), 146.7 (q, JC-F = 32.7 Hz, C), 
167.7, 173.3 (C). 19F-NMR (282 MHz, DMSO): δ = -67.0, -64.1 (CF3). IR (ATR, cm-1): 
ν̃ = 3273 (m), 2954 (m), 2917 (m), 2847 (m), 2711 (m), 2116 (w), 1906 (w), 1714 (s), 1590 
(m), 1486 (s), 1435 (w), 1399 (m), 1274 (s), 1126 (s), 992 (s), 873 (s), 734 (m). GC-MS (EI, 
70 eV): m/z (%): 289 (M+, 70), 270 (13), 258 (100), 257 (82), 229 (68), 210 (55). HRMS (EI, 
70 eV): calcd for C9H5F6NO3 (M+) 289.0168, found 289.0162.  
 
 
Ethyl 2,6-bis(trifluoromethyl)-1,4-dihydro-4-oxopyridine-3-carboxylate (20b). 
Starting with 2,4,6-tris(trifluoromethyl)-1,3,5-triazine (19) (0.18 mL, 
1.0 mmol), 1-ethoxy-1,3-bis(trimethylsilyloxy)-1,3-butadiene (3b) 
(0.549 g, 2.0 mmol), Me3SiOTf (0.18 mL, 1.0 mmol) in CH2Cl2 (2 mL) 
and then heating in EtOH (20 mL) for 15 h, the product 20b was 
isolated as a white solid (0.288 g, 95%); mp = 145-147 °C. 1H NMR (300 MHz, DMSO): 
δ = 1.21 (t, 3J = 7.5 Hz, 3H, CH3), 4.16 (q, 3J = 7.0 Hz, 2H, CH2), 6.55 (s, 1H, CH), 7.22 (bs, 
5H, NH+H2O). 13C NMR (75 MHz, DMSO): δ = 13.9 (CH3), 60.4 (CH2), 114.6 (CH), 121.8 (q, 
JC-F = 283.0 Hz, CF3), 122.0 (q, JC-F = 272.7 Hz, CF3), 122.9 (C), 142.7, 146.6 (q, JC-
F = 32.2 Hz, C), 167.1, 173.4 (C). 19F-NMR (282 MHz, DMSO): δ = -67.0, -63.8 (CF3). IR 
(ATR, cm-1): ν̃ = 3257 (w), 3049 (w), 2847 (w), 1696 (m), 1662 (w), 1592 (w), 1520 (w), 1479 
(s), 1404 (m), 1273 (s), 1183 (s), 1129 (s), 987 (s), 871 (m), 734 (m), 532 (w). GC-MS (EI, 
70 eV): m/z (%): 303 (M+, 14), 275 (23), 258 (66), 257 (100), 234 (13), 229 (57), 210 (29). 
HRMS (ESI): calcd for C10H8F6NO3 [(M+H)+] 304.0403, found 304.0406.  
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Benzyl 4-oxo-2,6-bis(trifluoromethyl)-1,4-dihydropyridine-3-carboxylate (20c).  
Starting with 2,4,6-tris(trifluoromethyl)-1,3,5-triazine (19) (0.18 mL, 
1.0 mmol), 1-benzyloxy-1,3-bis(trimethylsilyloxy)-1,3-butadiene (3c) 
(0.673 g, 2.0 mmol), Me3SiOTf (0.18 mL, 1.0 mmol) in CH2Cl2 (2 mL) 
and then heating in EtOH (20 mL) for 14 h, the product 20c was 
isolated as a slight yellow solid (0.209 g, 57%); mp = 92-94 °C. 1H NMR (300 MHz, MeOD): 
δ = 5.32 (s, 2H, CH2), 7.00 (s, 1H, CH), 7.31 -7.44 (m, 5H, Ph). 13C NMR (75 MHz, DMSO): 
δ = 66.9 (CH2), 113.2 (CH), 121.1 (q, JC-F = 273.7 Hz, CF3), 121.2 (q, JC-F = 272.6 Hz, CF3), 
121.3 (C), 143.5 (q, JC-F = 33.7 Hz, C), 147.4 (q, JC-F = 33.5 Hz, C), 165.1, 169.7 (C). 19F-
NMR (282 MHz, DMSO): δ = -67.1, -63.9 (CF3). IR (ATR, cm-1): ν̃ = 3181 (w), 3037 (w), 2894 
(w), 1725 (m), 1591 (m), 1467 (s), 1406 (s), 1303 (m), 1269 (s), 1187 (s), 1117 (s), 988 (s), 
750 (m), 695 (s). GC-MS (EI, 70 eV): m/z (%): 365 (M+, 6), 210 (13), 108 (16), 91 (100). 
HRMS (ESI): calcd for C15H10F6NO3 [(M+H)+] 366.0559, found 366.0563.  
 
 
Isopropyl 4-oxo-2,6-bis(trifluoromethyl)-1,4-dihydropyridine-3-carboxylate (20d).  
Starting with 2,4,6-tris(trifluoromethyl)-1,3,5-triazine (19) (0.18 mL, 
1.0 mmol), 1-isopropyloxy-1,3-bis(trimethylsilyloxy)-1,3-butadiene (3d) 
(0.577 g, 2.0 mmol), Me3SiOTf (0.18 mL, 1.0 mmol) in CH2Cl2 (2 mL) 
and then heating in EtOH (20 mL) for 22 h, the product 20d was 
isolated as a white solid (0.204 g, 64%); mp = 112-114 °C. 1H NMR (300 MHz, DMSO): 
δ = 1.22 (s, 3J = 6.0 Hz, 6H, CH3), 1.23 (s, 3H, CH3), 4.95-5.08 (m, 1H, CH), 6.57 (s, 1H, CH), 
7.23 (bs, 5H, NH+H2O). 13C NMR (75 MHz, DMSO): δ = 21.4 (CH3), 67.8 (CH), 114.5 (CH), 
121.8 (q, JC-F = 273.7 Hz, CF3), 121.9 (q, JC-F = 272.7 Hz, CF3), 123.2 (C), 142.6, 146.6 (q, 
JC-F = 32.2 Hz, C), 166.5, 173.3 (C). 19F-NMR (282 MHz, DMSO): δ = -67.0, -63.6 (CF3). IR 
(ATR, cm-1): ν̃ = 3341 (w), 3189 (w), 3086 (w), 3005 (w), 2918 (w), 1721 (m), 1675 (w), 1588 
(w), 1455 (m), 1409 (m), 1270 (s), 1187 (s), 1140 (s), 1099 (s), 987 (s), 873 (m), 634 (m). 
GC-MS (EI, 70 eV): m/z (%): 317 (M+, 2), 276 (62), 258 (100), 257 (64), 229 (24), 210 (27), 
43 (31). HRMS (ESI): calcd for C11H10F6NO3 [(M+H)+] 318.0559, found 318.0562.  
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Isobutyl 4-oxo-2,6-bis(trifluoromethyl)-1,4-dihydropyridine-3-carboxylate (20e).  
Starting with 2,4,6-tris(trifluoromethyl)-1,3,5-triazine (19) (0.18 mL, 
1.0 mmol), 1-isobutyloxy-1,3-bis(trimethylsilyloxy)-1,3-butadiene (3f) 
(0.605 g, 2.0 mmol), Me3SiOTf (0.18 mL, 1.0 mmol) in CH2Cl2 (2 mL) 
and then heating in EtOH (20 mL) for 22 h, the product 20e was 
isolated as a white solid (0.229 g, 69%); mp = 105-107 °C. 1H NMR (300 MHz, DMSO): 
δ = 0.90 (d, 3J = 6.0 Hz, 6H, (CH3)2), 1.84-198 (m, 1H, CH), 3.95 (d, 3J = 6.6 Hz, 2H, CH2), 
6.80 (s, 1H, CH), 7.20 (bs, 4H, NH+H2O). 13C NMR (75 MHz, DMSO): δ = 18.8 (CH3), 27.1 
(CH), 70.9 (CH2), 113.8 (CH), 121.5 (q, JC-F = 274.0 Hz, CF3), 121.6 (q, JC-F = 272.7 Hz, CF3), 
122.4 (C), 142.9, 146.9 (q, JC-F = 33.0 Hz, C), 166.2, 171.6 (C). 19F-NMR (282 MHz, DMSO): 
δ = -67.1, -63.9 (CF3). IR (ATR, cm-1): ν̃ = 3182 (w), 2963 (w), 2881 (w), 1727 (m), 1697 (m), 
1669 (m), 1591 (m), 1457 (s), 1409 (s), 1270 (s), 1179 (s), 1112 (s), 992 (s), 878 (m), 736 
(m). GC-MS (EI, 70 eV): m/z (%): 331 (M+, 1), 276 (27), 258 (100), 210 (37), 57 (50), 56 (28), 
41 (18). HRMS (ESI): calcd for C12H12F6NO3 [(M+H)+] 332.0716, found 332.0720; calcd for 
C12H11F6NNaO3 [(M+Na)+] 354.0535, found 354.0539. 
 
 
Isopentyl 4-oxo-2,6-bis(trifluoromethyl)-1,4-dihydropyridine-3-carboxylate (20f). 
Starting with 2,4,6-tris(trifluoromethyl)-1,3,5-triazine (19) (0.18 mL, 
1.0 mmol), 1-isopentyloxy-1,3-bis(trimethylsilyloxy)-1,3-butadiene 
(2g) (0.633 g, 2.0 mmol), Me3SiOTf (0.18 mL, 1.0 mmol) in CH2Cl2 
(2 mL) and then heating in EtOH (20 mL) for 25 h, the product 20f 
was isolated as a white solid (0.138 g, 40%); mp = 142-145 °C. 1H NMR (300 MHz, DMSO): 
δ = 0.87 (d, 3J = 9.0 Hz, 6H, (CH3)2), 1.84-155 (m, 2H, CH2), 1.64-1.75 (m, 1H, CH), 4.24 (t, 
3J = 6.6 Hz, 2H, CH2), 7.07 (bs, 5H, CH+NH+H2O). 13C NMR (75 MHz, DMSO): δ = 22.1 
(CH3), 24.3 (CH), 36.5, 63.8 (CH2), 113.0 (CH), 121.1 (q, JC-F = 273.7 Hz, CF3), 121.2 (q, JC-
F = 273.0 Hz, CF3), 121.6 (C), 143.4 (q, JC-F = 33.0 Hz, C), 147.3 (q, JC-F = 33.7 Hz, C), 
165.0, 169.1 (C). 19F-NMR (282 MHz, DMSO): δ = -67.1, -63.9 (CF3). IR (ATR, cm-1): 
ν̃ = 3192 (w), 3087 (w), 2962 (m), 2874 (w), 1715 (m), 1594 (m), 1527 (w), 1457 (m), 1431 
(m), 1403 (m), 1183 (s), 1144 (s), 975 (s), 878 (m), 736 (m), 635 (m). GC-MS (EI, 70 eV): 
m/z (%): 345 (M+, 1), 326 (6), 258 (46), 210 (18), 71 (79), 70 (75), 55 (32), 43 (100). HRMS 
(ESI): calcd for C13H14F6NO3 [(M+H)+] 346.0872, found 346.0872; calcd for C13H13F6NNaO3 
[(M+Na)+] 368.0692, found 368.0691. 
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Octyl 4-oxo-2,6-bis(trifluoromethyl)-1,4-dihydropyridine-3-carboxylate (20g).  
Starting with 2,4,6-tris(trifluoromethyl)-1,3,5-triazine (19) (0.18 mL, 
1.0 mmol), 1-octyloxy-1,3-bis(trimethylsilyloxy)-1,3-butadiene (3h) 
(0.717 g, 2.0 mmol), Me3SiOTf (0.18 mL, 1.0 mmol) in CH2Cl2 (2 mL) 
and then heating in EtOH (20 mL) for 22 h, the product 20g was 
isolated as a slight yellow oil (0.209 g, 54%).1H NMR (300 MHz, 
DMSO): δ = 0.81 (bs, 3H, CH3), 1.21 (bs, 10H, (CH2)5), 4.19 (t, 3J = 7.5 Hz, 2H, CH2), 7.03 (s, 
1H, CH), 7.07 (bs, 3H, NH+H2O). 13C NMR (100 MHz, DMSO): δ = 13.8 (CH3), 21.9, 25.1, 
27.8, 28.4, 28.5, 31.1, 65.2 (CH2), 113.0 (CH), 121.1 (q, JC-F = 274.0 Hz, CF3), 121.2 (q, JC-
F = 273.0 Hz, CF3), 121.7 (C), 143.3 (q, JC-F = 33.0 Hz, C), 147.2 (q, JC-F = 33.6 Hz, C), 
165.2, 169.7 (C). 19F-NMR (282 MHz, DMSO): δ = -67.1, -64.0 (CF3). IR (ATR, cm-1): 
ν̃ = 3201 (w), 2958 (w), 2927 (m), 2857 (w), 1719 (m), 1587 (w), 1455 (m), 1399 (m), 1307 
(m), 1264 (s), 1188 (s), 1143 (s), 975 (s), 881 (m), 736 (s). HRMS (ESI): calcd for 
C16H20F6NO3 [(M+H)+] 388.1432, found 388.1345. 
 
 
2-Methoxyethyl 4-oxo-2,6-bis(trifluoromethyl)-1,4-dihydropyridine-3-carboxylate (20h). 
Starting with 2,4,6-tris(trifluoromethyl)-1,3,5-triazine (19) 
(0.18 mL, 1.0 mmol), 1-(2-methoxyethoxy)-1,3-
bis(trimethylsilyloxy)-1,3-butadiene (3i) (0.609 g, 2.0 mmol), 
Me3SiOTf (0.18 mL, 1.0 mmol) in CH2Cl2 (2 mL) and then 
heating in EtOH (20 mL) for 13 h, the product 20h was 
isolated as a slight yellow solid (0.257 g, 77%); mp = 137-139 °C. 1H NMR (300 MHz, 
DMSO): δ = 3.25 (s, 3H, OCH3), 3.54, 4.22 (t, 2J = 4.8 Hz, 2H, CH2), 6.55 (s, 1H, CH), 7.20 
(bs, 3H, NH+H2O). 13C NMR (75 MHz, DMSO): δ = 58.0 (OCH3), 63.7, 69.6 (CH2), 115.6 
(CH), 121.8 (q, JC-F = 274.0 Hz, CF3), 122.0 (q, JC-F = 273.0 Hz, CF3), 122.7 (C), 142.7 (q, JC-
F = 33.2 Hz, C), 146.7 (q, JC-F = 32.5 Hz, C), 167.2, 173.4 (C). 19F-NMR (282 MHz, DMSO): 
δ = -67.0, -63.9 (CF3). IR (ATR, cm-1): ν̃ = 3186 (w), 3022 (w), 2963 (w), 2906 (w), 2793 (m), 
1746 (s), 1593 (m), 1523 (w), 1472 (s), 1412 (s), 1266 (s), 1186 (s), 1124 (s), 988 (s), 871 
(s), 735 (m), 701 (m). GC-MS (EI, 70 eV): m/z (%): 333 (M+, 1), 314 (18), 258 (100), 210 
(47), 58 (62), 45 (77). HRMS (ESI): calcd for C11H10F6NO4 [(M+H)+] 334.0509, found 
334.0514.  
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Methyl 5-methyl-4-oxo-2,6-bis(trifluoromethyl)-1,4-dihydropyridine-3-carboxylate (20i). 
Starting with 2,4,6-tris(trifluoromethyl)-1,3,5-triazine (19) (0.18 mL, 
1.0 mmol), 1-methoxy-1,3-bis(trimethylsilyloxy)-1,3-pentadiene (3j) 
(0.549 g, 2.0 mmol), Me3SiOTf (0.18 mL, 1.0 mmol) in CH2Cl2 (2 mL) 
and then heating in EtOH (20 mL) for 12 h, the product 20i was 
isolated as a white solid (0.105 g, 35%). 1H NMR (300 MHz, MeOD): δ = 2.20 (s, 3H, CH3), 
3.85 (s, 3H, OCH3). 13C NMR (75 MHz, MeOD): δ = 11.1 (CH3), 52.8 (OCH3), 122.2 (C), 
123.0 (q, JC-F = 272.6 Hz, CF3), 124.0 (q, JC-F = 273.5 Hz, CF3), 128.4 (C), 142.1 (q, JC-
F = 33.0 Hz, C), 145.5 (q, JC-F = 31.5 Hz, C), 170.0, 174.5 (C). 19F-NMR (282 MHz, DMSO): 
δ = -66.1, -65.1 (CF3). IR (ATR, cm-1): ν̃ = 3223 (w), 3046 (w), 2960 (w), 2924 (w), 2853 (w), 
1734 (m), 1661 (w), 1561 (w), 1437 (m), 1405 (m), 1240 (s), 1127 (s), 1028 (s), 957 (s), 641 
(s). GC-MS (EI, 70 eV): m/z (%): 303 (M+, 33), 271 (23), 251 (100). HRMS (EI, 70 eV): calcd 
for C10H7F6NO3 (M+) 303.03246, found 303.032939.  
 
 
 
 
 
 
GP 6: General Procedure for the Synthesis of 22. 
 
To a CH2Cl2 solution (2 mL/1.0 mmol of 19) of 19 (1.0 mmol) was added 3 (2.0 mmol) at -
78 °C. The temperature of the solution was allowed to warm to 20 °C during 12-14 h with 
stirring. To the solution was added HCl (10%, 10 mL) and the organic and the aqueous layer 
were separated. The latter was extracted with CH2Cl2 (2 × 10 mL). The combined organic 
layers were dried (Na2SO4), filtered, and the filtrate was concentrated in vacuo. The residue 
was purified by chromatography. 
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Methyl 7-oxo-1,3,5-tris(trifluoromethyl)-2,4,9-triazabicyclo[3.3.1]non-2-ene-6-
carboxylate (22a).  
Starting with 2,4,6-tris(trifluoromethyl)-1,3,5-triazine (19) (0.18 mL, 
1.0 mmol) and 1-methoxy-1,3-bis(trimethylsilyloxy)-1,3-butadiene 
(3a) (0.520 g, 2.0 mmol) in CH2Cl2 (2 mL), the product 22a was 
isolated as a white solid (0.173 g, 43%); mp = 98-99 °C. 1H NMR 
(300 MHz, CDCl3): δ = 2.86 (bs, 1H, NH), 3.00-3.03 (m, 2H, CH2), 
3.85 (s, 3H, OCH3), 4.01 (s, 1H, CH), 6.93 (bs, 1H, NH). 13C NMR (75 MHz, CDCl3): δ = 45.6 
(CH2), 53.3 (CH), 59.2 (OCH3), 70.4 (q, JC-F = 31.7 Hz, C), 74.2 (q, JC-F = 31.2 Hz, C), 116.6 
(q, JC-F = 276.3 Hz, CF3), 121.6 (q, JC-F = 282.7 Hz, CF3), 122.6 (q, JC-F = 279.7 Hz, CF3), 
147.5 (q, JC-F = 38.5 Hz, C), 166.3, 194.6 (C). 19F-NMR (282 MHz, CDCl3): δ = -83.5, -81.4, -
73.7 (CF3). IR (ATR, cm-1): ν̃ = 3341 (w), 3329 (w), 3279 (m), 3016 (w), 2964 (w), 2898 (w), 
2857 (w), 1751 (m), 1754 (s), 1729 (s), 1663 (m), 1523 (w), 1458 (w), 1339 (m), 1141 (s), 
1086 (s), 806 (s), 710 (s), 511 (s). GC-MS (EI, 70 eV): m/z (%): 401 (M+, 42), 300 (31), 286 
(71), 266 (52), 258 (100), 232 (28), 116 (55), 96 (35), 69 (52). Anal. calcd. for C11H8F9N3O3 
(401.19): C, 32.93; H, 2.01; N, 10.47. Found: C, 32.98; H, 2.14; N, 10.57. 
 
 
Methyl 8-methyl-7-oxo-1,3,5-tris(trifluoromethyl)-2,4,9-triazabicyclo[3.3.1]non-2-ene-6-
carboxylate (22b).  
Starting with 2,4,6-tris(trifluoromethyl)-1,3,5-triazine (19) (0.18 mL, 
1.0 mmol) and 1-methoxy-1,3-bis(trimethylsilyloxy)-1,3-pentadiene 
(3j) (0.549 g, 2.0 mmol) in CH2Cl2 (2 mL), the product 22b was 
isolated as a white solid (0.226 g, 54%); mp = 99-100 °C. 1H NMR 
(300 MHz, CDCl3): δ = 1.23-1.26 (dd, 3H, CH3), 2.98 (bs, 1H, NH), 
3.24 (q, 3J = 7.0 Hz, 1H, CH), 3.84 (s, 3H, OCH3), 4.07 (s, 1H, CH), 6.96 (bs, 1H, NH). 13C 
NMR (75 MHz, CDCl3): δ = 7.9 (CH3), 51.6, 53.6 (CH), 59.1 (OCH3), 70.1 (q, JC-F = 31.7 Hz, 
C), 71.7 (q, JC-F = 28.2 Hz, C), 116.5 (q, JC-F = 276.2 Hz, CF3), 121.6 (q, JC-F = 282.7 Hz, 
CF3), 122.9 (q, JC-F = 282.2 Hz, CF3), 147.2 (q, JC-F = 38.5 Hz, C), 166.5, 197.4 (C). 19F-NMR 
(282 MHz, CDCl3): δ = -81.6, -79.1, -73.6 (CF3). IR (ATR, cm-1): ν̃ = 3365 (w), 3341 (w), 3019 
(w), 2964 (w), 2947 (w), 2855 (w), 1743 (m), 1729 (s), 1668 (m), 1497 (w), 1460 (w), 1439 
(w), 1147 (s), 1092 (s), 995 (s), 721 (s). GC-MS (EI, 70 eV): m/z (%): 415 (M+, 6), 300 (31), 
286 (42), 266 (42), 258 (51), 130 (100), 101 (93), 69 (46). HRMS (ESI): calcd for 
C12H11N3O3F9 [(M+H)+] 416.0651, found 416.0656; calcd for C12H10F9N3NaO3 [(M+Na)+] 
438.0470, found 438.048. Anal. calcd. for C12H10F9N3O3 (415.21): C, 34.71; H, 2.43; N, 
10.12. Found: C, 34.77; H, 2.53; N, 9.87. 
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Methyl 7-oxo-8-phenethyl-1,3,5-tris(trifluoromethyl)-2,4,9-triazabicyclo[3.3.1]non-2-ene-
6-carboxylate (22c).  
Starting with 2,4,6-tris(trifluoromethyl)-1,3,5-triazine (19) 
(0.18 mL, 1.0 mmol) and 6-phenyl-1-methoxy-1,3-
bis(trimethylsilyloxy)-1,3-hexadiene (3ad) (0.729 g, 2.0 mmol) in 
CH2Cl2 (2 mL), the product 22c was isolated as a white solid 
(0.241 g, 42%); mp = 84-85 °C. 1H NMR (300MHz, CDCl3): 
δ = 2.04-2.21, 2.49-2.66 (m, 2H, CH2), 2.96 (bs, 1H, NH), 3.08-3.12 (m, 1H, CH), 3.87 (s, 3H, 
OCH3), 4.08 (bs, 1H, CH), 6.96 (bs, 1H, NH), 7.16-7.32 (m, 7H, Ph + CHCl3). 13C NMR 
(100 MHz, CDCl3): δ = 24.8, 33.7 (CH2), 53.2, 55.8 (CH), 59.7 (OCH3), 70.1 (q, JC-
F = 31.6 Hz, C), 74.6 (q, JC-F = 29.0 Hz, C), 116.5 (q, JC-F = 276.3 Hz, CF3), 121.6, 122.9 (q, 
JC-F = 282.6 Hz, CF3), 126.2 128.4, 128.5, 140.8 (Ph), 147.2 (q, JC-F = 38.0 Hz, C), 166.4, 
197.3 (C). 19F-NMR (282 MHz, CDCl3): δ = -81.4, -78.3, -73.6 (CF3). IR (ATR, cm-1): ν̃ = 3329 
(w), 3288 (m), 3031 (w), 2960 (w), 2936 (w), 2864 (w), 1751 (s), 1725 (s), 1662 (m), 1525 
(w), 1496 (w), 1211 (s), 1146 (s), 1091 (s), 698 (s), 492 (s). HRMS (ESI): calcd for 
C19H17N3O3F9 [(M+H)+] 506.1121, found 506.1129; calcd for C19H16ClF9N3NaO3 [(M+Na)+] 
528.094, found 528.0947.  
 
Methyl 8-(3-chloropropyl)-7-oxo-1,3,5-tris(trifluoromethyl)-2,4-9-triazabicyclo[3.3.1]non-
2-ene-6-carboxylate (20d).  
Starting with 2,4,6-tris(trifluoromethyl)-1,3,5-triazine (19) (0.18 mL, 
1.0 mmol) and 7-chloro-1-methoxy-1,3-bis(trimethylsilyloxy)-1,3-
heptadiene (3ag) (0.674 g, 2.0 mmol) in CH2Cl2 (2 mL), the product 
20d was isolated as a slight yellow solid (0.341 g, 71%); mp = 86-
88 °C. 1H NMR (300MHz, CDCl3): δ = 1.66-2.07 (m, 4H, (CH2)2), 
2.99 (bs, 1H, NH), 3.15-3.19 (m, 1H, CH), 3.49-3.54 (m, 2H, CH2), 3.85 (s, 3H, OCH3), 4.11 
(bs, 1H, CH), 6.97 (bs, 1H, NH). 13C NMR (75 MHz, CDCl3): δ = 20.9, 30.6, 44.5 (CH2), 53.3, 
56.3 (CH), 59.7 (OCH3), 70.0 (q, JC-F = 31.7 Hz, C), 74.6 (q, JC-F = 39.7 Hz, C), 116.5 (q, JC-
F = 276.3 Hz, CF3), 121.5 (q, JC-F = 282.7 Hz, CF3), 124.6 (q, JC-F = 283.5 Hz, CF3), 147.1 (q, 
JC-F = 37.5 Hz, C), 166.3, 197.1 (C). 19F-NMR (282 MHz, CDCl3): δ = -81.5, -78.4, -73.6 
(CF3). IR (ATR, cm-1): ν̃ = 3374 (w), 3305 (w), 3050 (w), 3018 (w), 2965 (w), 2942 (w), 2886 
(w), 1751 (m), 1724 (m), 1663 (m), 1510 (w), 1439 (w), 1237 (s), 1199 (s), 1155 (s), 1089 (s), 
714 (s). HRMS (ESI): calcd for C14H14N3O3F9Cl [(M+H)+] 478.0574, found 478.0578; calcd for 
C14H13ClF9N3NaO3 [(M+Na)+] 500.0393, found 500.0401. Anal. calcd. for C14H13ClF9N3O3 
(477.05): C, 35.20; H, 2.74; N, 8.80. Found: C, 35.28; H, 2.83; N, 8.76. 
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Methyl 8-(4-chlorobutyl)-7-oxo-1,3,5-tris(trifluoromethyl)-2,4,9-triazabicyclo[3.3.1]non-
2-ene-6-carboxylate (22e).  
Starting with 2,4,6-tris(trifluoromethyl)-1,3,5-triazine (19) 
(0.18 mL, 1.0 mmol) and 8-chloro-1-methoxy-1,3-
bis(trimethylsilyloxy)-1,3-octadiene (3ah) (0.702 g, 2 mmol) in 
CH2Cl2 (2 mL), the product 22e was isolated as a colorless oil 
(0.238 g, 48%).1H NMR (300MHz, CDCl3): δ = 1.31-1.93 (m, 6H, 
(CH2)3), 2.98 (bs, 1H, NH), 3.07-3.10 (m, 1H, CH), 3.49-3.55 (m, 2H, CH2), 3.84 (s, 3H, 
OCH3), 4.10 (bs, 1H, CH), 6.96 (bs, 1H, NH). 13C NMR (75 MHz, CDCl3): δ = 22.3, 25.5, 
32.4, 44.5 (CH2), 53.2, 56.8 (CH), 59.7 (OCH3), 70.1 (q, JC-F = 31.7 Hz, C), 74.6 (q, JC-
F = 28.0 Hz, C), 116.5 (q, JC-F = 276.3 Hz, CF3), 121.5, 122.9 (q, JC-F = 282.7 Hz, CF3), 147.3 
(q, JC-F = 38.2 Hz, C), 166.3, 197.2 (C). 19F-NMR (282 MHz, CDCl3): δ = -81.4, -78.3, -73.6 
(CF3). IR (ATR, cm-1): ν̃ = 3338 (w), 2960 (w), 2873 (w), 1748 (m), 1728 (m), 1672 (m), 1491 
(w), 1439 (w), 1151 (s), 1091 (s), 727 (m). HRMS (ESI): calcd for C15H16ClN3O3F9 [(M+H)+] 
492.0731, found 492.0733; calcd for C15H15ClF9N3NaO3 [(M+Na)+] 514.0550, found 
514.0553. Anal. calcd. for C14H13ClF9N3O3 (491.07): C, 35.20; H, 2.74; N, 8.80. Found: C, 
35.28; H, 2.83; N, 8.76. 
 
 
(Z)-Methyl 6,6,6-trifluoro-3-hydroxy-5,5-bis(2,2,2-trifluoroacetamido)hex-2-enoate (23a). 
Starting with 2,4,6-tris(trifluoromethyl)-1,3,5-triazine (19) 
(0.18 mL, 1.0 mmol) and 1-methoxy-1,3-bis(trimethylsilyloxy)-1,3-
butadiene (3a) (0.520 g, 2 mmol) in CH2Cl2 (2 mL) and then reflux 
in EtOH (20 mL) for 30 h at 90°C, the product 23a was isolated 
as a white solid (0.200 g, 47%); 1H NMR (300 MHz, CDCl3, 
25°C): δ = 3.37-3.58 (m, 2H; CH2), 3.77 (s, 3H; OCH3), 5.33 (bs, 1H; CH), 6.63 (bs, 1H; NH), 
11.27 (bs, 1H; NH); 13C NMR (75 MHz, CDCl3, 25°C): δ = 28.4 (CH2), 51.9 (OCH3), 71.0 (q, 
1J (C,F) = 32.3 Hz; C), 98.9 (CH), 115.1 (q, 1J (C,F) = 288.3 Hz; CF3), 117.0 (q, 1J 
(C,F) = 278.0 Hz; CF3), 123.2 (q, 1J (C,F) = 287.5 Hz; CF3), 143.1 (C), 146.8 (q, 2J 
(C,F) = 38.0 Hz; C), 155.6 (q, 2J (C,F) = 38.4 Hz; C), 168.7 (C); 19F-NMR (282 MHz, CDCl3, 
25°C): δ = -80.9, -75.5, -72.7 (CF3). 
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GP 7: General procedure for the synthesis of 31 and 32.  
 
Me3SiOTf (2.0 mmol) was added to chromone 28 (1.0 mmol) at 20 °C. After stirring for 1 h, 
CH2Cl2 (4 mL / mmol 28) and the 1,3-bis-silyl-enol ether 3 (2.0 mmol) were added at 0 °C. 
The mixture was stirred for 12 h at 0-20 °C and was then poured into an aqueous solution of 
hydrochloric acid (10%). The organic layer was separated and the aqueous layer was 
extracted with CH2Cl2 (2 x 10 mL). The combined organic layers were dried (Na2SO4), 
filtered, and the filtrate was concentrated in vacuo. The residue was purified by 
chromatography. 
 
 
 
 
 
 
 
Dimethyl 1,3-dihydroxy-9-oxo-4,4a,9,9a-tetrahydro-1H-xanthene-1,2-dicarboxylate 
(31a). 
Starting with 3-methoxalylchromone (8a) (0.232 g, 1.0 mmol) and 
1-methoxy-1,3-bis(trimethylsilyloxy)-1,3-butadiene (3a) (0.520 g, 
2.0 mmol), Me3SiOTf (0.36 mL, 2.0 mmol) in CH2Cl2 (4 mL), the 
product 31a was isolated as a white solid (0.183 g, 52%); 
mp = 170-171 °C. 1H NMR (300 MHz, CDCl3): δ = 2.90-3.16 (m, 2H, CH2), 3.24 (d, 
3J = 13.5 Hz, 1H, CH), 3.76 (s, 3H, OCH3), 3.87 (s, 3H, OCH3), 4.12 (bs, 1H, OH), 4.90-5.00 
(m, 1H, CH), 6.96-7.06 (m, 2H, Ar), 7.46-7.52 (m, 1H, Ar), 7.84-7.87 (m, 1H, Ar), 13.00 (s, 
1H, OH). 13C NMR (75 MHz, CDCl3): δ = 35.9 (CH2), 52.0, 53.4, 54.9 (CH/OCH3), 71.8 (CH), 
73.0 (C), 101.9 (C), 117.7 (Ar), 121.2 (C), 122.0, 127.3, 136.5 (Ar), 160.4, 171.0, 172.7, 
174.0, 189.8 (C). IR (ATR, cm-1): ν̃ = 3459 (m), 2950 (w), 2903 (w), 1746 (s), 1726 (s), 1683 
(s), 1655 (m), 1607 (s), 1466 (s), 1219 (s), 1083 (s), 854 (s), 764 (s), 466 (s). HRMS (ESI): 
calcd. for C17H17O8 [(M+H)+] 349.0918, found 349.0921; calcd. for C17H16NaO8 [(M+Na)+] 
371.0737, found 371.0743. Anal. calcd. for C17H16O8 (348.30): C, 58.62; H, 4.63. Found: C, 
58.64; H, 4.69. 
 
 
  
O
O
O OMe
OH
OMe
O
OH
 106 
Supplement 1: Experimental part 
2-Ethyl 1-methyl 1,3-dihydroxy-9-oxo-4,4a,9,9a-tetrahydro-1H-xanthene-1,2-
dicarboxylate (31b). 
Starting with 3-methoxalylchromone (8a) (0.232 g, 1.0 mmol) and 
1-ethoxy-1,3-bis(trimethylsilyloxy)-1,3-butadiene (3b) (0.549 g, 
2.0 mmol), Me3SiOTf (0.36 mL, 2.0 mmol) in CH2Cl2 (4 mL), the 
product 31b was isolated as a white solid (0.173 g, 47%); 
mp = 159-160 °C. 1H NMR (300 MHz, CDCl3): δ = 1.28 (t, 3J = 7.1 Hz, 3H, CH3CH2), 2.89-
3.15 (m, 2H, CH2), 3.24 (d, 3J = 13.5 Hz, 1H, CH), 3.87 (s, 3H, OCH3), 4.13 (bs, 1H, OH), 
4.15-4.35 (m, 2H, CH3CH2), 4.90-5.00 (m, 1H, CH), 6.95-7.06 (m, 2H, Ar), 7.46-7.52 (m, 1H, 
Ar), 7.84-7.87 (m, 1H, Ar), 13.11 (s, 1H, OH). 13C NMR (75 MHz, CDCl3): δ = 13.9 (CH3), 
35.9 (CH2), 53.4, 55.1 (CH/OCH3), 61.3 (CH2), 71.8 (CH), 73.0 (C), 101.9 (C), 117.7 (Ar), 
121.2 (C), 122.0, 127.3, 136.4 (Ar), 160.4, 170.6, 172.5, 174.0, 189.7 (C). IR (ATR, cm-1): 
ν̃ = 3463 (m), 2975 (w), 1743 (s), 1693 (m), 1637 (m), 1605 (s), 1578 (m), 1230 (s), 1095 (s), 
760 (s), 577 (s). MS (EI, 70 eV): m/z (%): 362 (M+, 3), 303 (35), 257 (100), 160 (16), 121 
(66). HRMS (ESI): calcd. for C18H18NaO8 [(M+Na)+] 385.0894, found 385.0901. Anal. calcd. 
for C18H18O8 (362.33): C, 59.64; H, 5.01. Found: C, 59.70; H, 5.01. 
 
 
2-Benzyl 1-methyl 1,3-dihydroxy-9-oxo-4,4a,9,9a-tetrahydro-1H-xanthene-1,2-
dicarboxylate (31c). 
Starting with 3-methoxalylchromone (8a) (0.232 g, 1.0 mmol) and 
1-benzyloxy-1,3-bis(trimethylsilyloxy)-1,3-butadiene (3c) (0.673 g, 
2.0 mmol), Me3SiOTf (0.36 mL, 2.0 mmol) in CH2Cl2 (4 mL), the 
product 31c was isolated as a slight yellow solid (0.174 g, 41%); 
mp = 166-168 °C. 1H NMR (300 MHz, CDCl3): δ = 2.90-3.16 (m, 2H, CH2), 3.23 (d, 
3J = 13.5 Hz, 1H, CH), 3.45 (s, 3H, OCH3), 4.11 (bs, 1H, OH), 4.89-4.99 (m, 1H, CH), 5.22 
(dd, 2J = 12.0 Hz, 2H, CH2Ph), 6.95-7.05 (m, 2H, Ar), 7.33-7.39 (m, 5H, Ph), 7.46-7.51 (m, 
1H, Ar), 7.82-7.86 (m, 1H, Ar), 13.07 (s, 1H, OH). 13C NMR (75 MHz, CDCl3): δ = 35.9 (CH2), 
52.9, 55.1 (CH/OCH3), 66.9 (CH2), 71.8 (CH), 73.1 (C), 101.8 (C), 117.7 (Ar), 121.2 (C), 
121.9, 127.3 (Ar), 128.5, 128.6, 128.7, 134.7 (Ph), 136.4 (Ar), 160.3, 170.5, 172.9, 173.7, 
189.7 (C). IR (ATR, cm-1): ν̃ = 3462 (m), 2953 (w), 1751 (s), 1688 (m), 1637 (m), 1603 (s), 
1577 (m), 1285 (s), 1229 (s), 757 (s), 697 (s), 586 (s). MS (EI, 70 eV): m/z (%): 424 (M+, 3), 
365 (43), 257 (38), 121 (23), 91 (100). HRMS (EI, 70 eV): calcd. for C23H20O8 (M+) 
424.11527, found 424.11508. Anal. calcd. for C23H20O8 (424.40): C, 65.09; H, 4.75. Found: 
C, 65.13; H, 4.66. 
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2-Isobutyl 1-methyl 1,3-dihydroxy-9-oxo-4,4a,9,9a-tetrahydro-1H-xanthene-1,2-
dicarboxylate (31d). 
Starting with 3-methoxalylchromone (8a) (0.232 g, 1.0 mmol) and 
1-isobutyloxy-1,3-bis(trimethylsilyloxy)-1,3-butadiene (3f) 
(0.605 g, 2.0 mmol), Me3SiOTf (0.36 mL, 2.0 mmol) in CH2Cl2 
(4 mL), the product 31d was isolated as a slight yellow solid 
(0.167 g, 43%); mp = 152-153 °C. 1H NMR (300 MHz, CDCl3): δ = 0.92-0.97 (m, 6H, (CH3)2), 
1.88-2.00 (m, 1H, CH(CH3)2), 2.89-3.15 (m, 2H, CH2), 3.24 (d, 3J = 13.2 Hz, 1H, CH), 3.86 (s, 
3H, OCH3), 3.92-4.01 (m, 2H, CH2CH(CH3)2), 4.15 (bs, 1H, OH), 4.89-4.99 (m, 1H, CH), 
6.95-7.05 (m, 2H, Ar), 7.46-7.52 (m, 1H, Ar), 7.84-7.87 (m, 1H, Ar), 13.18 (s, 1H, OH). 13C 
NMR (75 MHz, CDCl3): δ = 18.9, 19.1 (CH3), 27.5 (CH), 36.0 (CH2), 53.4, 55.1 (CH/OCH3), 
71.7 (CH2), 71.8 (CH), 73.0 (C), 101.8 (C), 117.7 (Ar), 121.3 (C), 122.0, 127.3, 136.4 (Ar), 
160.4, 170.9, 172.6, 173.8, 189.7 (C). IR (ATR, cm-1): ν̃ = 3476 (m), 2961 (w), 1749 (s), 1690 
(m), 1633 (m), 1605 (s), 1460 (m), 1294 (s), 1230 (s), 1076 (s), 764 (s). MS (EI, 70 eV): m/z 
(%): 390 (M+, 2), 331 (35), 257 (100), 121 (32). HRMS (EI, 70 eV): calcd. for C20H22O8 (M+) 
390.13092, found 390.13090. Anal. calcd. for C20H22O8 (390.38): C, 61.53; H, 5.68. Found: 
C, 61.44; H, 5.62. 
 
2-Isopentyl 1-methyl 1,3-dihydroxy-9-oxo-4,4a,9,9a-tetrahydro-1H-xanthene-1,2-
dicarboxylate (31e). 
Starting with 3-methoxalylchromone (8a) (0.232 g, 1.0 mmol) 
and 1-isopentyloxy-1,3-bis(trimethylsilyloxy)-1,3-butadiene 
(3g) (0.633 g, 2.0 mmol), Me3SiOTf (0.36 mL, 2.0 mmol) in 
CH2Cl2 (4 mL), the product 31e was isolated as a white solid 
(0.210 g, 52%); mp = 137-138 °C. 1H NMR (300 MHz, CDCl3): δ = 0.92 (d, 3J = 6.5 Hz, 6H, 
(CH3)2), 1.46-1.59 (m, 2H, CH2CH2CH), 1.61-1.76 (m, 1H, CH(CH3)2), 2.89-3.14 (m, 2H, 
(CH2), 3.22 (d, 3J = 13.4 Hz, 1H, CH), 3.86 (s, 3H, OCH3), 4.12 (bs, 1H, OH), 4.20 (t, 
3J = 6.9 Hz, 2H, OCH2), 4.89-4.99 (m, 1H, CH), 6.95-7.05 (m, 2H, Ar), 7.46-7.52 (m, 1H, Ar), 
7.84-7.87 (m, 1H, Ar), 13.13 (s, 1H, OH). 13C NMR (75 MHz, CDCl3): δ = 22.2, 22.4 (CH3), 
24.7 (CH), 35.9, 36.9 (CH2), 53.3, 55.0 (CH/OCH3), 64.1 (CH2), 71.8 (CH), 73.0 (C), 101.9 
(C), 117.7 (Ar), 121.3 (C), 122.0, 127.3, 136.4 (Ar), 160.4, 170.8, 172.5, 173.9, 189.7 (C). IR 
(ATR, cm-1): ν̃ = 3476 (m), 2958 (m), 1741 (s), 1687 (s), 1639 (m), 1603 (s), 1463 (m), 1241 
(s), 1077 (s), 859 (s), 762 (s). MS (EI, 70 eV): m/z (%): 404 (M+, 2), 345 (43), 257 (100), 121 
(33). HRMS (EI, 70 eV): calcd. for C21H24O8 (M+) 404.14657, found 404.14628. Anal. calcd. 
for C21H24O8 (404.41): C, 62.37; H, 5.98. Found: C, 62.27; H, 5.80. 
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Dimethyl 1,3-dihydroxy-4-methyl-9-oxo-4,4a,9,9a-tetrahydro-1H-xanthene-1,2-
dicarboxylate (31f). 
Starting with 3-methoxalylchromone (8a) (0.232 g, 1.0 mmol) and 
1-methoxy-1,3-bis(trimethylsilyloxy)-1,3-pentadiene (3j) (0.549 g, 
2.0 mmol), Me3SiOTf (0.36 mL, 2.0 mmol) in CH2Cl2 (4 mL), the 
product 31f was isolated as a white solid (0.152 g, 42%); 
mp = 156-157 °C. 1H NMR (400 MHz, CDCl3): δ = 1.46 (d, 
3J = 7.2 Hz, 3H, CH3), 3.12-3.18 (m, 1H, CH), 3.41 (d, 3J = 14.0 Hz, 1H, CH), 3.75 (s, 3H, 
OCH3), 3.87 (s, 3H, OCH3), 4.13 (bs, 1H, OH), 5.00-5.05 (m, 1H, CH), 6.96-7.03 (m, 2H, Ar), 
7.46-7.50 (m, 1H, Ar), 7.83-7.86 (m, 1H, Ar), 13.06 (s, 1H, OH). 13C NMR (100 MHz, CDCl3): 
δ = 12.2 (CH3), 38.2, 49.8 (CH), 52.0, 53.4 (OCH3), 73.0 (C), 73.5 (CH), 100.6 (C), 117.8 
(Ar), 121.0 (C), 121.8, 127.2, 136.4 (Ar), 160.5, 171.4, 174.1, 177.1, 190.3 (C). IR (ATR, cm-
1): ν̃ = 3475 (m), 2947 (w), 1746 (s), 1680 (s), 1657 (m), 1607 (s), 1467 (s), 1218 (s), 1101 
(s), 1044 (s), 780 (s). MS (EI, 70 eV): m/z (%): 362 (M+, 1), 303 (34), 271 (97), 174 (32), 151 
(22), 121 (100). HRMS (EI, 70 eV): calcd. for C18H18O8 (M+) 362.09962, found 362.09931. 
Anal. calcd. for C18H18O8 (362.33): C, 59.67; H, 5.01. Found: C, 59.50; H, 4.97. 
 
 
Dimethyl 7-bromo-1,3-dihydroxy-9-oxo-4,4a,9,9a-tetrahydro-1H-xanthene-1,2-
dicarboxylate (31g).  
Starting with 6-bromo-3-methoxalylchromone (8b) (0.309 g, 
1.0 mmol) and 1-methoxy-1,3-bis(trimethylsilyloxy)-1,3-
butadiene (3a) (0.520 g, 2.0 mmol), Me3SiOTf (0.36 mL, 
2.0 mmol) in CH2Cl2 (4 mL), the product 31g was isolated as 
a slight orange solid (0.220 g, 51%); mp = 160-162 °C. 1H NMR (300 MHz, CDCl3): δ = 2.89-
3.15 (m, 2H, CH2), 3.22 (d, 3J = 13.4 Hz, 1H, CH), 3.76 (s, 3H, OCH3), 3.87 (s, 3H, OCH3), 
4.11 (bs, 1H, OH), 4.88-4.98 (m, 1H, CH), 6.88 (d, 3J = 8.7 Hz, 1H, Ar), 7.54-7.58 (dd, 
3J = 8.8 Hz, 4J = 2.5 Hz 1H, Ar), 7.95 (d, 4J = 2.5 Hz, 1H, Ar), 12.99 (s, 1H, OH). 13C NMR 
(75 MHz, CDCl3): δ = 35.7 (CH2), 52.0, 53.5, 54.7 (CH/OCH3), 72.0 (CH), 72.9 (C), 101.9, 
114.7 (C), 119.8 (Ar), 122.4 (C), 129.8, 139.0 (Ar), 159.4, 170.0, 172.4, 173.8, 188.6 (C). IR 
(ATR, cm-1): ν̃ = 3461 (m), 2954 (w), 1749 (s), 1695 (m), 1659 (m), 1618 (m), 1597 (m), 1471 
(m), 1285 (s), 1218 (s), 1110 (s), 839 (s), 639 (s), 584 (s). HRMS (ESI): calcd. for 
C17H15Br79NaO8 [(M+Na)+] 448.9842, found 448.9840; calcd. for C17H15Br81NaO8 [(M+Na)+] 
450.9824, found 450.9822. Anal. calcd. for C17H15BrO8 (427.20): C, 47.80; H, 3.54. Found: C, 
48.05; H, 3.56. 
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2-Isobutyl 1-methyl 7-bromo-1,3-dihydroxy-9-oxo-4,4a,9,9a-tetrahydro-1H-xanthene-
1,2-dicarboxylate (31h). 
Starting with 6-bromo-3-methoxalylchromone (8b) (0.309 g, 
1.0 mmol) and 1-isobuoxy-1,3-bis(trimethylsilyloxy)-1,3-
butadiene (3f) (0.605 g, 2.0 mmol), Me3SiOTf (0.36 mL, 
2.0 mmol) in CH2Cl2 (4 mL), the product 31h was isolated as 
a white solid (0.375 g, 80%); mp = 129-131 °C. 1H NMR (300 MHz, CDCl3): δ = 0.92-0.97 (m, 
6H, (CH3)2), 1.88-1.04 (m, 1H, CH), 2.89-3.14 (m, 2H, CH2), 3.22 (d, 3J = 13.4 Hz, 1H, CH), 
3.86 (s, 3H, OCH3), 3.88-4.01 (m, 2H, CH2), 4.14 (bs, 1H, OH), 4.87-4.97 (m, 1H, CH), 6.88 
(d, 3J = 8.8 Hz, 1H, Ar), 7.54-7.58 (dd, 3J = 8.7 Hz, 4J = 2.4 Hz 1H, Ar), 7.95 (d, 4J = 2.5 Hz, 
1H, Ar), 13.18 (s, 1H, OH). 13C NMR (75 MHz, CDCl3): δ = 18.9, 19.1 (CH3), 27.5 (CH), 35.8 
(CH2), 53.5, 54.8 (CH/OCH3), 71.8 (CH2), 72.1 (CH), 72.9 (C), 101.8, 114.7 (C), 119.8 (Ar), 
122.5 (C), 129.8, 139.0 (Ar), 159.2, 170.8, 172.3, 173.6, 188.5 (C). IR (ATR, cm-1): ν̃ = 3430 
(w), 2952 (w), 2894 (w), 2731 (w), 1755 (m), 1692 (s), 1639 (m), 1598 (s), 1467 (m), 1409 
(s), 1231 (s), 1100 (s), 820 (s), 638 (s), 386 (s). MS (EI, 70 eV): m/z (%): 470 (M+, 5), 468 
(M+, 5), 411 (34), 409 (34), 364 (26), 362 (26), 337 (99), 335 (100), 201 (32), 199 (33). 
HRMS (ESI): calcd. for C20H21Br79NaO8 [(M+Na)+] 491.0312, found 491.0322; calcd. for 
C20H21Br81NaO8 [(M+Na)+] 493.0294, found 493.0307. Anal. calcd. for C20H21BrO8 (468.28): 
C, 51.19; H, 4.51. Found: C, 51.18; H, 4.67. 
 
Dimethyl 1,3-dihydroxy-7-methyl-9-oxo-4,4a,9,9a-tetrahydro-1H-xanthene-1,2-
dicarboxylate (31i). 
Starting with 6-methyl-3-methoxalylchromone (8c) (0.246 g, 
1.0 mmol) and 1-methoxy-1,3-bis(trimethylsilyloxy)-1,3-
butadiene (3a) (0.520 g, 2.0 mmol), Me3SiOTf (0.36 mL, 
2.0 mmol) in CH2Cl2 (4 mL), the product 31i was isolated as 
a slight orange solid (0.260 g, 71%); mp = 165-167 °C. 1H NMR (300 MHz, CDCl3): δ = 2.29 
(s. 3H, CH3), 2.87-3.24 (m, 2H, CH2), 3.49-3.54 (m, 1H, CH), 3.78 (s, 3H, OCH3), 3.89 (s, 3H, 
OCH3), 3.92 (bs, 1H, OH), 4.54 (bs, 1H, OH), 4.85-4.95 (m, 1H, CH), 6.88 (d, 3J = 8.4 Hz, 1H, 
Ar), 7.29-7.33 (m, 1H, Ar), 7.66-7.67 (m, 1H, Ar). 13C NMR (75 MHz, CDCl3): δ = 20.4 (CH3), 
46.1 (CH2), 52.7. 53.5, 54.5 (CH/OCH3), 62.9, 74.6 (CH), 75.5 (C), 117.5 (Ar), 120.5 (C), 
127.1 (Ar), 131.8 (C), 137.6 (Ar), 158.8, 167.9, 172.0, 188.3, 197.2 (C). IR (ATR, cm-1): 
ν̃ = 3454 (m), 2956 (w), 2923 (w), 1768 (s), 1726 (s), 1682 (s), 1617 (m), 1579 (w), 1488 (s), 
1220 (s), 1126 (s), 823 (s), 761 (s), 602 (s), 503 (s). HRMS (ESI): calcd. for C18H19O8 
[(M+H)+] 363.1074, found 360.1082; calcd. for C18H18NaO8 [(M+Na)+] 385.0893, found 
363.1082. Anal. calcd. for C18H18O8 (362.33): C, 59.67; H, 5.01. Found: C, 59.87; H, 5.12. 
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2-Isopropyl 1-methyl 1,3-dihydroxy-7-methyl-9-oxo-4,4a,9,9a-tetrahydro-1H-xanthene-
1,2-dicarboxylate (31j). 
Starting with 6-methyl-3-methoxalylchromone (8c) (0.246 g, 
1.0 mmol) and 1-isopropoxy-1,3-bis(trimethylsilyloxy)-1,3-
butadiene (3d) (0.577 g, 2.0 mmol), Me3SiOTf (0.36 mL, 
2.0 mmol) in CH2Cl2 (4 mL), the product 31j was isolated as 
a slight orange solid (0.176 g, 45%); mp = 128-130 °C. 1H NMR (300 MHz, CDCl3): δ = 1.24-
1.29 (m, 6H, (CH3)2), 2.28 (s. 3H, CH3), 2.86-3.12 (m, 2H, CH2), 3.20 (d, 3J = 13.4 Hz, 1H, 
CH), 3.87 (s, 3H, OCH3), 4.11 (bs, 1H, OH), 4.84-4.94 (m, 1H, CH), 5.06-5.15 (m, 1H, CH), 
6.87 (d, 3J = 8.4 Hz, 1H, Ar), 7.28-7.31 (m, 1H, Ar), 7.64 (d, 4J = 2.2 Hz, 1H, Ar), 13.18 (s, 
1H, OH). 13C NMR (75 MHz, CDCl3): δ = 20.4, 21.4, 21.6 (CH3), 35.9 (CH2), 53.2, 55.1 
(CH/OCH3), 69.3, 71.8 (CH), 73.0 102.7 (C), 117.4 (Ar), 120.9 (C), 126.8 (Ar), 131.4 (C), 
137.4 (Ar), 158.5, 170.2, 172.4, 174.0, 189.9 (C). IR (ATR, cm-1): ν̃ = 3493 (w), 2980 (w), 
2957 (w), 1734 (m), 1684 (s), 1612 (s), 1487 (m), 1441 (w), 1421 (w), 1217 (s), 1095 (s), 832 
(s), 796 (s), 586 (s). MS (EI, 70 eV): m/z (%): 390 (M+, 4), 331 (37), 271 (100), 135 (71). 
HRMS (EI): calcd. for C20H22O8 (M+) 390.1309, found 390.1306. Anal. calcd. for C20H22O8 
(390.38): C, 61.53; H, 5.68. Found: C, 61.50; H, 5.56. 
 
Methyl 1-(dichloromethyl)-1-hydroxy-4-methyl-3,9-dioxo-2,3,4,4a,9,9a-hexahydro-1H-
xanthene-2-carboxylate (32). 
Starting with 3-dichloroacetylchromone (8d) (0.257 g, 1.0 mmol) 
and 1-methoxy-1,3-bis(trimethylsilyloxy)-1,3-pentadiene (3j) 
(0.549 g, 2.0 mmol), Me3SiOTf (0.36 mL, 2.0 mmol) in CH2Cl2 
(4 mL), a mixture of isomers of 32 was isolated as a white solid 
(0.210 g, 54%); mp = 186-188 °C. 1H NMR (300 MHz, CDCl3): 
δ = 1.35 (d, 3J = 6.3 Hz, 0.3H, CH3), 1.39 (d, 3J = 6.3 Hz, 3H, CH3), 2.96-3.06 (m, 1H, CH), 
3.53-3.58 (m, 1H, CH), 3.75 (s, 0.8H, OCH3), 3.87 (s, 3H, OCH3), 4.18 (bs, 0.3H, OH), 4.19 
(bs, 1H, OH), 4.26-4.40 (m, 0.4H, CH), 4.42-4.50 (m, 0.4H, CH), 5.8 (d, 4J = 2.0 Hz, 1H, CH), 
6.99-7.03 (m, 0.6H, Ar), 7.03-7.11 (m, 2H, Ar), 7.48 (bs, 0.3H, Ar), 7.49-7.56 (m, 1H, Ar), 
7.78 (s, 1H, CHCl2), 7.86-7.89 (m, 0.3H, Ar), 7.92-7.95 (m, 1H, Ar). 13C NMR (75 MHz, 
CDCl3): δ = 10.2, 10.8 (CH3), 46.6, 48.3, 50.2, 51.9, 53.1, 53.3 (OCH3), 56.7, 62.1, 75.9 (CH), 
79.8 (C), 79.9 (CH), 81.2 (C), 81.7 (CH), 117.4, 117.6 (Ar), 121.5 (C), 121.9, 122.4, 127.6, 
128.0, 136.6 (Ar), 160.0, 170.7, 189.0, 200.4 (C). IR (ATR, cm-1): ν̃ = 3850 (w), 3732 (w), 
3667 (w), 3646 (w), 3626 (w), 3328 (w), 3042 (w), 2942 (w), 2874 (w), 1731 (s), 1704 (m), 
1667 (s), 1603 (s), 1581 (m), 1308 (s), 1201 (s), 767 (s), 611 (s). MS (ESI, 70 eV): m/z (%): 
409.0214 [(M+Na)+]. Anal. calcd. for C16H14Cl2O6 (373.18): C, 51.49; H, 3.78. Found: C, 
51.81; H, 4.24.  
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GP 8: General procedure for the synthesis of 33.  
 
Me3SiOTf (2.0 mmol) was added to chromone 8 (1.0 mmol) at 20 °C. After stirring for 1 h, 
CH2Cl2 (4 mL) and the 1,3-bis-silyl-enol ether 3 (2.0 mmol) were added at 0 °C. The mixture 
was stirred for 12 h at 0-20 °C and was then poured into an aqueous solution of hydrochloric 
acid (10%). The organic layer was separated and the aqueous layer was extracted with 
CH2Cl2 (2 x 10 mL). The combined organic layers were dried (Na2SO4), filtered, and the 
filtrate was concentrated in vacuo. To the mixture was added p-TsOH (3 mol%) and was 
heated at 80-90 °C in EtOH (4-8 mL/1 mmol of 8) during 5-10 h. The solvent was removed in 
vacuo and the product was purified by chromatography. 
 
 
 
 
 
 
Dimethyl 3-hydroxy-6-(2-hydroxybenzoyl)phthalate (33a). 
Starting with 3-methoxalylchromone (8a) (0.232 g, 1.0 mmol) and 
1-methoxy-1,3-bis(trimethylsilyloxy)-1,3-butadiene (3a) (0.520 g, 
2.0 mmol), Me3SiOTf (0.36 mL, 2.0 mmol) in CH2Cl2 (4 mL) and 
then 10 h heating in EtOH (4 mL) with 3 mol% of p-TsOH, the 
product 33a was isolated as a yellow solid (0.208 mg, 63%); mp = 153-154 °C. 1H NMR (300 
MHz, CDCl3): δ = 3.77 (s, 3H, OCH3), 3.49 (s, 3H, OCH3), 6.82-6.88 (m, 1H, Ar), 7.02-7.06 
(dd, 3J = 8.4 Hz, 4J = 0.9 Hz 1H, Ar), 7.11 (d, 3J = 8.7 Hz, 1H, Ar), 7.37-7.40 (dd, 3J = 8.0 Hz, 
4J = 1.6 Hz, 1H, Ar), 7.47-7.53 (m, 1H, Ar), 7.56 (d, 3J = 8.6 Hz, 1H, Ar), 11.08 (s, 1H, OH), 
11.62 (s, 1H, OH). 13C NMR (75 MHz, CDCl3): δ = 52.7, 53.3 (OCH3), 111.0 (C), 118.4, 118.8 
(Ar), 119.0, 128.3 (C), 133.1, 135.3 (Ar), 136.4 (C), 136.8 (Ar), 163.0, 163.1, 167.5, 168.9, 
199.6 (C). IR (ATR, cm-1): ν̃ = 3291 (w), 2961 (w), 1731 (m), 1683 (s), 1626 (s), 1609 (m), 
1590 (m), 1442 (s), 1320 (s), 1184(s), 1119 (s), 1012 (s), 759 (s), 719 (s), 638 (s), 530 (s), 
388 (s). GC-MS (EI, 70 eV): m/z (%) = 330 (M+, 7), 298 (37), 239 (100). HRMS (EI, 70 eV): 
calcd. for C17H14O7 (M+) 330.07340, found 330.07361. Anal. calcd. for C17H14O7 (330.29): C, 
61.82; H, 4.27. Found: C, 61.54; H, 4.28. 
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1-Butyl 2-methyl 6-hydroxy-3-(2-hydroxybenzoyl)phthalate (33b).
Starting with 3-methoxalylchromone (8a) (0.232 g, 1.0 mmol) 
and 1-butoxy-1,3-bis(trimethylsilyloxy)-1,3-butadiene (3e) 
(0.605 g, 2.0 mmol), Me3SiOTf (0.36 mL, 2.0 mmol) in CH2Cl2 
(4 mL) and then 10 h heating in EtOH (4 mL) with 3 mol% of p-
TsOH, the product 33b was isolated as a yellow oil (0.311 mg, 84%).1H NMR (300 MHz, 
CDCl3): δ = 0.94 (t, 3J = 7.4 Hz, 3H, CH3), 1.33-1.50 (m, 2H, CH2), 1.61-1.74 (m, 2H, CH2), 
3.73 (s, 3H, OCH3), 4.34 (t, 3J = 6.7 Hz, 2H, CH2), 6.82-6.87 (m, 1H, Ar), 7.02-7.05 (dd, 
3J = 8.4 Hz, 4J = 0.8 Hz, 1H, Ar), 7.11 (d, 3J = 8.7 Hz, 1H, Ar), 7.37-7.40 (dd, 3J = 8.1 Hz, 
4J = 1.6 Hz, 1H, Ar), 7.46-7.52 (m, 1H, Ar), 7.54 (d, 3J = 8.6 Hz, 1H, Ar), 11.27 (s, 1H, OH), 
11.64 (s, 1H, OH). 13C NMR (75 MHz, CDCl3): δ = 13.5 (CH3), 18.8, 30.1 (CH2), 52.6 (OCH3), 
66.7 (CH2), 111.0 (C), 118.3, 118.4, 118.8 (Ar), 119.0, 128.2 (C), 133.1, 135.1 (Ar), 136.3 
(C), 136.7 (Ar), 163.0, 163.1, 167.4, 168.7, 199.7 (C). IR (ATR, cm-1): ν̃ = 2958 (w), 2874 (w), 
1736 (s), 1673 (s), 1625 (s), 1608 (m), 1581 (s), 1442 (s), 1325 (s), 1211(s), 1146 (s), 1018 
(s), 756 (s) , 641 (s). GC-MS (EI, 70 eV): m/z (%) = 372 (M+, 7), 340 (47), 284 (21), 283 (34), 
239 (100), 212 (22). HRMS (EI, 70 eV): calcd. for C20H20O7 (M+) 372.12035, found 
372.12116. Anal. calcd. for C20H20O7 (372.37): C, 64.51; H, 5.41. Found: C, 64.28; H, 5.54. 
 
1-Methyl 2-octyl 3-hydroxy-6-(2-hydroxybenzoyl)phthalate (33c). 
Starting with 3-methoxalylchromone (8a) (0.232 g, 1.0 mmol) 
and 1-octyloxy-1,3-bis(trimethylsilyloxy)-1,3-butadiene (3h) 
(0.717 g, 2.0 mmol), Me3SiOTf (0.36 mL, 2.0 mmol) in CH2Cl2 
(4 mL) and then 10 h heating in EtOH (4 mL) with 3 mol% of p-
TsOH, the product 33c was isolated as a yellow oil (0.342 mg, 80%).1H NMR (300 MHz, 
CDCl3): δ = 0.86 (t, 3J = 6.7 Hz, 3H, CH3), 1.26-1.42 (m, 10H, (CH2)5), 1.66-1.76 (m, 2H, 
CH2), 3.74 (s, 3H, OCH3), 4.34 (t, 3J = 6.8 Hz, 2H, CH2), 6.83-6.88 (m, 1H, Ar), 7.03-7.06 (dd, 
3J = 8.4 Hz, 4J = 0.8 Hz, 1H, Ar), 7.11 (d, 3J = 8.7 Hz, 1H, Ar), 7.37-7.41 (dd, 3J = 8.0 Hz, 
4J = 1.5 Hz, 1H, Ar), 7.47-7.53 (m, 1H, Ar), 7.55 (d, 3J = 8.6 Hz, 1H, Ar), 11.28 (s, 1H, OH), 
11.65 (s, 1H, OH). 13C NMR (75 MHz, CDCl3): δ = 14.0 (CH3), 22.5, 25.7, 28.2, 29.1, 29.2, 
31.7 (CH2), 52.6 (OCH3), 67.1 (CH2), 111.1 (C), 118.4, 118.8 (Ar), 119.1, 128.3 (C), 133.1, 
135.2 (Ar), 136.4 (C), 136.8 (Ar), 163.0, 163.3, 167.4, 168.7, 199.7 (C). IR (ATR, cm-1): 
ν̃ = 2925 (m), 2855 (m), 1738 (s), 1674 (s), 1627 (s), 1609 (m), 1583 (s), 1443 (s), 1329 (s), 
1214(s), 1147 (s), 1018 (s), 757 (s), 642 (s). GC-MS (EI, 70 eV): m/z (%) = 428 (M+, 4), 396 
(47), 284 (44), 283 (42), 239 (100), 212 (22). HRMS (ESI): calcd. for C24H29O7 [(M+H)+] 
429.1902, found 429.1902; calcd. for C24H28NaO7 [(M+Na)+] 451.1727, found 451.1730. Anal. 
calcd. for C24H28O7 (428.47): C, 67.28; H, 6.59. Found: C, 67.23; H, 7.42. 
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Dimethyl 3-hydroxy-6-(2-hydroxybenzoyl)-4-methylphthalate (33d).
Starting with 3-methoxalylchromone (8a) (0.232 g, 1.0 mmol) 
and 1-methoxy-1,3-bis(trimethylsilyloxy)-1,3-pentadiene (3j) 
(0.549 g, 2.0 mmol), Me3SiOTf (0.36 mL, 2.0 mmol) in CH2Cl2 
(4 mL) and then 10 h heating in EtOH (4 mL) with 3 mol% of p-
TsOH, the product 33d was isolated as a slight yellow solid 
(0.230 mg, 67%); mp = 98-100 °C. 1H NMR (300 MHz, CDCl3): δ = 2.31 (s, 3H, CH3), 3.73 (s, 
3H, OCH3), 3.93 (s, 3H, OCH3), 6.82-6.88 (m, 1H, Ar), 7.02-7.05 (dd, 3J = 8.4 Hz, 
4J = 0.8 Hz, 1H, Ar), 7.38-7.42 (m, 2H, Ar), 7.47-7.53 (m, 1H, Ar), 11.30 (s, 1H, OH), 11.66 
(s, 1H, OH). 13C NMR (75 MHz, CDCl3): δ = 16.0 (CH3), 52.6, 53.2 (OCH3), 111.0 (C), 118.3, 
118.8 (Ar), 119.2, 127.8, 128.23 (C), 133.1 (Ar), 133.8 (C), 135.4, 136.6 (Ar), 161.5, 162.9, 
167.7, 169.4, 200.0 (C). IR (ATR, cm-1): ν̃ = 3004 (w), 2951 (w), 2850 (w), 1728 (s), 1676 (s), 
1622 (s), 1601 (s), 1577 (s), 1438 (s), 1349 (s), 1253 (s), 1151 (s), 1048 (s), 980 (s), 762 (s), 
662 (s). GC-MS (EI, 70 eV): m/z (%) = 344 (M+, 5), 312 (35), 280 (32), 253 (100). HRMS (EI, 
70 eV): calcd. for C18H16O7 (M+) 344.08905, found 344.09011. Anal. calcd. for C18H16O7 
(344.32): C, 62.79; H, 4.64. Found: C, 62.70; H, 4.69. 
 
 
Dimethyl 5-ethyl-3-(2-hydroxybenzoyl)phthalate (33e). 
Starting with 3-methoxalylchromone (8a) (0.232 g, 1.0 mmol) and 
1-methoxy-1,3-bis(trimethylsilyloxy)-1,3-hexadiene (3k) (0.577 g, 
2.0 mmol), Me3SiOTf (0.36 mL, 2.0 mmol) in CH2Cl2 (4 mL) and 
then 10 h heating in EtOH (4 mL) with 3 mol% of p-TsOH, the 
product 33e was isolated as a slight yellow solid (0.237 mg, 
66%); mp = 126-128 °C.1H NMR (300 MHz, CDCl3): δ = 1.21 (t, 3J = 7.4 Hz , 3H, CH3), 2.73 
(q, 3J = 7.4 Hz, 2H, CH2), 3.74 (s, 3H, OCH3), 3.93 (s, 3H, OCH3), 6.83-6.88 (m, 1H, Ar), 
7.03-7.06 (dd, 3J = 8.4 Hz, 4J = 0.8 Hz, 1H, Ar), 7.37-7.42 (m, 2H, Ar), 7.47-7.53 (m, 1H, Ar), 
11.31 (s, 1H, OH), 11.68 (s, 1H, OH). 13C NMR (75 MHz, CDCl3): δ = 13.2 (CH3), 22.9 (CH2), 
52.6, 53.2 (OCH3), 111.3 (C), 118.3, 118.7 (Ar), 119.2, 127.9 (C), 133.1 (Ar), 133.7 (C), 
133.9 (Ar), 134.0 (C), 136.6 (Ar), 161.2, 163.0, 167.8, 169.5, 200.1 (C). IR (ATR, cm-1): 
ν̃ = 2973 (w), 2954 (w), 1725 (s), 1675 (s), 1624 (s), 1599 (s), 1575 (m), 1446 (s), 1359 (s), 
1248 (s), 1154 (s), 755 (s), 716 (s), 657 (s), 384 (s). GC-MS (EI, 70 eV): m/z (%) = 358 (M+, 
5), 326 (37), 294 (24), 267 (100). HRMS (ESI): calcd. for C19H19O7 [(M+H)+] 359.1125, found 
359.1122; calcd. for C19H18NaO7 [(M+Na)+] 381.0945, found 381.0943. Anal. calcd. for 
C19H18O7 (358.34): C, 63.68; H, 5.06. Found: C, 63.71; H, 5.22. 
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Dimethyl 3-(2-hydroxybenzoyl)-5-nonylphthalate (33f). 
Starting with 3-methoxalylchromone (8a) (0.232 g, 1.0 mmol) 
and 1-methoxy-1,3-bis(trimethylsilyloxy)-1,3-tridecadiene (3y) 
(0.773 g, 2.0 mmol), Me3SiOTf (0.36 mL, 2.0 mmol) in CH2Cl2 
(4 mL) and then 10 h heating in EtOH (4 mL) with 3 mol% of p-
TsOH, the product 33f was isolated as a slight yellow oil 
(0.318 mg, 70%).1H NMR (300 MHz, CDCl3): δ = 0.86 (t, 3J = 6.8 Hz , 3H, CH3), 1.21-1.29 
(m, 12H, (CH2)6), 1.54-1.61 (m, 2H, CH2), 2.68 (t, 3J = 7.5 Hz, 2H, CH2), 3.75 (s, 3H, OCH3), 
3.93 (s, 3H, OCH3), 6.82-6.88 (m, 1H, Ar), 7.03-7.06 (dd, 3J = 8.4 Hz, 4J = 1.0 Hz, 1H, Ar), 
7.38-7.41 (m, 2H, Ar), 7.48-7.53 (m, 1H, Ar), 11.31 (s, 1H, OH), 11.68 (s, 1H, OH). 13C NMR 
(75 MHz, CDCl3): δ = 14.0 (CH3), 22.6, 28.9, 29.2, 29.3, 29.4, 29.5, 29.7, 31.8 (CH2), 52.7, 
53.2 (OCH3), 110.4 (C), 118.3, 118.7 (Ar), 119.2, 127.7, 132.7 (C), 133.1 (Ar), 133.8 (C), 
134.8, 136.6 (Ar), 161.3, 163.0, 167.8, 169.5, 200.1 (C). IR (ATR, cm-1): ν̃ = 3074 (w), 2948 
(m), 2925 (s), 2853 (m), 1739 (s), 1685 (s), 1625 (s), 1610 (m), 1577 (m), 1439 (s), 1359 (s), 
1241 (s), 1152 (s), 1057 (s), 770 (s). MS (EI, 70 eV): m/z (%) = 456 (M+, 10), 425 (41), 424 
(90), 397 (46), 393 (39), 392 (98), 366 (34), 365 (100), 281 (32), 280 (89), 252 (25), 121 (32), 
84 (28), 83 (23), 71 (27), 69 (30), 57 (48), 55 (39), 44 (38), 43 (65), 41 (43). HRMS (EI, 70 
eV): calcd. for C26H32O7 (M+) 456.21425, found 456.21447. Anal. calcd. for C29H32O7 
(456.53): C, 68.40; H, 7.07. Found: C, 68.88; H, 7.08. 
 
 
Dimethyl 3-(2-hydroxybenzoyl)-5-tetradecylphthalate (33g). 
Starting with 3-methoxalylchromone (8a) (0.232 g, 1.0 mmol) and 
1-methoxy-1,3-bis(trimethylsilyloxy)-1,3-octadecadiene (3ab) 
(0.913 g, 2.0 mmol), Me3SiOTf (0.36 mL, 2.0 mmol) in CH2Cl2 
(4 mL) and then10 h heating in EtOH (4 mL) with 3 mol% of p-
TsOH, the product 33g was isolated as a yellow solid (0.390 mg, 
74%); mp = 82-84 °C. 1H NMR (300 MHz, CDCl3): δ = 0.87 (t, 3J = 6.7 Hz , 3H, CH3), 1.24-
1.29 (m, 22H, (CH2)11), 1.54-1.64 (m, 2H, CH2), 2.68 (t, 3J = 7.5 Hz, 2H, CH2), 3.75 (s, 3H, 
OCH3), 3.93 (s, 3H, OCH3), 6.82-6.88 (m, 1H, Ar), 7.03-7.06 (dd, 3J = 8.3 Hz, 4J = 0.8 Hz, 
1H, Ar), 7.38-7.41 (m, 2H, Ar), 7.47-7.53 (m, 1H, Ar), 11.31 (s, 1H, OH), 11.68 (s, 1H, OH). 
13C NMR (75 MHz, CDCl3): δ = 14.1 (CH3), 22.6, 28.9, 29.2, 29.3, 29.4, 29.5, 29.6, 29.7, 31.9 
(CH2), 52.6, 53.2 (OCH3), 110.4 (C), 118.3, 118.7 (Ar), 119.2, 127.7, 132.7 (C), 133.1 (Ar), 
133.8 (C), 134.8, 136.6 (Ar), 161.3, 163.0, 167.8, 169.5, 200.1 (C). IR (ATR, cm-1): ν̃ = 2953 
(w), 2916 (s), 2848 (m), 1729 (s), 1674 (s), 1627 (s), 1602 (m), 1576 (m), 1446 (s), 1359 (s), 
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1269 (s), 1211 (s), 1155 (s), 766 (s), 723 (s), 664 (s). MS (EI, 70 eV): m/z (%) = 526 (M+, 3), 
495 (34), 494 (100), 467 (30), 463 (24), 462 (76), 453 (55), 282 (22), 280 (62), 121 (21), 44 
(40), 43 (26), 41 (20). HRMS (EI, 70 eV): calcd. for C31H42O7 (M+) 526.29251, found 
526.29356. Anal. calcd. for C31H42O7 (526.66): C, 70.70; H, 8.04. Found: C, 70.86; H, 8.06. 
 
 
Dimethyl 5-hexadecyl-3-(2-hydroxybenzoyl)phthalate (33h). 
Starting with 3-methoxalylchromone (8a) (0.232 g, 1.0 mmol) 
and 1-methoxy-1,3-bis(trimethylsilyloxy)-1,3-icosadiene (3ac) 
(0.969 g, 2.0 mmol), Me3SiOTf (0.36 mL, 2.0 mmol) in CH2Cl2 
(4 mL) and then 10 h heating in EtOH (3 mL) with 3 mol% of p-
TsOH, the product 33h was isolated as a slight yellow solid 
(0.399 mg, 72%); mp = 78-80 °C. 1H NMR (300 MHz, CDCl3): δ = 0.87 (t, 3J = 6.6 Hz , 3H, 
CH3), 1.24-1.29 (m, 26H, (CH2)13), 1.54-1.61 (m, 2H, CH2), 2.68 (t, 3J = 7.5 Hz, 2H, CH2), 
3.75 (s, 3H, OCH3), 3.93 (s, 3H, OCH3), 6.82-6.88 (m, 1H, Ar), 7.03-7.06 (dd, 3J = 8.4 Hz, 
4J = 0.8 Hz, 1H, Ar), 7.38-7.41 (m, 2H, Ar), 7.47-7.53 (m, 1H, Ar), 11.31 (s, 1H, OH), 11.68 
(s, 1H, OH). 13C NMR (75 MHz, CDCl3): δ = 14.1 (CH3), 22.6, 28.9, 29.3, 29.4, 29.5, 29.6, 
29.7, 31.9 (CH2), 52.7, 53.2 (OCH3), 110.4 (C), 118.3, 118.7 (Ar), 119.2, 127.7, 132.7 (C), 
133.1 (Ar), 133.8 (C), 134.8, 136.6 (Ar), 161.3, 163.0, 167.8, 169.5, 200.1 (C). IR (ATR, cm-
1): ν̃ = 2916 (s), 2848 (s), 1741 (s), 1686 (s), 1624 (s), 1608 (m), 1577 (m), 1439 (s), 1359 
(s), 1254 (s), 1221 (s), 1198 (s), 1154 (s), 1057 (s), 759 (s), 600 (s). MS (EI, 70 eV): m/z 
(%) = 554 (M+, 4), 523 (41), 522 (100), 495 (33), 490 (62), 463 (36), 280 (34), 69 (27), 55 
(28), 44 (92), 43 (51), 41 (27). HRMS (EI, 70 eV): calcd. for C33H46O7 (M+) 554.32381, found 
554.32305. Anal. calcd. for C33H46O7 (554.71): C, 71.45; H, 8.36. Found: C, 71.58; H, 8.65. 
 
 
Dimethyl 3-(2-hydroxybenzoyl)-5-phenethylphthalate (33i). 
Starting with 3-methoxalylchromone (8a) (0.232 g, 1.0 mmol) 
and 1-methoxy-6-phenyl-1,3-bis(trimethylsilyloxy)-1,3-hexadiene 
(3ad) (0.729 g, 2.0 mmol), Me3SiOTf (0.36 mL, 2.0 mmol) in 
CH2Cl2 (4 mL) and then 10 h heating in EtOH (4 mL) with 3 
mol% of p-TsOH, the product 33i was isolated as a yellow solid 
(0.161 mg, 37%); mp = 129-131 °C. 1H NMR (300 MHz, CDCl3): 
δ = 2.98-3.10 (m, 24H, (CH2)2), 3.82 (s, 3H, OCH3), 4.01 (s, 3H, 
OCH3), 6.79-6.84 (m, 1H, Ar), 7.06-7.36 (m, 8H, Ar), 7.50-7.56 
(m, 1H, Ar), 11.48 (s, 1H, OH), 11.73 (s, 1H, OH). 13C NMR (75 MHz, CDCl3): δ = 32.2, 34.6 
(CH2), 52.7, 53.3 (OCH3), 110.5 (C), 118.2, 118.9 (Ar), 119.0 (C), 126.0 (Ar), 127.6 (C), 
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128.4, 128.5 (Ar), 131.0 (C), 133.1 (Ar), 134.3 (C), 135.4, 136.6 (Ar), 161.4, 163.0, 167.8, 
169.5, 199.8 (C). IR (ATR, cm-1): ν̃ = 3032 (w), 2952 (w), 1723 (s), 1669 (s), 1622 (s), 1594 
(s), 1574 (s), 1434 (s), 1344 (s), 1267 (s), 1220 (s), 1148 (s), 1052 (s), 975 (s), 815 (s), 763 
(s), 698 (s). MS (EI, 70 eV): m/z (%) = 434 (M+, 13), 403 (24), 402 (66), 375 (28), 371 (25), 
370 (100), 343 (78), 279 (38), 251 (48), 91 (55). HRMS (EI, 70 eV): calcd. for C25H22O7 (M+) 
434.13600, found 434.13619. Anal. calcd. for C25H22O7 (434.44): C, 69.12; H, 5.10. Found: C, 
69.15; H, 4.99. 
 
 
Dimethyl 4-(3-chloropropyl)-3-hydroxy-6-(2-hydroxybenzoyl)phthalate (33j).  
Starting with 3-methoxalylchromone (8a) (0.232 g, 1.0 mmol) and 
1-methoxy-7-chlor-1,3-bis(trimethylsilyloxy)-1,3-pentadiene (3ag) 
(0.674 g, 2.0 mmol), Me3SiOTf (0.36 mL, 2.0 mmol) in CH2Cl2 
(4 mL), the precipitated product 33j was isolated as a slight 
yellow solid (0.216 mg, 53%); mp = 160-161 °C. 1H NMR (300 
MHz, CDCl3): δ = 2.06-2.15 (m, 2H, CH2), 2.88 (t, 3J = 7.4 Hz , 2H, CH2), 3.54 (t, 3J = 6.3 Hz , 
2H, CH2), 3.75 (s, 3H, OCH3), 3.94 (s, 3H, OCH3), 6.83-6.89 (m, 1H, Ar), 7.03-7.06 (dd, 
3J = 8.4 Hz, 4J = 0.9 Hz, 1H, Ar), 7.37-7.40 (dd, 3J = 8.0 Hz, 4J = 1.5 Hz, 1H, Ar), 7.46 (s, 1H, 
Ar), 7.48-7.54 (m, 1H, Ar), 11.38 (s, 1H, OH), 11.65 (s, 1H, OH). 13C NMR (75 MHz, CDCl3): 
δ = 27.4, 31.2, 44.2 (CH2), 52.7, 53.3 (OCH3), 110.6 (C), 118.4, 118.8 (Ar), 119.1 (C), 127.9, 
130.5 (C), 133.1 (Ar), 134.6 (C), 135.3, 136.8 (Ar), 161.3, 163.0, 167.6, 169.4, 199.8 (C). IR 
(ATR, cm-1): ν̃ = 3168 (w), 3002 (w), 2954 (w), 2849 (w), 1723 (s), 1677 (s), 1622 (s), 1595 
(s), 1576 (s), 1436 (s), 1255 (s), 1154 (s), 1053 (s), 979 (s), 816 (s), 770 (s), 633 (s). MS (EI, 
70 eV): m/z (%) = 406 (M+, 7), 374 (53), 317 (34), 315 (100), 307 (56), 280 (49), 279 (90), 69 
(31), 57 (33), 43 (29). HRMS (ESI): calcd. for C20H20Cl35O7 [(M+H)+] 407.0892, found 
407.0888; calcd. for C20H19Cl35NaO7 [(M+Na)+] 429.0712, found 429.0712; calcd. for 
C20H19Cl37NaO7 (M+Na+) 431.0691, found 431.0690.  Anal. calcd. for C20H19ClO7 (406.08): 
C, 59.05; H, 4.71. Found: C, 59.18; H, 4.65. 
 
 
Dimethyl 4-(3-chloropropyl)-3-hydroxy-6-(2-hydroxybenzoyl)phthalate (33k). 
Starting with 3-methoxalylchromone (8a) (0.232 g, 1.0 mmol) 
and 1-methoxy-8-chlor-1,3-bis(trimethylsilyloxy)-1,3-hexadiene 
(3ah) (0.702 g, 2.0 mmol), Me3SiOTf (0.36 mL, 2.0 mmol) in 
CH2Cl2 (4 mL), and then 10 h heating in EtOH (4 mL) with 3 
mol% of p-TsOH, the product 33k was isolated as a yellow solid 
(0.237 mg, 56%); mp = 87-88 °C. 1H NMR (300 MHz, CDCl3): δ = 1.71-1.87 (m, 4H, (CH2)2), 
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2.73 (t, 3J = 7.0 Hz , 2H, CH2), 3.55 (t, 3J = 6.3 Hz , 2H, CH2), 3.74 (s, 3H, OCH3), 3.94 (s, 
3H, OCH3), 6.83-6.89 (m, 1H, Ar), 7.03-7.06 (dd, 3J = 8.4 Hz, 4J = 0.9 Hz, 1H, Ar), 7.36-7.41 
(dd, 3J = 8.0 Hz, 4J = 1.6 Hz, 1H, Ar), 7.41 (s, 1H, Ar), 7.48-7.54 (m, 1H, Ar), 11.34 (s, 1H, 
OH), 11.65 (s, 1H, OH). 13C NMR (75 MHz, CDCl3): δ = 26.2, 28.9, 32.1, 44.6 (CH2), 52.7, 
53.3 (OCH3), 110.5 (C), 118.4, 118.8 (Ar), 119.2 (C), 127.9, 131.8 (C), 133.1 (Ar), 134.1 (C), 
134.8, 136.7 (Ar), 161.2, 163.0, 167.7, 169.4, 199.9 (C). IR (ATR, cm-1): ν̃ = 2994 (w), 2949 
(m), 2927 (m), 2898 (m), 1723 (s), 1675 (s), 1623 (s), 1597 (s), 1547 (s), 1437 (s), 1348 (s), 
1223 (s), 1151 (s), 1054 (s), 762 (s), 742 (s), 648 (s), 634 (s). MS (EI, 70 eV): m/z (%) = 420 
(M+, 10), 390 (38), 389 (33), 388 (85), 361 (26), 331 (66), 330 (36), 329 (100), 321 (34), 293 
(73), 121 (26). HRMS (EI, 70 eV): calcd. for C21H21O7Cl (M+) 420.09703, found 420.09622. 
Anal. calcd. for C21H21ClO7 (420.84): C, 59.93; H, 5.03. Found: C, 60.87; H, 5.10. 
 
 
Dimethyl 3-(5-bromo-2-hydroxybenzoyl)-6-hydroxyphthalate (33l).  
Starting with 6-brom-3-methoxalylchromone (8b) (0.309 g, 
1.0 mmol) and 1-methoxy-1,3-bis(trimethylsilyloxy)-1,3-
butadiene (3a) (0.520 g, 2.0 mmol), Me3SiOTf (0.36 mL, 
2.0 mmol) in CH2Cl2 (8 mL), and then 5 h heating in EtOH 
(4 mL) with 3 mol% of p-TsOH, the product 33l was isolated as a yellow solid (0.200 mg, 
49%); mp = 112-118 °C. 1H NMR (300 MHz, CDCl3): δ = 3.83 (s, 3H, OCH3), 4.00 (s, 3H, 
OCH3), 7.01 (d, 3J = 8.8 Hz, 1H, Ar), 7.21 (d, 3J = 8.7 Hz, 1H, Ar), 7.53 (d, 4J = 2.4 Hz, 1H, 
Ar), 7.59-7.64 (m, 2H, Ar), 11.18 (s, 1H, OH), 11.58 (s, 1H, OH). 13C NMR (75 MHz, CDCl3): 
δ = 52.8, 53.4 (OCH3), 110.4, 111.1 (C), 118.7 (Ar), 120.3 (C), 120.4 (Ar), 127.6 (C), 134.9, 
135.1 (Ar), 136.6 (C), 139.4 (Ar), 161.9, 163.4, 167.4, 168.8, 198.6 (C). IR (ATR, cm-1): 
ν̃ = 3305 (w), 2950 (w), 2927 (m), 1738 (m), 1686 (m), 1628 (m), 1590 (m), 1464 (m), 1434 
(m), 1184 (s), 1144 (s), 1120 (s), 1019 (s), 942 (s), 648 (s), 525 (s). MS (EI, 70 eV): m/z 
(%) = 409 (M+, 2), 378 (46), 376 (46), 319 (99), 318 (33), 317 (100). HRMS (ESI): calcd. for 
C17H13Br79NaO7 [(M+Na)+] 430.9736, found 430.9728; calcd. for C17H13Br81NaO7 [(M+Na)+] 
432.9718, found 432.97135. Anal. calcd. for C17H13BrO7 (409.18): C, 49.90; H, 3.20. Found: 
C, 49.66; H, 3.44. 
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1-Isobutyl 2-methyl 3-(5-bromo-2-hydroxybenzoyl)-6-hydroxyphthalate (33m).  
Starting with 6-brom-3-methoxalylchromone (8b) (0.309 g, 
1.0 mmol) and 1-isobutoxy-1,3-bis(trimethylsilyloxy)-1,3-
butadiene (3f) (0.605 g, 2.0 mmol), Me3SiOTf (0.36 mL, 
2.0 mmol) in CH2Cl2 (4 mL), and then 5 h heating in EtOH 
(8 mL) with 3 mol% of p-TsOH, the product 33m was isolated as a yellow solid (0.325 mg, 
72%); mp = 106-108 °C. 1H NMR (300 MHz, CDCl3): δ = 0.97 (d, 3J = 6.0 Hz, 6H, (CH3)2), 
1.95-2.08 (m, 1H, CH), 3.74 (s, 3H, OCH3), 4.14 (d, 3J = 6.9 Hz, 2H, CH2), 6.96 (d, 
3J = 8.8 Hz, 1H, Ar), 7.15 (d, 3J = 8.7 Hz, 1H, Ar), 7.49-7.59 (m, 3H, Ar), 11.32 (s, 1H, OH), 
11.56 (s, 1H, OH). 13C NMR (75 MHz, CDCl3): δ = 19.0 ((CH3)2), 27.6 (CH), 52.7 (OCH3), 
73.0 (CH2), 110.4, 111.2 (C), 118.7 (Ar), 120.3 (C), 120.4 (Ar), 127.6 (C), 134.9 (Ar), 136.4 
(C), 139.4 (Ar), 161.9, 163.6, 167.2, 168.6, 198.8 (C). IR (ATR, cm-1): ν̃ = 2959 (w), 1724 (s), 
1669 (m), 1625 (m), 1602 (m), 1581 (m), 1464 (s), 1321 (s), 1221 (s), 1147 (s), 1018 (s), 624 
(s). MS (EI, 70 eV): m/z (%) = 451 (M+, 2), 420 (46), 418 (45), 364 (100), 363 (29), 362 (96), 
319 (70), 318 (21), 317 (69) 57 (29). Anal. calcd. for C20H19BrO7 (451.26): C, 53.23; H, 4.24. 
Found: C, 53.37; H, 4.42. 
 
 
Dimethyl 6-(5-bromo-2-hydroxybenzoyl)-3-hydroxy-4-methylphthalate (33n). 
Starting with 6-brom-3-methoxalylchromone (8b) (0.309 g, 
1.0 mmol) and 1-methoxy-1,3-bis(trimethylsilyloxy)-1,3-
pentadiene (3j) (0.549 g, 2.0 mmol), Me3SiOTf (0.36 mL, 
2.0 mmol) in CH2Cl2 (4 mL), and then 5 h heating in EtOH 
(8 mL) with 3 mol% of p-TsOH, the product 33n was isolated 
as a yellow solid (0.318 mg, 75%); mp = 150-153 °C. 1H NMR (300 MHz, CDCl3): δ = 2.33 (s, 
3H, CH3), 3.73 (s, 3H, OCH3), 3.94 (s, 3H, OCH3), 6.95 (d, 3J = 8.8 Hz, 1H, Ar), 7.39 (bs, 1H, 
Ar), 7.48 (d, 4J = 2.4 Hz, 1H, Ar), 7.57 (dd, 3J = 8.8 Hz, 4J = 2.4 Hz, 1H, Ar), 11.33 (s, 1H, 
OH), 11.56 (s, 1H, OH). 13C NMR (75 MHz, CDCl3): δ = 16.0 (CH3), 52.7, 53.3 (OCH3), 110.3, 
110.4 (C), 120.4 (Ar), 120.5, 127.2, 128.5 (C), 134.9, 135.0, 139.3 (Ar), 161.8, 161.9, 167.7, 
169.4, 199.2 (C). IR (ATR, cm-1): ν̃ = 2954 (w), 1734 (s), 1673 (m), 1630 (m), 1595 (m), 1464 
(m), 1357 (s), 1255 (s), 1158 (s), 1053 (s), 990 (s), 803 (s), 683 (s), 625 (s), 416 (s). MS (EI, 
70 eV): m/z (%) = 423 (M+, 2), 392 (52), 390 (50), 360 (36), 358 (34), 333 (96), 332 (33), 331 
(100). HRMS (EI, 70 eV): calcd. for C18H15O7Br79 (M+) 421.99957, found 421.99850; calcd. 
for C18H15O7Br81 (M+) 423.9975, found 423.99705. Anal. calcd. for C18H15BrO7 (423.21): C, 
51.08; H, 3.57. Found: C, 51.17; H, 3.66. 
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Dimethyl 6-(5-bromo-2-hydroxybenzoyl)-3-hydroxy-4-nonylphthalate (33o). 
Starting with 6-brom-3-methoxalylchromone (8b) (0.309 g, 
1.0 mmol) and 1-methoxy-1,3-bis(trimethylsilyloxy)-1,3-
tridecadiene (3y) (0.773 g, 2.0 mmol), Me3SiOTf (0.36 mL, 
2.0 mmol) in CH2Cl2 (4 mL), and then 5 h heating in EtOH 
(8 mL) with 3 mol% of p-TsOH, the product 33o was isolated 
as a yellow oil (0.414 mg, 77%).1H NMR (300 MHz, CDCl3): δ = 0.86 (t, 3J = 6.6 Hz, 3H, 
CH3), 1.25-1.36 (m, 12H, (CH2)6), 1.56-1.66 (m, 2H, CH2), 2.70 (t, 3J = 7.5 Hz, 2H, CH2), 3.76 
(s, 3H, OCH3), 3.94 (s, 3H, OCH3), 6.96 (d, 3J = 8.8 Hz, 1H, Ar), 7.38 (bs, 1H, Ar), 7.50 (d, 
4J = 2.4 Hz, 1H, Ar), 7.57 (dd, 3J = 8.8 Hz, 4J = 2.4 Hz, 1H, Ar), 11.36 (s, 1H, OH), 11.59 (s, 
1H, OH). 13C NMR (75 MHz, CDCl3): δ = 14.1 (CH3), 22.6, 28.9, 29.3, 29.4, 29.7, 31.8 (CH2), 
52.7, 53.3 (OCH3), 110.3, 110.5 (C), 120.4 (Ar), 120.5, 127.0, 133.1, 133.9 (C), 134.6, 135.1, 
139.2 (Ar), 161.6, 161.9, 167.7, 169.4, 199.1 (C). IR (ATR, cm-1): ν̃ = 3068 (w), 2953 (w), 
2920 (s), 2853 (m), 1729 (s), 1688 (m), 1634 (s), 1610 (m), 1438 (s), 1264 (s), 1227 (s), 
1192 (s), 1167 (s), 975 (s), 811 (s), 713 (s), 695 (s). MS (EI, 70 eV): m/z (%) = 535 (M+, 2), 
505 (28), 504 (100), 503 (29), 502 (94), 445 (78), 444 (17), 443 (76), 360 (46), 359 (13), 358 
(45). HRMS (ESI): calcd. for C26H31Br79NaO7 [(M+Na)+] 557.1145, found 557.1140; calcd. for 
C26H31Br81NaO7 [(M+Na)+] 559.1129, found 559.1144. Anal. calcd. for C26H31BrO7 (535.42): 
C, 58.32; H, 5.84. Found: C, 57.06; H, 6.33. 
 
Dimethyl 6-(5-bromo-2-hydroxybenzoyl)-4-hexadecyl-3-hydroxyphthalate (33p). 
Starting with 6-brom-3-methoxalylchromone (8b) (0.309 g, 
1.0 mmol) and 1-methoxy-1,3-bis(trimethylsilyloxy)-1,3-
icosadiene (3ac) (0.969 g, 2.0 mmol), Me3SiOTf (0.36 mL, 
2.0 mmol) in CH2Cl2 (4 mL), and then 5 h heating in EtOH 
(8 mL) with 3 mol% of p-TsOH, the product 33p was isolated 
as a yellow solid (0.340 mg, 54%); mp = 82-83 °C. 1H NMR (300 MHz, CDCl3): δ = 0.80 (t, 
3J = 6.7 Hz, 3H, CH3), 1.17-1.24 (m, 26H, (CH2)13), 1.49-1.59 (m, 2H, CH2), 2.63 (t, 
3J = 7.5 Hz, 2H, CH2), 3.69 (s, 3H, OCH3), 3.87 (s, 3H, OCH3), 6.89 (d, 3J = 8.8 Hz, 1H, Ar), 
7.31 (bs, 1H, Ar), 7.43 (d, 4J = 2.4 Hz, 1H, Ar), 7.50 (dd, 3J = 8.8 Hz, 4J = 2.4 Hz, 1H, Ar), 
11.29 (s, 1H, OH), 11.52 (s, 1H, OH). 13C NMR (75 MHz, CDCl3): δ = 14.1 (CH3), 22.6, 28.9, 
29.3, 29.4, 29.5, 29.6, 29.7, 29.8, 31.9 (CH2), 52.7, 53.3 (OCH3), 110.3, 110.5 (C), 120.4 
(Ar), 120.5, 127.0, 133.1, 133.9 (C), 134.6, 135.0, 139.2 (Ar), 161.6, 161.9, 167.7, 169.4, 
199.1 (C). IR (ATR, cm-1): ν̃ = 2955 (w), 2919 (s), 2852 (s), 1731 (s), 1673 (s), 1634 (s), 1608 
(w), 1583 (w), 1435 (s), 1264 (s), 1226 (s), 1208 (s), 1191 (s), 1170 (s), 979 (s), 701 (s), 692 
(s). MS (EI, 70 eV): m/z (%) = 633 (M+, 1), 603 (32), 602 (100), 601 (32), 600 (93), 570 (11), 
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568 (10), 543 (19), 541 (18), 360 (17), 358 (16). HRMS (ESI): calcd. for C33H45Br79NaO7 
[(M+Na)+] 655.2240, found 655.2238; calcd. for C33H45Br81NaO7 [(M+Na)+] 657.2226, found 
657.2229. Anal. calcd. for C33H43BrO7 (633.61): C, 62.55; H, 7.16. Found: C, 62.56; H, 7.47. 
 
Dimethyl 6-(5-bromo-2-hydroxybenzoyl)-4-(4-chlorobutyl)-3-hydroxyphthalate (33q). 
Starting with 6-brom-3-methoxalylchromone (8b) (0.309 g, 
1.0 mmol) and 1-methoxy-8-chlor-1,3-bis(trimethylsilyloxy)-
1,3-pentadiene (3ah) (0.702 g, 2.0 mmol), Me3SiOTf 
(0.36 mL, 2.0 mmol) in CH2Cl2 (4 mL), and then 5 h heating 
in EtOH (8 mL) with 3 mol% of p-TsOH, the product 33q was 
isolated as a yellow oil (0.412 mg, 82%). 1H NMR (300 MHz, CDCl3): δ = 1.72-1.88 (m, 4H, 
(CH2)2), 2.75 (t, 3J = 7.0 Hz, 2H, CH2), 3.57 (t, 3J = 6.1 Hz, 2H, CH2), 3.75 (s, 3H, OCH3), 3.94 
(s, 3H, OCH3), 6.96 (d, 3J = 8.7 Hz, 1H, Ar), 7.39 (bs, 1H, Ar), 7.48 (d, 4J = 2.3 Hz, 1H, Ar), 
7.58 (dd, 3J = 8.8 Hz, 4J = 2.5 Hz, 1H, Ar), 11.40 (s, 1H, OH), 11.55 (s, 1H, OH). 13C NMR 
(75 MHz, CDCl3): δ = 26.2, 28.9, 31.9, 44.6 (CH2), 52.7, 53.4 (OCH3), 110.3, 110.6 (C), 120.4 
(Ar), 120.5, 127.1, 132.1, 134.2 (C), 134.7, 135.0, 139.3 (Ar), 161.6, 161.9, 167.5, 169.3, 
198.9 (C). IR (ATR, cm-1): ν̃ = 2951 (w), 1735 (s), 1675 (s), 1628 (s), 1602 (w), 1573 (w), 
1462 (m), 1251 (s), 1189 (s), 1162 (s), 1052 (s), 808 (s), 692 (s). HRMS (ESI): calcd. for 
C21H20BrClNaO7 [(M+Na)+] 520.9973, found 520.9972; calcd. for C21H20BrClNaO7 [(M+Na)+] 
522.9952, found 522.9955; calcd. for C21H20BrClNaO7 [(M+Na)+] 524.9935, found 524.9933. 
Anal. calcd. for C21H20BrClO7 (499.74): C, 50.47; H, 4.03. Found: C, 50.48; H, 4.26. 
 
Dimethyl 3-hydroxy-6-(2-hydroxy-5-methylbenzoyl)phthalate (33r).  
Starting with 6-methyl-3-methoxalylchromone (8c) (0.246 g, 
1.0 mmol) and 1-methoxy-1,3-bis(trimethylsilyloxy)-1,3-
butadiene (3a) (0.520 g, 2.0 mmol), Me3SiOTf (0.36 mL, 
2.0 mmol) in CH2Cl2 (4 mL), and then 5 h heating in EtOH 
(8 mL) with 3 mol% of p-TsOH, the product 33r was isolated as a yellow solid (0.207 mg, 
60%); mp = 116-120 °C. 1H NMR (300 MHz, CDCl3): δ = 2.22 (s, 3H, CH3), 3.76 (s, 3H, 
OCH3), 3.94 (s, 3H, OCH3), 6.94 (d, 3J = 8.4 Hz, 1H, Ar), 7.11-7.15 (m, 2H, Ar), 7.31 (dd, 
3J = 8.4 Hz, 4J = 2.1 Hz, 1H, Ar), 7.56 (d, 3J = 8.6 Hz, 1H, Ar), 11.09 (s, 1H, OH), 11.44 (s, 
1H, OH). 13C NMR (75 MHz, CDCl3): δ = 20.3 (CH3), 52.7, 53.3 (OCH3), 110.9 (C), 118.1, 
118.4 (Ar), 118.7, 128.0, 128.6 (C), 132.6, 135.3 (Ar), 136.3 (C), 137.8 (Ar), 160.9, 163.0, 
167.6, 168.9, 199.5 (C). IR (ATR, cm-1): ν̃ = 3031 (w), 2953 (w), 1726 (s), 1674 (m), 1630 
(m), 1612 (m), 1585 (m), 1440 (s), 1324 (s), 1210 (s), 1144 (s), 713 (s), 650 (s), 652 (s). GC-
MS (EI, 70 eV): m/z (%) = 344 (M+, 11), 312 (34), 253 (100), 252 (20). HRMS (EI, 70 eV): 
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calcd. for C18H16O7 (M+) 344.08905, found 344.08950. Anal. calcd. for C18H16O7 (344.32): C, 
62.79; H, 4.68. Found: C, 62.77; H, 4.97. 
 
2-Isopropyl 1-methyl 3-hydroxy-6-(2-hydroxy-5-methylbenzoyl)phthalate (33s). 
Starting with 6-methyl-3-methoxalylchromone (8c) (0.246 g, 
1.0 mmol) and 1-isopropoxy-1,3-bis(trimethylsilyloxy)-1,3-
butadiene (3d) (0.577 g, 2.0 mmol), Me3SiOTf (0.36 mL, 
2.0 mmol) in CH2Cl2 (4 mL), and then 5 h heating in EtOH 
(8 mL) with 3 mol% of p-TsOH, the product 33s was isolated as a yellow oil (0.236 mg, 
63%).1H NMR (300 MHz, CDCl3): δ = 1.35 (d, 3J = 6.0 Hz, 6H, (CH3)2), 2.22 (s, 3H, CH3), 
3.73 (s, 3H, OCH3), 5.25-5.34 (m, 1H, CH), 6.94 (d, 3J = 8.4 Hz, 1H, Ar), 7.11 (d, 3J = 8.6 Hz, 
1H, Ar), 7.15 (d, 4J = 2.1 Hz, 1H, Ar), 7.31 (dd, 3J = 8.4 Hz, 4J = 2.1 Hz, 1H, Ar), 7.54 (d, 
3J = 8.7 Hz, 1H, Ar), 11.34 (s, 1H, OH), 11.47 (s, 1H, OH). 13C NMR (75 MHz, CDCl3): 
δ = 20.4, 21.4 (CH3), 52.5 (OCH3), 71.2 (CH), 111.2 (C), 118.1, 118.3 (Ar), 118.8, 128.0, 
128.4 (C), 132.7, 135.0 (Ar), 136.2 (C), 137.8 (Ar), 160.9, 163.3, 167.4, 168.2, 199.7 (C). IR 
(ATR, cm-1): ν̃ = 2984 (w), 1736 (m), 1671 (m), 1631 (m), 1608 (m), 1582 (m), 1320 (s), 1215 
(s), 1096 (s), 802 (s), 647 (s). GC-MS (EI, 70 eV): m/z (%) = 372 (M+, 14), 340 (39), 298 (74), 
253 (100). HRMS (ESI): calcd. for C20H20NaO7 [(M+Na)+] 395.1101, found 395.1100. 
 
Dimethyl 3-hydroxy-6-(2-hydroxy-5-methylbenzoyl)-4-methylphthalate (33t). 
Starting with 6-methyl-3-methoxalylchromone (8c) (0.246 g, 
1.0 mmol) and 1-methoxy-1,3-bis(trimethylsilyloxy)-1,3-
pentadiene (3j) (0.549 g, 2.0 mmol), Me3SiOTf (0.36 mL, 
2.0 mmol) in CH2Cl2 (4 mL), and then 5 h heating in EtOH 
(8 mL) with 3 mol% of p-TsOH, the product 33t was isolated 
as a yellow solid (0.264 mg, 74%); mp = 110-114 °C. 1H NMR (300 MHz, CDCl3): δ = 2.22 (s, 
3H, CH3), 2.32 (s, 3H, CH3), 3.71 (s, 3H, OCH3), 3.93 (s, 3H, OCH3), 6.94 (d, 3J = 8.4 Hz, 1H, 
Ar), 7.14 (d, 4J = 2.1 Hz, 1H, Ar), 7.31 (dd, 3J = 8.4 Hz, 4J = 2.2 Hz, 1H, Ar), 7.40 (bs, 1H, Ar), 
11.28 (s, 1H, OH), 11.47 (s, 1H, OH). 13C NMR (75 MHz, CDCl3): δ = 16.0, 20.3 (CH3), 52.6, 
53.2 (OCH3), 110.1 (C), 118.0 (Ar), 118.9, 127.9, 128.1, 128.4, (C), 132.7 (Ar), 133.6 (C), 
135.2, 137.7 (Ar), 160.8, 161.4, 167.7, 169.5, 200.0 (C). IR (ATR, cm-1): ν̃ = 3030 (w), 2995 
(w), 2950 (w), 2923 (w), 1736 (s), 1686 (s), 1630 (s), 1598 (s), 1484 (s), 1438 (s), 1351 (s), 
1242 (s), 1206 (s), 1155 (s), 1049 (s), 986 (s), 815 (s), 671 (s). GC-MS (EI, 70 eV): m/z 
(%) = 358 (M+, 10), 326 (36), 294 (35), 267 (100). HRMS (EI, 70 eV): calcd. for C19H18O7 (M+) 
358.10470, found 358.10607. Anal. calcd. for C19H18O7 (358.34): C, 63.68; H, 5.06. Found: C, 
63.66; H, 5.20. 
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Dimethyl 3-hydroxy-6-(2-hydroxy-5-methylbenzoyl)-4-nonylphthalate (33v).
Starting with 6-methyl-3-methoxalylchromone (8c) (0.246 g, 
1.0 mmol) and 1-methoxy-1,3-bis(trimethylsilyloxy)-1,3-
tridecadiene (3y) (0.773 g, 2.0 mmol), Me3SiOTf (0.36 mL, 
2.0 mmol) in CH2Cl2 (4 mL), and then 5 h heating in EtOH 
(8 mL) with 3 mol% of p-TsOH, the product 33v was isolated 
as a yellow oil (0.298 mg, 63%). 1H NMR (300 MHz, CDCl3): δ = 0.86 (t, 3J = 6.7 Hz, 3H, 
CH3), 1.20-1.36 (m, 12H, (CH2)6), 1.55-1.65 (m, 2H, CH2), 2.22 (s, 3H, CH3), 2.69 (t, 
3J = 7.5 Hz, 2H, CH2), 3.74 (s, 3H, OCH3), 3.93 (s, 3H, OCH3), 6.95 (d, 3J = 8.4 Hz, 1H, Ar), 
7.16 (d, 4J = 2.0 Hz, 1H, Ar), 7.32 (dd, 3J = 8.5 Hz, 4J = 2.2 Hz, 1H, Ar), 7.40 (bs, 1H, Ar), 
11.31 (s, 1H, OH), 11.50 (s, 1H, OH). 13C NMR (75 MHz, CDCl3): δ = 14.0, 20.3 (CH3), 22.6, 
28.9, 29.2, 29.3, 29.4, 29.5, 29.7, 31.8 (CH2), 52.6, 53.2 (OCH3), 110.3 (C), 118.1 (Ar), 
118.9, 127.9, 128.0, 132.7 (C), 132.8 (Ar), 133.7 (C), 134.9, 137.7 (Ar), 160.9, 161.2, 167.9, 
169.5, 200.0 (C). IR (ATR, cm-1): ν̃ = 2923 (s), 2853 (m), 1737 (s), 1675 (s), 1632 (s), 1607 
(m), 1482 (m), 1436 (s), 1354 (s), 1251 (s), 1206 (s), 1153 (s), 1052 (s), 719 (s), 675 (s). MS 
(EI, 70 eV): m/z (%) = 470 (M+, 8), 438 (70), 406 (29), 379 (100), 294 (42). HRMS (ESI): 
calcd. for C27H35O7 [(M+H)+] 471.2383, found 471.2383; calcd. for C27H34NaO7 [(M+Na)+] 
493.2196, found 493.2203. Anal. calcd. for C27H34O7 (470.55): C, 68.92; H, 7.28. Found: C, 
69.06; H, 7.22. 
 
Dimethyl 4-hexadecyl-3-hydroxy-6-(2-hydroxy-5-methylbenzoyl)phthalate (33w). 
Starting with 6-methyl-3-methoxalylchromone (8c) (0.246 g, 
1.0 mmol) and 1-methoxy-1,3-bis(trimethylsilyloxy)-1,3-
icosadiene (3ac) (0.969 g, 2.0 mmol), Me3SiOTf (0.36 mL, 
2.0 mmol) in CH2Cl2 (4 mL), and then 5 h heating in EtOH 
(8 mL) with 3 mol% of p-TsOH, the product 33w was 
isolated as an orange solid (0.409 mg, 72%); mp = 65-68 °C. 1H NMR (300 MHz, CDCl3): 
δ = 0.87 (t, 3J = 6.6 Hz, 3H, CH3), 1.24-1.30 (m, 26H, (CH2)13), 1.55-1.62 (m, 2H, CH2), 2.22 
(s, 2H, CH3), 2.69 (t, 3J = 7.5 Hz, 2H, CH2), 3.74 (s, 3H, OCH3), 3.93 (s, 3H, OCH3), 6.95 (d, 
3J = 8.4 Hz, 1H, Ar), 7.16 (d, 4J = 1.8 Hz, 1H, Ar), 7.31 (dd, 3J = 8.5 Hz, 4J = 2.1 Hz, 1H, Ar), 
7.39 (bs, 1H, Ar), 11.31 (s, 1H, OH), 11.50 (s, 1H, OH). 13C NMR (75 MHz, CDCl3): δ = 14.1, 
20.3 (CH3), 22.6, 28.9, 29.3, 29.4, 29.5, 29.6, 29.7, 29.8, 31.9 (CH2), 52.6, 53.2 (OCH3), 
110.3 (C), 118.1 (Ar), 118.9, 127.9, 128.0, 132.7 (C), 132.9 (Ar), 133.7 (C), 134.9, 137.7 (Ar), 
160.9, 161.2, 167.8, 169.5, 200.0 (C). IR (ATR, cm-1): ν̃ = 2954 (w), 2919 (s), 2852 (s), 1733 
(s), 1672 (s), 1632 (s), 1583 (w), 1488 (w), 1437 (s), 1207 (s), 1154 (s), 981 (s), 708 (s). MS 
(EI, 70 eV): m/z (%) = 568 (M+, 5), 537 (41), 536 (100), 504 (25), 477 (44), 294 (28). HRMS 
(ESI): calcd. for C34H49O7 [(M+H)+] 569.3472, found 569.3471; calcd. for C34H48NaO7 
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[(M+Na)+] 591.3292, found 591.3301. Anal. calcd. for C34H48O7 (568.74): C, 71.80; H, 8.51. 
Found: C, 71.78; H, 8.82. 
 
 
 
 
GP 9: General Procedure for the synthesis of 34a,b. 
 
To a CH2Cl2 solution (1.5 mL / mmol 30) of 30 (1.0 mmol) was added Me3SiOTf (2.0 mmol). 
After stirring for 1 h, CH2Cl2 (8.5 mL / mmol 30) was added, the solution was cooled to 0 °C 
and 2 (3.0 mmol) was added. The temperature of the solution was allowed to warm to 20 °C 
during 12-14 h with stirring. To the solution was added HCl (10%, 15 mL) and the organic 
and the aqueous layer were separated. The latter was extracted with CH2Cl2 (3 × 15 mL). 
The combined organic layers were dried (Na2SO4), filtered, and the filtrate was concentrated 
in vacuo. The residue was purified by chromatography. 
 
 
 
Methyl 1-hydroxy-3,9-dioxo-1-(trifluoromethyl)-2,3,4,4a,9,9a-hexahydro-1H-
thioxanthene-2-carboxylate (34a).  
Starting with 3-trifluoroacetylthiochromone (30) (0.258 g, 
1.0 mmol), 1-methoxy-1,3-bis(trimethylsilyloxy)-1,3-butadiene 
(3a) (0.781 g, 3.0 mmol) and Me3SiOTf (0.444 g, 2.0 mmol) in 
CH2Cl2 (10 mL), the product 34a was isolated as a colourless 
solid (0.151 g, 40%); mp = 145-147 °C 1H NMR (300 MHz, CDCl3): δ = 2.86-3.18 (m, 2H, 
CH2), 3.81 (s, 3H, OCH3), 3.89-4.01 (m, 2H, CH+OH), 4.28-4.33 (m, 1H, CH), 7.14 (s, 1H, 
CH), 7.28-7.34 (m, 2H, Ph), 7.48-7.53 (m, 1H, Ph), 8.03-8.06 (m, 1H, Ph). 13C NMR (75 MHz, 
CDCl3): δ = 37.3 (CH), 42.3 (CH2), 50.9 (CH), 53.3 (OCH3), 61.8 (CH), 78.3 (q, JC-F = 28.0 
Hz, C-1), 125.3 (q, JC-F = 288.4 Hz, CF3), 126.7, 127.2, 128.1 (CH), 131.7 (C), 134.7 (CH), 
139.4, 166.3, 195.5, 198.0 (C). 19F NMR (282 MHz, CDCl3): -72.6 (CF3). IR (ATR, cm-1): ν̃ 
= 3435 (w), 3311 (w), 3041 (w), 3001 (w), 2976 (w), 2950 (w), 2914 (w), 2883 (w), 2854 (w), 
1733 (m), 1716 (s), 1686 (m), 1644 (m), 1585 (m), 1459 (w), 1207 (s), 1176 (s), 767 (s), 592 
(s). EI (70 eV): m/z (%): 374 (M+, 17), 297 (21), 259 (100), 189 (42), 163 (17), 137 (20), 136 
(87), 108 (22), 43 (15). HRMS (EI, 70 eV): calcd. for C16H13F3O5S (M+) 374.04303, found 
374.04312. Anal. calcd. for C16H13F3O5S (374.33): C, 51.34; H, 3.50; S, 8.57. Found: C, 
51.45; H, 3.61; S, 8.63. 
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Isopropyl 1-hydroxy-3,9-dioxo-1-(trifluoromethyl)-2,3,4,4a,9,9a-hexahydro-1H-
thioxanthene-2-carboxylate (34b). 
Starting with methyl 3-trifluoroacetylthiochromone (30) (0.258 g, 
1.0 mmol), 1-isopropyloxy-1,3-bis(trimethylsilyloxy)-1,3-butadiene 
3d (0.865 g, 3.0 mmol) and Me3SiOTf (0.444 g, 2.0 mmol) in 
CH2Cl2 (10 mL), the product 34b was isolated as a colourless 
solid (0.128 g, 32 %); mp = 137-139 °C. 1H NMR (300 MHz, CDCl3): δ = 1.27-1.33 (m, 6H, 
(CH3)2), 2.84-3.18 (m, 2H, CH2), 3.89-4.00 (m, 2H, CH+OH), 4.33-4.38 (m, 1H, CH), 5.03-
5.11 (m, 1H, CH), 7.06 (s, 1H, CH), 7.27-7.33 (m, 2H, Ph), 7.47-7.52 (m, 1H, Ph), 8.02-8.05 
(m, 1H, Ph). 13C NMR (75 MHz, CDCl3): δ = 21.53 (CH3), 37.4 (CH), 42.3 (CH2), 50.9, 62.2, 
70.9 (CH), 78.4 (q, JC-F = 27.9 Hz, C-1), 125.3 (q, JC-F = 288.4 Hz, CF3), 126.7, 128.1, 130.1 
(CH), 131.8 (C), 134.7 (CH), 139.5, 165.3, 195.9, 198.1 (C). 19F NMR (282 MHz, CDCl3): -
72.6 (CF3). IR (ATR, cm-1): ν̃ = 3386 (w), 3348 (w), 3080 (w), 3063 (w), 2980 (w), 2966 (w), 
2940 (w), 2903 (w), 2887 (w), 1717 (s), 1701 (s), 1688 (s), 1655 (m), 1584 (m), 1461 (w), 
1181 (s), 1157 (s), 1096 (s), 761 (s), 598 (m). EI (70 eV): m/z (%): 402 (M+, 6), 297 (20), 259 
(36), 189 (21), 177 (12), 176 (100), 163 (17), 137 (21), 136 (67), 108 (19), 69 (28), 45 (18), 
44 (15), 43 (30). HRMS (EI, 70 eV): calcd. for C18H17F3O5S (M+) 402.07433, found 
402.07488. Anal. calcd. for C18H17F3O5S (402.38): C, 53.73; H, 4.26; S, 7.97. Found: C, 
54.06; H, 4.26; S, 7.96. 
 
 
 
 
GP 10: General procedure for the synthesis of 35a,b. 
 
To a CH2Cl2 solution (10 mL / mmol 33) of 33 (1.0 equiv) was added pyridine (4.0 equiv) at -
78 °C under argon atmosphere. After stirring for 10 min, Tf2O (2.4 equiv) was added at -
78°C. The mixture was allowed to warm to 0 °C and stirred for 4 h. The reaction mixture was 
extracted with water. The organic layer was separated, dried (Na2SO4), filtered and the 
filtrate and was concentrated in vacuo. Products were isolated by column chromatography. 
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Dimethyl 3-(trifluoromethylsulfonyloxy)-6-(2-(trifluoromethylsulfonyloxy)benzoyl) 
phthalate (35a). 
Starting with dimethyl 3-hydroxy-6-(2-
hydroxybenzoyl)phthalate (33a) (0.642 g, 1.9 mmol), 
pyridine (0.6 mL, 7.6 mmol) and Tf2O (0.7 mL, 4.6 mmol) in 
CH2Cl2 (19 mL), the product 35a was isolated as a yellow oil 
(0.738 g, 64%). 1H NMR (300 MHz, CDCl3): δ = 3.74 (s, 3H, 
OCH3), 4.01 (s, 3H, OCH3), 7.64-7.77 (m, 6H, Ar). 13C NMR 
(75 MHz, CDCl3): δ = 53.3, 53.4 (OCH3), 118.5, 118.6 (q, JC-F = 319.6 Hz, CF3), 122.9, 123.9 
(Ar), 127.6 (C), 128.4 (Ar), 130.2 (C), 132.6, 134.6 (Ar), 138.5, 147.3, 147.9, 163.2, 165.1, 
190.5 (C). 19F NMR (235 MHz, CDCl3):  = -72.9, -72.8 (CF3). IR (ATR, cm-1): ν̃ = 2954 (w), 
1733 (s), 1672 (s), 1630 (s), 1594 (m), 1464 (m), 1447 (m), 1255 (s), 1157 (s), 1053 (s), 802 
(s), 683 (s). HRMS (ESI): calcd. for C19H13F6O11S2 [(M+H)+] 594.9798, found 594.9802; 
calcd. for C19H12F6NaO11S2 [(M+Na)+] 616.9617, found 616.9616. Anal. calcd. for 
C19H12F6O11S2 (594.41): C, 38.39; H, 2.03; S, 10.79. Found: C, 39.09; H, 2.21; S, 11.01. 
 
 
Dimethyl 3-(2-bromo-5-(trifluoromethylsulfonyloxy)benzoyl)-6-
(trifluoromethylsulfonyloxy)phthalate (35b). 
Starting with dimethyl 3-(5-bromo-2-hydroxybenzoyl)-6-
hydroxyphthalate (33l) (1.0 g, 2.4 mmol), pyridine (0.7 mL, 
9.7 mmol) and Tf2O (0.9 mL, 5.8 mmol) in CH2Cl2 (25 mL), 
the product 35b was isolated as a yellow solid (1.2 g, 73%); 
mp = 86-87 °C. 1H NMR (300 MHz, CDCl3): δ = 3.73 (s, 3H, 
OCH3), 3.97 (s, 3H, OCH3), 7.29 (d, 3J = 8.7 Hz, 1H, Ar), 
7.54 (d, 3J = 8.6 Hz, 1H, Ar), 7.65-7.69 (m, 2H, Ar), 7.80 
(dd, 3J = 8.7 Hz, 4J = 2.4 Hz, 1H, Ar). 13C NMR (75 MHz, CDCl3): δ = 53.3, 53.4 (OCH3), 
118.4, 118.5 (q, JC-F = 320.6 Hz, CF3), 122.0 (C), 124.0, 124.4 (Ar), 127.7, 131.8 (C), 132.6, 
134.8, 137.3 (Ar), 137.6, 146.0, 148.2, 163.0, 165.0, 189.2 (C). 19F NMR (235 MHz, CDCl3): 
 = -72.8, -72.6 (CF3). IR (ATR, cm-1): ν̃ = 3096 (w), 2952 (w), 1736 (s), 1696 (m), 1584 (w), 
1422 (s), 1385 (w), 1207 (s), 1135 (s), 1000 (s), 824 (s), 605 (s). HRMS (ESI): calcd. for 
C19H12Br79F6O11S2 [(M+H)+] 672.8903, found 672.8891; calcd. for C19H12Br81F6O11S2 [(M+H)+] 
674.8884, found 674.8877; calcd. for C19H11Br79F6NaO11S2 [(M+Na)+] 694.8722, found 
694.8727; calcd. for C19H11Br81F6NaO11S2 [(M+Na)+] 696.8703, found 696.8709. Anal. calcd. 
for C19H11BrF6O11S2 (673.31): C, 33.89; H, 1.65; S, 9.52. Found: C, 34.38; H, 1.77; S, 10.37. 
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GP 11: General Procedure for double Suzuki reactions – synthesis of 36a-d. 
 
A 1,4-dioxane (5 mL/mmol 35a) solution of the arylboronic acid (2.0 equiv), K3PO4 
(3.0 equiv), 6mol% Pd(PPh3)4, and 35a (1.0 equiv) was stirred at 90°C for 4 h under argon 
atmosphere. After cooling to 20 °C, the reaction mixture was poured into water. The organic 
and the aqueous layer were separated, and the latter was extracted with CH2Cl2. The 
combined organic layers were dried (Na2SO4), filtered and the filtrate was concentrated in 
vacuo. The residue was purified by column chromatography. 
 
 
 
 
 
 
 
 
 
Dimethyl 4'-methoxy-4-(4'-methoxybiphenylcarbonyl)biphenyl-2,3-dicarboxylate (36a). 
Starting with dimethyl 3-(trifluoromethylsulfonyloxy)-6-(2-
(trifluoromethylsulfonyloxy) benzoyl) phthalate (35a) 
(0.382 g, 0.7 mmol), K3PO4 (0.408 g, 1.9 mmol), Pd(PPh3)4 
(6mol%) and 4-methoxyphenylboronic acid (0.244 g, 
1.6 mmol) in 1,4-dioxane (3 mL), the product 36a was 
isolated as a yellow solid (0.195 g, 60%); mp = 59-62 °C. 1H 
NMR (300 MHz, CDCl3): δ = 3.61 (s, 3H, OCH3), 3.72 (s, 
3H, OCH3), 3.75 (s, 3H, OCH3), 3.83 (s, 3H, OCH3), 6.74-7.68 (m, 14H, Ar). 13C NMR 
(75 MHz, CDCl3): δ = 52.4, 52.7, 55.2, 55.3 (OCH3), 113.7, 113.9, 126.8, 129.2, 130.3, 
130.4, 130.5, 130.8 (Ar), 131.3 (C), 131.5 (Ar), 132.0, 132.2, 136.4, 137.3, 142.0, 143.2, 
159.0, 159.6, 167.9, 168.1, 196.8 (C). IR (ATR, cm-1): ν̃ = 2948 (w), 2836 (w), 1726 (s), 1659 
(m), 1607 (m), 1579 (m), 1514 (s), 1240 (s), 1177 (s), 829 (s), 762 (s). GC-MS (EI, 70 eV): 
m/z (%) = 510 (M+, 100), 419 (43), 211 (31). HRMS (ESI): calcd. for C31H27O7 [(M+H)+] 
511.1751, found 511.1757; calcd. for C31H26NaO7 [(M+Na)+] 533.1570, found 533.1582. Anal. 
calcd. for C31H26O7 (510.53): C, 72.93; H, 5.13. Found: C, 72.78; H, 5.56. 
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Dimethyl 4'-ethyl-4-(4'-ethylbiphenylcarbonyl)biphenyl-2,3-dicarboxylate (10b).
Starting with dimethyl 3-(trifluoromethylsulfonyloxy)-6-(2-
(trifluoromethylsulfonyloxy) benzoyl) phthalate (35a) (0.356 g, 
0.6 mmol), K3PO4 (0.382 g, 1.8 mmol), Pd(PPh3)4 (6mol%) 
and 4-ethylphenylboronic acid (0.224 g, 1.5 mmol) in 1,4-
dioxane (3 mL), the product 36b was isolated as a white solid 
(0.183 g, 60%); mp = 48-50 °C. 1H NMR (300 MHz, CDCl3): 
δ = 1.21 (t, 3J = 7.5 Hz, 3H, CH3), 1.30 (t, 3J = 7.5 Hz, 3H, 
CH3), 2.61 (q, 3J = 7.5 Hz, 2H, CH2), 2.73 (q, 3J = 7.5 Hz, 2H, CH2), 3.64 (s, 3H, OCH3), 3.79 
(s, 3H, OCH3), 7.09-7.74 (m, 15H, Ar + CHCl3). 13C NMR (75 MHz, CDCl3): δ = 15.3, 15.5 
(CH3), 28.4, 28.5 (CH2), 52.3, 52.7 (OCH3), 126.9, 127.7, 127.9, 128.0, 129.2, 130.3, 130.4, 
130.7, 131.4, 131.5 (Ar), 132.0, 132.6, 136.3, 136.5, 137.1, 137.4, 142.4, 143.5, 144.3, 
167.9, 168.0, 196.8 (C). IR (ATR, cm-1): ν̃ = 2962 (w), 2871 (w), 1728 (s), 1661 (m), 1612 
(w), 1585 (m), 1515 (w), 1232 (s), 1150 (s), 940 (s), 828 (s), 761 (s). GC-MS (EI, 70 eV): m/z 
(%) = 506 (M+, 5), 474 (43), 443 (42), 442 (100), 424 (52), 414 (45), 413 (67), 207 (41). 
HRMS (ESI): calcd. for C33H31O5 [(M+H)+] 507.2166, found 507.2178; calcd. for C31H30NaO5 
[(M+Na)+] 529.1985, found 529.1998. Anal. calcd. for C33H30O5 (506.59): C, 78.24; H, 5.97. 
Found: C, 78.24; H, 6.16. 
 
Dimethyl 4'-chloro-4-(4'-chlorobiphenylcarbonyl)biphenyl-2,3-dicarboxylate (36c). 
Starting with dimethyl 3-(trifluoromethylsulfonyloxy)-6-(2-
(trifluoromethylsulfonyloxy) benzoyl) phthalate (35a) (0.356 g, 
0.6 mmol), K3PO4 (0.382 g, 1.8 mmol), Pd(PPh3)4 (6mol%) 
and 4-chlorophenylboronic acid (0.234 g, 1.5 mmol) in 1,4-
dioxane (3 mL), the product 36c was isolated as a yellow solid 
(0.218 g, 70%); mp = 148-150 °C. 1H NMR (300 MHz, CDCl3): 
δ = 3.53 (s, 3H, OCH3), 3.58 (s, 3H, OCH3), 7.10-7.65 (m, 
15H, Ar + CHCl3). 13C NMR (75 MHz, CDCl3): δ = 52.6, 52.9 (OCH3), 127.5, 128.2, 128.7, 
129.3, 130.5, 130.6, 131.0, 131.3, 131.8 (Ar), 132.2, 132.3, 133.5, 134.5, 137.1, 137.3, 
137.4, 138.3, 141.2, 142.4, 167.3, 167.5, 196.3 (C). IR (ATR, cm-1): ν̃ = 2955 (w), 1938 (w), 
1747 (s), 1722 (s), 1663 (m), 1583 (w), 1494 (w), 1253 (s), 1151 (s), 1086 (s), 828 (s), 785 
(s), 674 (s). GC-MS (EI, 70 eV): m/z (%) = 520 (M+, 39), 519 (M+, 24), 518 (M+, 59), 429 (65), 
428 (26), 427 (100), 333 (24), 332 (11), 331 (73), 215 (62), 152 (51). HRMS (ESI): calcd. for 
C29H20Cl2NaO5 [(M+Na)+] 541.0580, found 541.0578; calcd. for C29H20Cl2NaO5 [(M+Na)+] 
543.0558, found 543.0569. Anal. calcd. for C29H20Cl2O5 (519.37): C, 67.06; H, 3.88. Found: 
C, 66.96; H, 3.88. 
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Dimethyl 3'-(trifluoromethyl)-4-(3'-(trifluoromethyl)biphenylcarbonyl)biphenyl-2,3-
dicarboxylate (36d). 
Starting with dimethyl 3-(trifluoromethylsulfonyloxy)-6-
(2-(trifluoromethylsulfonyloxy) benzoyl) phthalate (35a) 
(0.356 g, 0.6 mmol), K3PO4 (0.382 g, 1.8 mmol), 
Pd(PPh3)4 (6mol%) and 3-
(trifluoromethyl)phenylboronic acid (0.284 g, 1.5 mmol) 
in 1,4-dioxane (3 mL), the product 36d was isolated as 
a yellow oil (0.137 g, 39%). 1H NMR (300 MHz, CDCl3): 
δ = 3.63 (s, 3H, OCH3), 3.68 (s, 3H, OCH3), 7.29-7.82 (m, 16H, Ar + CHCl3). 13C NMR 
(75 MHz, CDCl3): δ = 52.4, 52.8 (OCH3), 124.1, 124.8, 125.0, 125.7 (q, JC-F = 3.9 Hz, CH), 
127.9, 128.7, 129.0 (Ar), 129.5, 130.1, 130.6, 137 (C), 130.8, 131.1, 131.2, 131.4, 132.0 (Ar), 
132.3, 132.5 (C), 132.8 (Ar), 137.0, 137.8, 139.5, 140.7, 141.0, 141.9, 167.1, 167.3, 196.0 
(C). 19F NMR (235 MHz, CDCl3):  = -62.3, -62.2 (CF3). IR (ATR, cm-1): ν̃ = 3011 (w), 2957 
(w), 1726 (s), 1661 (m), 1592 (w), 1428 (w), 1406 (w), 1333 (s), 1239 (s), 1116 (s), 1067 (s), 
808 (s), 767 (s), 695 (s). GC-MS (EI, 70 eV): m/z (%) = 586 (M+, 27), 495 (61), 365 (100), 
249 (71), 201 (35). HRMS (ESI): calcd. for C31H20F6NaO5 [(M+Na)+] 609.1107, found 
609.1100. Anal. calcd. for C31H20F6O5 (586.48): C, 63.40; H, 3.44. Found: C, 63.46; H, 3.57. 
 
 
 
 
 
GP 12: General Procedure for triple Suzuki reactions – synthesis of 37 
 
A 1,4-dioxane (5 mL/mmol 35b) solution of the arylboronic acid (4.0 equiv), KF (4.5 equiv), 
6mol% Pd(PPh3)4, and 35b (1.0 equiv) was stirred at 90°C for 4 h under argon atmosphere. 
After cooling to 20 °C, the reaction mixture was poured into water. The organic and the 
aqueous layer were separated, and the latter was extracted with CH2Cl2. The combined 
organic layers were dried (Na2SO4), filtered and the filtrate was concentrated in vacuo. The 
residue was purified by column chromatography. 
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Dimethyl 4-(4-phenylbiphenylcarbonyl)biphenyl-2,3-dicarboxylate (37). 
Starting with 35b (0.336 g, 0.5 mmol), KF (0.130 g, 2.2 mmol), 
Pd(PPh3)4 (6mol%) and phenylboronic acid (0.243 g, 2.0 mmol) 
in 1,4-dioxane (2.5 mL), the product 37 was isolated as a yellow 
solid (0.130 g, 50%); mp = 155-157 °C. 1H NMR (300 MHz, 
CDCl3): δ = 3.49 (s, 3H, OCH3), 3.64 (s, 3H, OCH3), 7.10-7.83 
(m, 23H, Ar + CHCl3). 13C NMR (75 MHz, CDCl3): δ = 52.4, 52.8 
(OCH3), 127.0, 124.4, 127.9, 128.2, 128.3, 128.4, 128.8, 129.0, 
129.2 (Ar), 130.0, 130.9, 131.1, 131.6, 132.8, 136.6, 137.8, 
139.0, 139.4, 140.1, 141.2, 143.7, 167.8, 196.6 (C). IR (ATR, cm-1): ν̃ = 3050 (w), 3028 (w), 
2996 (w), 2948 (w), 2855 (w), 1739 (s), 1723 (s), 1588 (w), 1473 (w), 1232 (s), 1150 (s), 754 
(s), 692 (s). GC-MS (EI, 70 eV): m/z (%) = 526 (M+, 88), 525 (39), 436 (42), 435 (100), 297 
(45), 257 (44), 228 (33). HRMS (ESI): calcd. for C35H26NaO5 [(M+Na)+] 549.1672, found 
549.1670. Anal. calcd. for C35H26O5 (526.58): C, 79.83; H, 4.98. Found: C, 79.90; H, 4.91. 
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Supplement 2 
Crystallographic data 
 
 
Crystal data and structure refinement for 9z  
 
Identification code      ks1007t  
Empirical formula      C12H13Cl3O4 
Formula weight       327.57  
Temperature        200(2) K  
Wavelength        0.71073 Å  
Crystal system, space group   Triclinic, P-1  
Unit cell dimensions      a = 8.5809(5) Å    = 115.336(5)°  
b = 9.3838(6) Å    = 105.449(5)° 
c = 10.1271(6) Å    = 94.711(5)°  
Volume          692.15(7) Å3  
Z            2  
Calculated density      1.572 mg/m3 
Absorption coefficient     0.668 mm-1 
F(000)          336  
Crystal size        0.38 x 0.38 x 0.30 mm  
Θ range for data collection   2.36 to 27.91°  
Limiting indices       -11<=h<=11, -12<=k<=12, -13<=l<=13  
Reflections collected / unique  11891 / 3306 [R(int) = 0.0248]  
Completeness to Θ = 27.91°   99.8 %  
Absorption correction     None  
Refinement method      Full-matrix least-squares on F2  
Data / restraints / parameters  3306 / 0 / 179  
Goodness-of-fit on F2     1.001  
Final R indices [I>2sigma(I)]   R1 = 0.0240, wR2 = 0.0624  
R indices (all data)      R1 = 0.0322, wR2 = 0.0639  
Largest diff. peak and hole   0.326 and -0.247 e. A-3 
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Crystal data and structure refinement for 9ac  
 
Identification code      ks1009  
Empirical formula      C10H9Cl3O4  
Formula weight       299.52  
Temperature        200(2) K  
Wavelength        0.71073 Å  
Crystal system, space group   Monoclinic, P2(1)/c  
Unit cell dimensions      a = 7.6005(3) Å    = 90°  
b = 19.7289(6) Å    = 97.652(3)°  
c = 7.9532(3) Å    = 90°  
Volume          1181.96(7) Å3  
Z            4 
Calculated density      1.683 mg/m3 
Absorption coefficient     0.773 mm-1  
F(000)          608  
Crystal size        0.45 x 0.40 x 0.03 mm  
Θ range for data collection   2.06 to 27.93°  
Limiting indices       -9<=h<=9, -26<=k<=25, -10<=l<=10  
Reflections collected / unique  19990 / 2821 [R(int) = 0.0336]  
Completeness to Θ = 27.93°   99.8 %  
Absorption correction     Numerical  
Max. and min. transmission   0.9888 and 0.6905  
Refinement method      Full-matrix least-squares on F2  
Data / restraints / parameters  2821 / 0 / 160  
Goodness-of-fit on F2     0.923  
Final R indices [I>2sigma(I)]   R1 = 0.0236, wR2 = 0.0550  
R indices (all data)      R1 = 0.0331, wR2 = 0.0567  
Largest diff. peak and hole   0.341 and -0.190 e. Å-3 
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Crystal data and structure refinement for 10aj 
 
Identification code      is_ld105 
Empirical formula      C10H9F3O3S 
Formula weight       266.23 
Temperature        173(2) K 
Wavelength        0.71073 Å 
Crystal system, space group   Monoclinic, P21/n  
Unit cell dimensions      a = 7.1074(2) Å    = 90° 
            b = 11.7647(4) Å    = 97.112(2)° 
            c = 26.2080(7) Å    = 90° 
Volume          2174.56(11) Å3 
Z            8 
Calculated density      1.626 mg/m3 
Absorption coefficient     0.333 mm−1 
F(000)          1088 
Crystal size        0.76 x 0.17 x 0.11 mm 
Θ range for data collection   2.33 to 29.99° 
Limiting indices       -9≤h≤9, -16≤k≤14, -36≤l≤35 
Reflections collected / unique  24815 / 6293 [R(Int) = 0.0366] 
Completeness to Θ = 29.99°   99.3 % 
Absorption correction     Multi-scan 
Max. and min. transmission   0.9643 and 0.7860 
Refinement method      Full-matrix least-squares on F2 
Data / restraints / parameters  6293 / 0 / 375 
Goodness-of-fit on F2     1.042 
Final R indices [I>2σ(I)]    R1 = 0.0443, wR2 = 0.1103 
R indices (all data)      R1 = 0.0712, wR2 = 0.1201 
Largest diff. peak and hole   0.324 and -0.368 e. Å−3 
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Crystal data and structure refinement for 10aq 
 
Identification code      is_ld76b 
Empirical formula      C15H11F3O2S 
Formula weight       312.30 
Temperature        173(2) K 
Wavelength        0.71073 Å 
Crystal system, space group   Monoclinic, P21 
Unit cell dimensions      a = 8.9606(3) Å    = 90° 
            b = 8.1807(2) Å    = 114.197(2)° 
            c = 10.6159(3) Å    = 90° 
Volume          709.82(4) Å3 
Z            2 
Calculated density      1.461 mg/m3 
Absorption coefficient     0.262 mm−1 
F(000)          320 
Crystal size        0.66 x 0.30 x 0.26 mm 
Θ range for data collection   2.49 to 31.06° 
Limiting indices       -12≤h≤9, -11≤k≤11, -11≤l≤15 
Reflections collected / unique  8690 / 4329 [R(Int) = 0.0145] 
Completeness to Θ = 31.06°   99.6 % 
Absorption correction     Multi-scan 
Max. and min. transmission   0.9349 and 0.8459 
Refinement method      Full-matrix least-squares on F2 
Data / restraints / parameters  4329 / 1 / 195 
Goodness-of-fit on F2     1.057 
Final R indices [I>2σ(I)]    R1 = 0.0401, wR2 = 0.1111 
R indices (all data)      R1 = 0.0418, wR2 = 0.1126 
Largest diff. peak and hole   0.564 and -0.326 e. Å−3 
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Crystal data and structure refinement for 11a 
 
Identification code      ks837  
Empirical formula      C9H7F3O4  
Formula weight       236.15  
Temperature        200(2) K  
Wavelength        0.71073 Å  
Crystal system, space group   Monoclinic, P2(1)/c  
Unit cell dimensions      a = 12.5362(7) Å    = 90°  
            b = 4.65657(16) Å   = 94.503(4)°  
            c = 16.8665(9) Å    = 90°  
Volume          981.55(8) Å3  
Z            4 
Calculated density      1.598 mg/m3  
Absorption coefficient     0.160 mm-1  
F(000)          480  
Crystal size        0.50 x 0.25 x 0.17 mm  
 range for data collection    2.42 to 27.50°.  
Limiting indices       -16h16, -5k6, -21l21  
Reflections collected / unique  14702 / 2245 [R(int) = 0.0311]  
Completeness to  = 27.50   100.0 %  
Absorption correction     Numerical  
Max. and min. transmission   0.9239 and 0.7999  
Refinement method      Full-matrix least-squares on F2  
Data / restraints / parameters  2245 / 0 / 145  
Goodness-of-fit on F2     0.989  
Final R indices [I>2(I)]    R1 = 0.0294, wR2 = 0.0717  
R indices (all data)      R1 = 0.0448, wR2 = 0.0745  
Largest diff. peak and hole   0.208 and -0.183 e. Å -3  
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Crystal data and structure refinement for 12i  
 
Identification code      ks902m  
Empirical formula      C11H13F3O5 
Formula weight       282.21  
Temperature        200(2) K  
Wavelength        0.71073 Å  
Crystal system, space group   Monoclinic, C2/c  
Unit cell dimensions      a = 16.8907(13) Å    = 90°  
b = 9.8633(6) Å     = 98.844(6)°  
c = 14.5585(11) Å    = 90°.  
Volume          2396.6(3) Å3  
Z            8 
Calculated density      1.564 mg/m3 
Absorption coefficient     0.151 mm-1  
F(000)          1168  
Crystal size        0.45 x 0.45 x 0.20 mm  
Θ range for data collection   2.40 to 28.00°  
Limiting indices       -22<=h<=22, -13<=k<=13, -19<=l<=19  
Reflections collected / unique  20174 / 2899 [R(int) = 0.0369]  
Completeness to Θ = 28.00°   100.0 %  
Absorption correction     None  
Refinement method      Full-matrix least-squares on F2  
Data / restraints / parameters  2899 / 0 / 180  
Goodness-of-fit on F2     1.017  
Final R indices [I>2sigma(I)]   R1 = 0.0324, wR2 = 0.0875  
R indices (all data)      R1 = 0.0462, wR2 = 0.0912  
Extinction coefficient     0.0047(6)  
Largest diff. peak and hole   0.235 and -0.208 e. Å-3  
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Crystal data and structure refinement for 13r  
 
Identification code      ks1027  
Empirical formula      C10H11F3O4S 
Formula weight       284.25  
Temperature        200(2) K  
Wavelength        0.71073 Å  
Crystal system, space group   Monoclinic, P2(1)/c  
Unit cell dimensions      a = 7.7539(3) Å    = 90° 
b = 17.4533(7) Å    = 102.291(3)° 
c = 8.6744(3) Å   = 90° 
Volume          1147.01(8) Å3  
Z            4 
Calculated density      1.646 mg/m3 
Absorption coefficient     0.327 mm-1  
F(000)          584  
Crystal size        0.45 x 0.40 x 0.15 mm  
Θ range for data collection   2.33 to 28.00°  
Limiting indices       -10<=h<=10, -22<=k<=22, -11<=l<=10  
Reflections collected / unique  19752 / 2769 [R(int) = 0.0250]  
Completeness to Θ = 28.00°   100.0 %  
Absorption correction     Numerical  
Max. and min. transmission   0.9611 and 0.8544  
Refinement method      Full-matrix least-squares on F2  
Data / restraints / parameters  2769 / 0 / 169  
Goodness-of-fit on F2     1.036  
Final R indices [I>2sigma(I)]   R1 = 0.0268, wR2 = 0.0722  
R indices (all data)      R1 = 0.0355, wR2 = 0.0742  
Largest diff. peak and hole   0.411 and -0.260 e. Å-3 
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Crystal data and structure refinement for 12v 
 
Identification code is_ld117 
Empirical formula C11H13F3O4S 
Formula weight 298.27 
Temperature 173(2) K 
Wavelength 0.71073 Å 
Crystal system, space group Monoclinic, C2/c 
Unit cell dimensions a = 17.1795(6) Å 
 = 90°. 
b = 10.0815(3) Å 
 = 98.235(2)°. 
c = 14.9817(5) Å 
 = 90°. 
Volume 2568.00(15) Å3 
Z 8 
Calculated density) 1.543 mg/m3 
Absorption coefficient 0.296 mm−1 
F(000) 1232 
Crystal size 0.40 x 0.33 x 0.32 mm 
Θ range for data collection 2.35 to 30.00° 
Limiting indices -24≤h≤19, -14≤k≤14, -21≤l≤21 
Reflections collected / unique 14469 / 3736 [R(int) = 0.0184] 
Completeness to Θ = 30.00° 99.9 % 
Absorption correction Multi-scan 
Max. and min. transmission 0.9111 and 0.8907 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 3736 / 0 / 179 
Goodness-of-fit on F2 1.075 
Final R indices [I>2σ(I)] R1 = 0.0306, wR2 = 0.0885 
R indices (all data) R1 = 0.0361, wR2 = 0.0916 
Largest diff. peak and hole 0.466 and -0.226 e. Å−3 
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Crystal data and structure refinement for 20b  
 
Identification code      ks1097t  
Empirical formula      C10H9F6NO4  
Formula weight       321.18  
Temperature        200(2) K  
Wavelength         0.71073 Å  
Crystal system, space group   Tetragonal, P4(2)/n  
Unit cell dimensions      a = 18.858(3) Å    = 90° 
b = 18.858(3) Å    = 90° 
c = 7.5275(15) Å    = 90° 
Volume          2677.0(8) Å3  
Z            8 
Calculated density      1.594 mg/m3 
Absorption coefficient     0.173 mm-1  
F(000)          1296  
Crystal size        0.50 x 0.40 x 0.34 mm  
Θ range for data collection   2.16 to 27.50°.  
Limiting indices       -24<=h<=24, -24<=k<=24, -9<=l<=9  
Reflections collected / unique  42937 / 3077 [R(int) = 0.0308]  
Completeness to Θ = 27.50°   99.9 %  
Absorption correction     None  
Refinement method      Full-matrix least-squares on F^2  
Data / restraints / parameters  3077 / 33 / 227  
Goodness-of-fit on F2     1.112  
Final R indices [I>2sigma(I)]   R1 = 0.0632, wR2 = 0.1913  
R indices (all data)      R1 = 0.0783, wR2 = 0.1993  
Largest diff. peak and hole   0.554 and -0.513 e. Å-3 
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Crystal data and structure refinement for 22a  
 
Identification code      ks1048  
Empirical formula      C11H8F9N3O3  
Formula weight       401.20  
Temperature        200(2) K  
Wavelength        0.71073 Å  
Crystal system, space group   Monoclinic, P2(1)/c  
Unit cell dimensions      a = 20.5341(7) Å    = 90°  
b = 8.39476(18) Å   = 103.639(3)°  
c = 17.3957(6) Å    = 90° 
Volume          2914.09(15) Å3  
Z            8 
Calculated density      1.829 mg/m3 
Absorption coefficient     0.206 mm-1  
F(000)          1600  
Crystal size        0.40 x 0.40 x 0.15 mm  
Θ range for data collection   2.04 to 26.00°  
Limiting indices       -25<=h<=25, -10<=k<=10, -20<=l<=21  
Reflections collected / unique  39943 / 5728 [R(int) = 0.0310]  
Completeness to Θ = 26.00°   100.0 %  
Absorption correction     Numerical  
Max. and min. transmission   0.9751 and 0.8955  
Refinement method      Full-matrix least-squares on F2  
Data / restraints / parameters  5728 / 66 / 543  
Goodness-of-fit on F2     0.881  
Final R indices [I>2sigma(I)]   R1 = 0.0266, wR2 = 0.0585  
R indices (all data)      R1 = 0.0440, wR2 = 0.0613  
Largest diff. peak and hole   0.269 and -0.178 e. Å-3 
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Crystal data and structure refinement for 22d  
 
Identification code      ks1072  
Empirical formula      C14H13ClF9N3O3  
Formula weight       477.72  
Temperature        200(2) K  
Wavelength        0.71073 Å  
Crystal system, space group   Monoclinic, P2(1)/n  
Unit cell dimensions      a = 10.2723(3) Å    = 90°  
b = 10.5001(4) Å    = 101.059(2)°  
c = 17.7270(5) Å    = 90° 
Volume          1876.53(10) Å3  
Z            4 
Calculated density      1.691 Mg/m^3 
Absorption coefficient     0.313 mm-1 
F(000)          960  
Crystal size        0.45 x 0.40 x 0.35 mm  
Θ range for data collection   2.13 to 29.24°  
Limiting indices       -14<=h<=14, -14<=k<=14, -24<=l<=23  
Reflections collected / unique  35131 / 5072 [R(int) = 0.0279]  
Completeness to Θ = 29.24°   99.3 %  
Absorption correction     Numerical  
Max. and min. transmission   0.9497 and 0.8651  
Refinement method      Full-matrix least-squares on F2  
Data / restraints / parameters  5072 / 124 / 337  
Goodness-of-fit on F2     1.050  
Final R indices [I>2sigma(I)]   R1 = 0.0437, wR2 = 0.1189  
R indices (all data)      R1 = 0.0614, wR2 = 0.1254  
Largest diff. peak and hole   0.454 and -0.494 e. Å-3 
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Crystal data and structure refinement for 23a  
 
Identification code      ks1080  
Empirical formula      C11H9F9N2O5  
Formula weight       420.20  
Temperature        200(2) K  
Wavelength        0.71073 Å  
Crystal system, space group   Orthorhombic, Fdd2  
Unit cell dimensions      a = 14.206(3) Å    = 90°  
b = 33.868(7) Å    = 90°  
c = 13.014(3) Å    = 90°  
Volume          6261(2) Å3  
Z            16 
Calculated density      1.783 mg/m3 
Absorption coefficient     0.204 mm-1  
F(000)          3360  
Crystal size        0.50 x 0.47 x 0.33 mm  
Θ range for data collection   2.21 to 27.94°  
Limiting indices       -18<=h<=18, -44<=k<=44, -17<=l<=17  
Reflections collected / unique  26143 / 3749 [R(int) = 0.0307]  
Completeness to Θ = 27.94°   99.7 %  
Absorption correction     None  
Refinement method      Full-matrix least-squares on F2  
Data / restraints / parameters  3749 / 1 / 253  
Goodness-of-fit on F2     0.892  
Final R indices [I>2sigma(I)]   R1 = 0.0285, wR2 = 0.0652  
R indices (all data)      R1 = 0.0396, wR2 = 0.0674  
Absolute structure parameter  0.2(5)  
Largest diff. peak and hole   0.225 and -0.198 e. Å-3 
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Crystal data and structure refinement for 31b  
 
Identification code      ks1145t  
Empirical formula      C18H18O8  
Formula weight       362.32  
Temperature        150(2) K  
Wavelength        0.71073 Å  
Crystal system, space group   Triclinic, P-1  
Unit cell dimensions      a = 8.2989(6) Å    = 86.560(5)°  
b = 10.1312(7) Å    = 83.809(5)°  
c = 10.4773(7) Å    = 70.127(5)°  
Volume          823.36(10) A3  
Z            2 
Calculated density      1.461 mg/m3 
Absorption coefficient     0.116 mm-1  
F(000)          380  
Crystal size        0.50 x 0.30 x 0.25 mm  
Θ range for data collection   1.96 to 27.91°  
Limiting indices       -10<=h<=10, -13<=k<=13, -13<=l<=13  
Reflections collected / unique  13589 / 3926 [R(int) = 0.0249]  
Completeness to Θ = 27.91°   99.7 %  
Absorption correction     None  
Refinement method      Full-matrix least-squares on F2  
Data / restraints / parameters  3926 / 0 / 245  
Goodness-of-fit on F2     1.065  
Final R indices [I>2sigma(I)]   R1 = 0.0365, wR2 = 0.0938  
R indices (all data)      R1 = 0.0497, wR2 = 0.0971  
Largest diff. peak and hole   0.335 and -0.249 e. A-3 
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Crystal data and structure refinement for 31c  
 
Identification code      ks1189  
Empirical formula      C23H20O8  
Formula weight       424.39  
Temperature        150(2) K  
Wavelength        0.71073 Å  
Crystal system, space group   Triclinic, P-1  
Unit cell dimensions      a = 7.9176(4) Å    = 89.052(5)°  
b = 11.1261(6) Å    = 80.895(4)°  
c = 11.5814(7) Å    = 77.206(4)°  
Volume          982.18(9) Å3  
Z            2  
Calculated density      1.435 mg/m3 
Absorption coefficient     0.109 mm-1  
F(000)          444  
Crystal size        0.45 x 0.35 x 0.16 mm  
Θ range for data collection   1.78 to 27.50°  
Limiting indices       -10<=h<=10, -14<=k<=14, -15<=l<=15  
Reflections collected / unique  16353 / 4524 [R(int) = 0.0296]  
Completeness to Θ = 27.50°   100.0 %  
Absorption correction     Numerical  
Max. and min. transmission   0.9731 and 0.8339  
Refinement method      Full-matrix least-squares on F2  
Data / restraints / parameters  4524 / 0 / 289  
Goodness-of-fit on F2     0.850  
Final R indices [I>2sigma(I)]   R1 = 0.0326, wR2 = 0.0741  
R indices (all data)      R1 = 0.0527, wR2 = 0.0773  
Largest diff. peak and hole    0.295 and -0.180 e. Å-3 
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Crystal data and structure refinement for 32  
 
Identification code      ks1140  
Empirical formula      C17H16Cl2O6  
Formula weight       387.20  
Temperature        150(2) K  
Wavelength        0.71073 Å  
Crystal system, space group   Monoclinic, C 2/c  
Unit cell dimensions      a = 27.4384(10) Å    = 90°  
b = 5.6289(2) Å     = 112.241(3)°  
c = 22.7063(8) Å     = 90°  
Volume          3246.0(2) A3  
Z            8 
Calculated density      1.585 mg/m3 
Absorption coefficient     0.433 mm-1  
F(000)          1600  
Crystal size        0.50 x 0.45 x 0.30 mm  
Θ range for data collection   1.60 to 27.93° 
Limiting indices       -36<=h<=36, -7<=k<=7, -29<=l<=29  
Reflections collected / unique  25744 / 3889 [R(int) = 0.0245]  
Completeness to Θ = 27.93°   99.5 %  
Absorption correction     Numerical  
Max. and min. transmission   0.9389 and 0.7898  
Refinement method      Full-matrix least-squares on F2  
Data / restraints / parameters  3889 / 0 / 232  
Goodness-of-fit on F2     1.016  
Final R indices [I>2sigma(I)]   R1 = 0.0264, wR2 = 0.0702  
R indices (all data)      R1 = 0.0339, wR2 = 0.0719  
Largest diff. peak and hole   0.395 and -0.176 e. Å-3 
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Crystal data and structure refinement for 33i  
 
Identification code      ks1189  
Empirical formula      C23H20O8  
Formula weight       424.39  
Temperature        150(2) K  
Wavelength        0.71073 Å  
Crystal system, space group   Triclinic, P-1  
Unit cell dimensions      a = 7.9176(4) Å    = 89.052(5)°  
b = 11.1261(6) Å    = 80.895(4)°  
c = 11.5814(7) Å    = 77.206(4)°  
Volume          982.18(9) Å 3  
Z            2 
Calculated density      1.435 mg/m3 
Absorption coefficient     0.109 mm-1  
F(000)          444  
Crystal size        0.45 x 0.35 x 0.16 mm  
Θ range for data collection   1.78 to 27.50°  
Limiting indices       -10<=h<=10, -14<=k<=14, -15<=l<=15  
Reflections collected / unique  16353 / 4524 [R(int) = 0.0296]  
Completeness to Θ = 27.50°   100.0 %  
Absorption correction     Numerical  
Max. and min. transmission   0.9731 and 0.8339  
Refinement method      Full-matrix least-squares on F2  
Data / restraints / parameters  4524 / 0 / 289  
Goodness-of-fit on F2     0.850  
Final R indices [I>2sigma(I)]   R1 = 0.0326, wR2 = 0.0741  
R indices (all data)      R1 = 0.0527, wR2 = 0.0773  
Largest diff. peak and hole   0.295 and -0.180 e. Å-3 
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Crystal data and structure refinement for 33j  
 
Identification code      ks1245  
Empirical formula      C20H19ClO7  
Formula weight       406.80  
Temperature        150(2) K  
Wavelength        0.71073 Å  
Crystal system, space group   Monoclinic, P2(1)/n  
Unit cell dimensions      a = 9.7224(3) Å    = 90°  
b = 8.1879(2) Å    = 95.519(3)°  
c = 23.1457(8) Å    = 90° 
Volume          1834.00(10) A3  
Z            4 
Calculated density      1.473 mg/m3 
Absorption coefficient     0.250 mm-1  
F(000)          848  
Crystal size        0.30 x 0.25 x 0.22 mm  
Θ range for data collection   1.77 to 27.91°  
Limiting indices       -12<=h<=12, -10<=k<=10, -30<=l<=30  
Reflections collected / unique  30879 / 4380 [R(int) = 0.0336]  
Completeness to Θ = 27.91°   99.9 %  
Absorption correction     Numerical  
Max. and min. transmission   0.9655 and 0.8322  
Refinement method      Full-matrix least-squares on F2  
Data / restraints / parameters  4380 / 0 / 263  
Goodness-of-fit on F2     0.968  
Final R indices [I>2sigma(I)]   R1 = 0.0303, wR2 = 0.0720  
R indices (all data)      R1 = 0.0446, wR2 = 0.0743  
Largest diff. peak and hole   0.272 and -0.373 e. Å-3 
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Crystal data and structure refinement for 33p  
 
Identification code      ks1279  
Empirical formula      C33H45BrO7  
Formula weight       633.60  
Temperature        150(2) K  
Wavelength        0.71073 Å  
Crystal system, space group   Triclinic, P-1  
Unit cell dimensions      a = 9.0595(4) Å    = 73.732(3)° 
b = 11.5721(5) Å    = 84.917(3)°  
c = 15.5179(6) Å    = 87.568(3)°  
Volume          1555.32(11) Å3  
Z            2 
Calculated density      1.353 mg/m3 
Absorption coefficient     1.368 mm-1  
F(000)          668  
Crystal size        0.50 x 0.35 x 0.15 mm  
Θ range for data collection   1.96 to 29.22°  
Limiting indices       -12<=h<=12, -15<=k<=15, -21<=l<=21  
Reflections collected / unique  29997 / 8406 [R(int) = 0.0537]  
Completeness to Θ = 29.22°   99.5 %  
Absorption correction     Numerical  
Max. and min. transmission   0.8415 and 0.5578  
Refinement method      Full-matrix least-squares on F2  
Data / restraints / parameters  8406 / 0 / 381  
Goodness-of-fit on F2     0.874  
Final R indices [I>2sigma(I)]   R1 = 0.0343, wR2 = 0.0633  
R indices (all data)      R1 = 0.0580, wR2 = 0.0669  
Largest diff. peak and hole   0.568 and -0.437 e. A-3 
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Crystal data and structure refinement for 34a  
 
Identification code      ks971  
Empirical formula      C16H13F3O5S  
Formula weight       374.32  
Temperature        200(2) K  
Wavelength        0.71073 Å  
Crystal system, space group   Monoclinic, P2/n  
Unit cell dimensions      a = 11.8379(4) Å    = 90°  
b = 12.0659(3) Å    = 114.905(3)°  
c = 12.0697(4) Å    = 90°  
Volume          1563.66(8) A3  
Z            4 
Calculated density      1.590 mg/m3 
Absorption coefficient     0.266 mm-1  
F(000)          768  
Crystal size        0.5 x 0.5 x 0.2 mm  
Θ range for data collection   1.69 to 29.20°  
Limiting indices       -16<=h<=16, -16<=k<=16, -16<=l<=16  
Reflections collected / unique  29451 / 4224 [R(int) = 0.0226]  
Completeness to Θ = 29.20°   99.3 %  
Absorption correction     Numerical  
Max. and min. transmission   0.9511 and 0.8689  
Refinement method      Full-matrix least-squares on F2  
Data / restraints / parameters  4224 / 0 / 231  
Goodness-of-fit on F2     1.042  
Final R indices [I>2sigma(I)]   R1 = 0.0292, wR2 = 0.0771  
R indices (all data)      R1 = 0.0375, wR2 = 0.0793  
Largest diff. peak and hole   0.374 and -0.216 e. Å-3 
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Ar        Aromatic 
Anal       Elemental Analysis 
ATR       Attenuated Total Reflection 
n-BuLi      n-Butyllithium 
d        Day 
DCM/CH2Cl2    Dichloromethane 
DMF       Dimethylformamide 
DEPT      Distortionless Enhancement by Polarisation Transfer 
DiPA       Diisoproylamin 
ε        Extinction coefficient 
E        Extinction 
EI        Electron Ionization 
ESI       Electrospray Ionization 
Et2O       Diethyl ether 
EU       European Union 
GC       Gas Chromatography 
h        Hour 
HRMS      High Resolution Mass Spectroscopy 
HOMO      Highest Occupied Molecule Orbital 
Hz       Hertz 
IR        Infrared Spectroscopy 
J        Coupling constant 
LDA       Lithium Diisopropylamide 
LUMO      Lowes Unoccupied Molecule Orbital 
λ        Wavelength 
MS       Mass Spectrometry 
Me3SiOTf     Trimethylsilyl trifluoro methanesulfonate 
Me3SiCl      Trimethylsilyl chloride 
mp       Melting Point 
NEt3       Triethylamine 
NMR       Nuclear Magnetic Resonance 
O-H….O      Hydrogen bond 
PABA      para-Aminobenzoic Acid 
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Ph       Phenyl 
p-TsOH / PTSA   para-Toluenesulfonic Acid 
R        Alkyl rest 
RF        Perfuorinated 
Tf2O       Trifluoromethanesulfonic anhydride 
TFA       Trifluoroacetic Acid 
THF       Tetrahydrofurane 
TLC       Thin Layer Chromatography 
UV       Ultraviolet 
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